vglaqkqalqeopaoieayqeivcmshcgersnstmocko length 6 359213 page 359213 

<!DOCTYPE html>

<html id="doc" lang="en" class="page-article">
<head id="Head1">
    <!-- charset must appear in the first 1024 bytes of the document -->
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />

<script>
      var SCM = SCM || {};
      if (SCM.AMA && SCM.AMA.DataLayerAsync) {
        SCM.AMA.DataLayerAsync.push("arrSisAffinity", "", "array");
        SCM.AMA.DataLayerAsync.push("SubStatus", "no", "string");
      }

      var googletag = window.googletag || {};
      googletag.cmd = googletag.cmd || [];

          
          if (typeof Storage !== "undefined")
          {
              var targetingParamStr = localStorage.getItem("bcDFPTargetingParams");
              if (targetingParamStr)
              {
                  var targetingParameters = JSON.parse(targetingParamStr);     // set page-level targeting parameters
                  jQuery.each(targetingParameters, function (index, param) {
                      googletag.cmd.push(function () {
                          window.googletag.pubads().setTargeting(param.key, param.value);
                      });
                  });
              }
          }
          
      if (!googletag.pubads) {
        (function () {
          var gads = document.createElement('script');
          var useSSL = 'https:' == document.location.protocol;
          gads.src = (useSSL ? 'https:' : 'http:') +
            '//securepubads.g.doubleclick.net/tag/js/gpt.js';
              gads.setAttribute("async", "");
              gads.setAttribute("defer", "");
          var node = document.getElementsByTagName('script')[0];
          node.parentNode.insertBefore(gads, node);
          })();

        var App = App || {};
        App.Ads = App.Ads || {};
        App.Ads.adPath = App.Ads.adPath || '/6479/' + 'ama.jama';
        App.Ads.Mappings = App.Ads.Mappings || {};
        App.Ads.slots = App.Ads.slots || [];
        App.Ads.fromGoogle = !('yes' === 'yes');

        App.isCollection = App.isCollection || !!document.getElementsByClassName('pg_collection').length;

        
        googletag.cmd.push(function () {

          googletag.pubads()
            .setTargeting('environment', ['newjama'])
            .setTargeting('site', ['ama.jama'])
            .setTargeting('sect', ['scholarly'])
            .setTargeting('sub', ['no'])
            .setTargeting('device', ['cis5550-crawler'])
            .setTargeting('usaphys', ['no'])
            .setTargeting('memberstat', ['no'])
            .setTargeting('pracset', [''])
            .setTargeting('specialty', ['other'])
            .setTargeting('occupation', [''])
            .setTargeting('useraffinity', [''])
            .setTargeting('direct', ['yes'])
            .setTargeting('bot', ['yes'])
            .setTargeting('datacenter', ['no'])
            .setTargeting('selfMPA', [''])
            .setTargeting('selfSpecialty', ['']);

          if (App.isCollection) {
            googletag.pubads().setTargeting('collection', ['']);
          }

          var testParam = getQueryVariable('test');

          if (testParam) {
            googletag.pubads().setTargeting('test', [testParam]);
          }

          function getQueryVariable(variable) {
            var query = window.location.search.substring(1);
            var vars = query.split('&');
            for (var i = 0; i < vars.length; i++) {
              var pair = vars[i].split('=');
              if (decodeURIComponent(pair[0]) == variable) {
                return decodeURIComponent(pair[1]);
              }
            }
          }

          googletag.pubads().disableInitialLoad();
          googletag.enableServices();
        });
      }
</script>


<meta name="viewport" content="width=device-width, initial-scale=1" /><meta name="format-detection" content="telephone=no" /><link rel="shortcut icon" href="//cdn.jamanetwork.com/UI/app/img/favicons/jama/favicon.ico">
<link rel="icon" type="image/png" href="//cdn.jamanetwork.com/UI/app/img/favicons/jama/favicon-192x192.png" sizes="192x192">
<link rel="apple-touch-icon" sizes="180x180" href="//cdn.jamanetwork.com/UI/app/img/favicons/jama/apple-touch-icon-180x180.png">
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
    
    <link rel="stylesheet" href="//cdn.jamanetwork.com/UI/app/dist/app.min.css?v=638488852237037766">
    
    
    
    
    <link href="//cdn.jsdelivr.net/chartist.js/latest/chartist.min.css" type="text/css" rel="stylesheet" />
    

    <meta property="og:title" content="USPSTF Recommendation: Screening for Prediabetes and Type 2 Diabetes" />
    <meta property="og:type" content="Article" />
    <meta property="og:url" content="https://jamanetwork.com/journals/jama/fullarticle/2783414" />
    <meta property="og:image" content="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938758/jus210018fa_1634939302.09698.png?Expires=2147483647&amp;Signature=QF6Xl~8BfI8TrP3k6AZT-dHUwPl2L40Wmf5jjdh5UTbp6q3Cbe9UTwr0AKiaXbqCy~B5XkfodDbLvfTlc8ec09KotQJOMTsrr-i7qvfY4fRfDztvQm0WgLi3MLPMFqMSt601b6hy5XsV9uXvcTC4bgZf2MZDzzhfGXyMnERpg5YnS-hmDqs6AOgYGW7jzqQDRmUGSiJXgOzuw~RIyl6aytpPBOuNa1jkVqsNBDLc6bQyKK9jl7LM8xVSbSB5uKiASXfmjZ-yExLdLU4ptfnBSkf4W45nE3LPmYcr7fRAjjNOlqYcU980pI8FBZntBbqIznBVhzwuzKpKan5kmWGcrQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" />
    <meta property="og:image" content="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938758/jus210018t1_1634939302.11693.png?Expires=2147483647&amp;Signature=QEU4YRsVNfgM4Saw2t4fLpgyicj5yrkNuxqyC0An1VB3EsF8oG6c3yTBsopeuRNjDl7F9olMTCTkYN1qx1Y8kblA4GsKVSE34vSYu9riBd5hhQnbvZX8cEbEq~uRdVb2jBgcLX3ki0Sakdq3lDAJZZrgSvlirwASjMmJsi9qhHz95sqo8ZDEUs4FMDeWdT32188RrxDgpB4nANWtxwqnTU6D8cimW7Uby4XVu9sIuHUh24nop09sgcrGk8r5kjm3UvzYNshgPK8W4HKx2SeYO8dDHvZXYM5JfQMHOgQYZ2xNvWZHjjT5-xGyZLoqmP3Vih-AtQFNBRTKInYpcZNelQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" />
    <meta property="og:image" content="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938758/jus210018f1_1634939302.12692.png?Expires=2147483647&amp;Signature=fuAafKP4fCUu4vBDgyPNPP~ZV5aww-LLZUzH3f8HuZ-ZdnoYibc-g0D0q16Ouy84vvM1hou9DdZvH9mCJ9bBg8xPPCUgM1ciI-uRVphZfUb7WNZL2NLF4GbhyIGOfab3GHz2R~oxajDaWWinmqk-uquHbdn-hGygtfFoxsuUx1EIJ2vB-oeefVr1KEeNwbbhcmETRXuu6iKYik8JUXxMoL8cBSh-v4rhRK0d6dCD9ICVngyMGgV92Ad~2hIzJmnEsIq~6qt3u8iCLLIDN3XD8gtEhkgTV2SHNiKiexKqdzDmAboapDzTFaFvACqewIqmSlwQtc3n8sePGzkmWSuRUg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" />
    <meta property="og:description" content="This 2021 Recommendation Statement from the US Preventive Services Task Force recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 years who have overweight or obesity and that clinicians should offer or refer patients with prediabetes to effective preventive..." />
        <meta property="fb:pages" content="87087958340" />
        <meta property="fb:pages" content="122228711814384" />
        <meta property="fb:pages" content="1648414928738217" />
        <meta property="fb:pages" content="117506346528" />
        <meta property="fb:pages" content="97538728726" />
        <meta property="fb:pages" content="114116793520" />
        <meta property="fb:pages" content="100679858757" />
        <meta property="fb:pages" content="759822190741773" />
        <meta property="fb:pages" content="100265333750" />
        <meta property="fb:pages" content="234770525256" />
        <meta property="fb:pages" content="98784919862" />
        <meta property="fb:pages" content="120829458202" />
        <meta property="fb:pages" content="124842870398" />
        <meta property="fb:pages" content="110245330325636" />
        <meta name="twitter:card" content="summary_large_image" />
        <meta name="twitter:site" content="@JAMA_current" />
        <meta name="twitter:image" content="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938758/jus210018fa_1634939302.09698.png?Expires=2147483647&amp;Signature=QF6Xl~8BfI8TrP3k6AZT-dHUwPl2L40Wmf5jjdh5UTbp6q3Cbe9UTwr0AKiaXbqCy~B5XkfodDbLvfTlc8ec09KotQJOMTsrr-i7qvfY4fRfDztvQm0WgLi3MLPMFqMSt601b6hy5XsV9uXvcTC4bgZf2MZDzzhfGXyMnERpg5YnS-hmDqs6AOgYGW7jzqQDRmUGSiJXgOzuw~RIyl6aytpPBOuNa1jkVqsNBDLc6bQyKK9jl7LM8xVSbSB5uKiASXfmjZ-yExLdLU4ptfnBSkf4W45nE3LPmYcr7fRAjjNOlqYcU980pI8FBZntBbqIznBVhzwuzKpKan5kmWGcrQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" />




<script type="application/ld+json">
    {
  "@context": "https://schema.org/",
  "@type": "Article",
  "headline": "Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement",
  "author": "US Preventive Services Task Force",
  "url": "https://jamanetwork.com/journals/jama/fullarticle/2783414",
  "datePublished": "2021-08-24",
  "description": "This 2021 Recommendation Statement from the US Preventive Services Task Force recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 years who have overweight or obesity and that clinicians should offer or refer patients with prediabetes to effective preventive interventions (B recommendation).",
  "publisher": {
    "@type": "Organization",
    "name": "JAMA Network",
    "logo": {
      "@type": "ImageObject",
      "url": "//cdn.jamanetwork.com/UI/app/img/favicons/jama/favicon.ico"
    }
  },
  "image": [
    "https://cdn.jamanetwork.com/ama/content_public/journal/jama/938758/jus210018fa_1634939302.09698.png?Expires=2147483647&Signature=QF6Xl~8BfI8TrP3k6AZT-dHUwPl2L40Wmf5jjdh5UTbp6q3Cbe9UTwr0AKiaXbqCy~B5XkfodDbLvfTlc8ec09KotQJOMTsrr-i7qvfY4fRfDztvQm0WgLi3MLPMFqMSt601b6hy5XsV9uXvcTC4bgZf2MZDzzhfGXyMnERpg5YnS-hmDqs6AOgYGW7jzqQDRmUGSiJXgOzuw~RIyl6aytpPBOuNa1jkVqsNBDLc6bQyKK9jl7LM8xVSbSB5uKiASXfmjZ-yExLdLU4ptfnBSkf4W45nE3LPmYcr7fRAjjNOlqYcU980pI8FBZntBbqIznBVhzwuzKpKan5kmWGcrQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
    "https://cdn.jamanetwork.com/ama/content_public/journal/jama/938758/jus210018t1_1634939302.11693.png?Expires=2147483647&Signature=QEU4YRsVNfgM4Saw2t4fLpgyicj5yrkNuxqyC0An1VB3EsF8oG6c3yTBsopeuRNjDl7F9olMTCTkYN1qx1Y8kblA4GsKVSE34vSYu9riBd5hhQnbvZX8cEbEq~uRdVb2jBgcLX3ki0Sakdq3lDAJZZrgSvlirwASjMmJsi9qhHz95sqo8ZDEUs4FMDeWdT32188RrxDgpB4nANWtxwqnTU6D8cimW7Uby4XVu9sIuHUh24nop09sgcrGk8r5kjm3UvzYNshgPK8W4HKx2SeYO8dDHvZXYM5JfQMHOgQYZ2xNvWZHjjT5-xGyZLoqmP3Vih-AtQFNBRTKInYpcZNelQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
    "https://cdn.jamanetwork.com/ama/content_public/journal/jama/938758/jus210018f1_1634939302.12692.png?Expires=2147483647&Signature=fuAafKP4fCUu4vBDgyPNPP~ZV5aww-LLZUzH3f8HuZ-ZdnoYibc-g0D0q16Ouy84vvM1hou9DdZvH9mCJ9bBg8xPPCUgM1ciI-uRVphZfUb7WNZL2NLF4GbhyIGOfab3GHz2R~oxajDaWWinmqk-uquHbdn-hGygtfFoxsuUx1EIJ2vB-oeefVr1KEeNwbbhcmETRXuu6iKYik8JUXxMoL8cBSh-v4rhRK0d6dCD9ICVngyMGgV92Ad~2hIzJmnEsIq~6qt3u8iCLLIDN3XD8gtEhkgTV2SHNiKiexKqdzDmAboapDzTFaFvACqewIqmSlwQtc3n8sePGzkmWSuRUg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA"
  ],
  "articleSection": [
    "Summary of Recommendation",
    "Importance",
    "USPSTF Assessment of Magnitude of Net Benefit",
    "Practice Considerations",
    "Patient Population Under Consideration",
    "Assessment of Risk",
    "Screening Tests",
    "Screening Intervals",
    "Preventive Interventions",
    "Additional Tools and Resources",
    "Other Related USPSTF Recommendations",
    "Update of Previous USPSTF Recommendation",
    "Supporting Evidence",
    "Scope of Review",
    "Benefits of Early Detection and Treatment",
    "Screening for Diabetes",
    "Effect of Interventions for Screen-Detected Type 2 Diabetes or Prediabetes on Health Outcomes",
    "Effect of Interventions for Newly or Recently Diagnosed Type 2 Diabetes on Health Outcomes",
    "Effect of Interventions for Prediabetes on Progression to Diabetes",
    "Harms of Screening and Treatment",
    "Response to Public Comment",
    "Research Needs and Gaps",
    "Recommendations of Others",
    "Article Information"
  ],
  "keyWords": "diabetes mellitus, non-insulin-dependent, screening procedure, prediabetes syndrome, united states preventive services task force, overweight, obesity, diabetes mellitus"
}
</script>
<meta name="citation_author" content="US Preventive Services Task Force" /><meta name="citation_author" content="Karina W. Davidson" /><meta name="citation_author_institution" content="Feinstein Institutes for Medical Research at Northwell Health, Manhasset, New York" /><meta name="citation_author" content="Michael J. Barry" /><meta name="citation_author_institution" content="Harvard Medical School, Boston, Massachusetts" /><meta name="citation_author" content="Carol M. Mangione" /><meta name="citation_author_institution" content="University of California, Los Angeles" /><meta name="citation_author" content="Michael Cabana" /><meta name="citation_author_institution" content="Albert Einstein College of Medicine, New York, New York" /><meta name="citation_author" content="Aaron B. Caughey" /><meta name="citation_author_institution" content="Oregon Health &amp; Science University, Portland" /><meta name="citation_author" content="Esa M. Davis" /><meta name="citation_author_institution" content="University of Pittsburgh, Pittsburgh, Pennsylvania" /><meta name="citation_author" content="Katrina E. Donahue" /><meta name="citation_author_institution" content="University of North Carolina at Chapel Hill" /><meta name="citation_author" content="Chyke A. Doubeni" /><meta name="citation_author_institution" content="Mayo Clinic, Rochester, Minnesota" /><meta name="citation_author" content="Alex H. Krist" /><meta name="citation_author_institution" content="Fairfax Family Practice Residency, Fairfax, Virginia" /><meta name="citation_author_institution" content="Virginia Commonwealth University, Richmond" /><meta name="citation_author" content="Martha Kubik" /><meta name="citation_author_institution" content="George Mason University, Fairfax, Virginia" /><meta name="citation_author" content="Li Li" /><meta name="citation_author_institution" content="University of Virginia, Charlottesville" /><meta name="citation_author" content="Gbenga Ogedegbe" /><meta name="citation_author_institution" content="New York University, New York, New York" /><meta name="citation_author" content="Douglas K. Owens" /><meta name="citation_author_institution" content="Stanford University, Stanford, California" /><meta name="citation_author" content="Lori Pbert" /><meta name="citation_author_institution" content="University of Massachusetts Medical School, Worcester" /><meta name="citation_author" content="Michael Silverstein" /><meta name="citation_author_institution" content="Boston University, Boston, Massachusetts" /><meta name="citation_author" content="James Stevermer" /><meta name="citation_author_institution" content="University of Missouri, Columbia" /><meta name="citation_author" content="Chien-Wen Tseng" /><meta name="citation_author_institution" content="University of Hawaii, Honolulu" /><meta name="citation_author_institution" content="Pacific Health Research and Education Institute, Honolulu, Hawaii" /><meta name="citation_author" content="John B. Wong" /><meta name="citation_author_institution" content="Tufts University School of Medicine, Boston, Massachusetts" /><meta name="citation_title" content="Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement" /><meta name="citation_firstpage" content="736" /><meta name="citation_lastpage" content="743" /><meta name="citation_doi" content="10.1001/jama.2021.12531" /><meta name="citation_keyword" content="diabetes mellitus, type 2" /><meta name="citation_keyword" content="screening" /><meta name="citation_keyword" content="prediabetes" /><meta name="citation_keyword" content="united states preventive services task force" /><meta name="citation_keyword" content="overweight" /><meta name="citation_keyword" content="obesity" /><meta name="citation_keyword" content="diabetes mellitus" /><meta name="citation_abstract" content="&lt;h3&gt;Importance&lt;/h3&gt;&lt;p&gt;An estimated 13% of all US adults (18 years or older) have diabetes, and 34.5% meet criteria for prediabetes. The prevalences of prediabetes and diabetes are higher in older adults. Estimates of the risk of progression from prediabetes to diabetes vary widely, perhaps because of differences in the definition of prediabetes or the heterogeneity of prediabetes. Diabetes is the leading cause of kidney failure and new cases of blindness among adults in the US. It is also associated with increased risks of cardiovascular disease, nonalcoholic fatty liver disease, and nonalcoholic steatohepatitis and was estimated to be the seventh leading cause of death in the US in 2017. Screening asymptomatic adults for prediabetes and type 2 diabetes may allow earlier detection, diagnosis, and treatment, with the ultimate goal of improving health outcomes.&lt;/p&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;p&gt;To update its 2015 recommendation, the USPSTF commissioned a systematic review to evaluate screening for prediabetes and type 2 diabetes in asymptomatic, nonpregnant adults and preventive interventions for those with prediabetes.&lt;/p&gt;&lt;h3&gt;Population&lt;/h3&gt;&lt;p&gt;Nonpregnant adults aged 35 to 70 years seen in primary care settings who have overweight or obesity (defined as a body mass index ≥25 and ≥30, respectively) and no symptoms of diabetes.&lt;/p&gt;&lt;h3&gt;Evidence Assessment&lt;/h3&gt;&lt;p&gt;The USPSTF concludes with moderate certainty that screening for prediabetes and type 2 diabetes and offering or referring patients with prediabetes to effective preventive interventions has a moderate net benefit.&lt;/p&gt;&lt;h3&gt;Conclusions and Recommendation&lt;/h3&gt;&lt;p&gt;The USPSTF recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 years who have overweight or obesity. Clinicians should offer or refer patients with prediabetes to effective preventive interventions. (B recommendation)&lt;/p&gt;" /><meta name="citation_journal_title" content="JAMA" /><meta name="citation_journal_abbrev" content="JAMA" /><meta name="citation_volume" content="326" /><meta name="citation_issue" content="8" /><meta name="citation_publication_date" content="2021/08/24" /><meta name="citation_issn" content="0098-7484" /><meta name="citation_publisher" content="American Medical Association" /><meta name="citation_reference" content="Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020. Accessed June 29, 2021. https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf " /><meta name="citation_reference" content="citation_author=Jonas  D; citation_author=Crotty  K; citation_author=Yun  JD; citation_publisher=Agency for Healthcare Research and Quality, ;  citation_title=Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: An Evidence Review for the U.S. Preventive Services Task Force. Evidence Synthesis No. 207;  citation_year=2021; " /><meta name="citation_reference" content="citation_title=A simple model for predicting two-year risk of diabetes development in individuals with prediabetes.; citation_author=Glauber  H; citation_author=Vollmer  WM; citation_author=Nichols  GA;  citation_journal_title=Perm J;  citation_year=2018;  citation_volume=22;  citation_pages=17-050; " /><meta name="citation_reference" content="citation_title=Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research.; citation_author=Leon  BM; citation_author=Maddox  TM;  citation_journal_title=World J Diabetes;  citation_year=2015;  citation_volume=6;  citation_issue=13;  citation_pages=1246-1258; " /><meta name="citation_reference" content="citation_title=High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels.; citation_author=Portillo-Sanchez  P; citation_author=Bril  F; citation_author=Maximos  M;  citation_journal_title=J Clin Endocrinol Metab;  citation_year=2015;  citation_volume=100;  citation_issue=6;  citation_pages=2231-2238; " /><meta name="citation_reference" content="citation_title=The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis.; citation_author=Younossi  ZM; citation_author=Golabi  P; citation_author=de Avila  L;  citation_journal_title=J Hepatol;  citation_year=2019;  citation_volume=71;  citation_issue=4;  citation_pages=793-801; " /><meta name="citation_reference" content="Procedure Manual. US Preventive Services Task Force. Published May 2021. Accessed June 29, 2021. https://uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual " /><meta name="citation_reference" content="citation_title=Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.; citation_author=Zheng  Y; citation_author=Ley  SH; citation_author=Hu  FB;  citation_journal_title=Nat Rev Endocrinol;  citation_year=2018;  citation_volume=14;  citation_issue=2;  citation_pages=88-98; " /><meta name="citation_reference" content="citation_title=Development and risk factors of type 2 diabetes in a nationwide population of women with polycystic ovary syndrome.; citation_author=Rubin  KH; citation_author=Glintborg  D; citation_author=Nybo  M; citation_author=Abrahamsen  B; citation_author=Andersen  M;  citation_journal_title=J Clin Endocrinol Metab;  citation_year=2017;  citation_volume=102;  citation_issue=10;  citation_pages=3848-3857; " /><meta name="citation_reference" content="citation_title=Social determinants of health and diabetes: a scientific review.; citation_author=Hill-Briggs  F; citation_author=Adler  NE; citation_author=Berkowitz  SA;  citation_journal_title=Diabetes Care;  citation_year=2020;  citation_volume=44;  citation_issue=1;  citation_pages=258-279; " /><meta name="citation_reference" content="Diabetes and Asian Americans. Centers for Disease Control and Prevention. Accessed June 29, 2021. https://www.cdc.gov/diabetes/library/spotlights/diabetes-asian-americans.html " /><meta name="citation_reference" content="citation_title=Trends in the prevalence of type 2 diabetes in Asians versus Whites: results from the United States National Health Interview Survey, 1997-2008.; citation_author=Lee  JW; citation_author=Brancati  FL; citation_author=Yeh  HC;  citation_journal_title=Diabetes Care;  citation_year=2011;  citation_volume=34;  citation_issue=2;  citation_pages=353-357; " /><meta name="citation_reference" content="citation_title=Optimum BMI cut points to screen Asian Americans for type 2 diabetes.; citation_author=Araneta  MR; citation_author=Kanaya  AM; citation_author=Hsu  WC;  citation_journal_title=Diabetes Care;  citation_year=2015;  citation_volume=38;  citation_issue=5;  citation_pages=814-820; " /><meta name="citation_reference" content="citation_title=Classification and diagnosis of diabetes: standards of medical care in diabetes—2020.; citation_author=American Diabetes Association;  citation_journal_title=Diabetes Care;  citation_year=2020;  citation_volume=43;  citation_pages=S14-S31; " /><meta name="citation_reference" content="citation_title=A1C to detect diabetes in healthy adults: when should we recheck?; citation_author=Takahashi  O; citation_author=Farmer  AJ; citation_author=Shimbo  T; citation_author=Fukui  T; citation_author=Glasziou  PP;  citation_journal_title=Diabetes Care;  citation_year=2010;  citation_volume=33;  citation_issue=9;  citation_pages=2016-2017; " /><meta name="citation_reference" content="citation_title=Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis.; citation_author=Kahn  R; citation_author=Alperin  P; citation_author=Eddy  D;  citation_journal_title=Lancet;  citation_year=2010;  citation_volume=375;  citation_issue=9723;  citation_pages=1365-1374; " /><meta name="citation_reference" content="citation_title=Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe).; citation_author=Herman  WH; citation_author=Ye  W; citation_author=Griffin  SJ;  citation_journal_title=Diabetes Care;  citation_year=2015;  citation_volume=38;  citation_issue=8;  citation_pages=1449-1455; " /><meta name="citation_reference" content="citation_title=Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.; citation_author=Diabetes Prevention Program Research Group; citation_author=Knowler  WC; citation_author=Barrett-Connor  E; citation_author=Fowler  SE;  citation_journal_title=N Engl J Med;  citation_year=2002;  citation_volume=346;  citation_issue=6;  citation_pages=393-403; " /><meta name="citation_reference" content="citation_title=Long-term effects of metformin on diabetes prevention: identification of subgroups that benefited most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study.; citation_author=Diabetes Prevention Program Research Group;  citation_journal_title=Diabetes Care;  citation_year=2019;  citation_volume=42;  citation_issue=4;  citation_pages=601-608; " /><meta name="citation_reference" content="citation_title=Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force recommendation statement.; citation_author=US Preventive Services Task Force; citation_author=Curry  SJ; citation_author=Krist  AH; citation_author=Owens  DK;  citation_journal_title=JAMA;  citation_year=2018;  citation_volume=320;  citation_issue=11;  citation_pages=1163-1171; " /><meta name="citation_reference" content="citation_title=Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. Preventive Services Task Force recommendation statement.; citation_author=US Preventive Services Task Force; citation_author=Siu  AL;  citation_journal_title=Ann Intern Med;  citation_year=2015;  citation_volume=163;  citation_issue=11;  citation_pages=861-868; " /><meta name="citation_reference" content="citation_title=Reconsidering the age thresholds for type II diabetes screening in the U.S.; citation_author=Chung  S; citation_author=Azar  KM; citation_author=Baek  M; citation_author=Lauderdale  DS; citation_author=Palaniappan  LP;  citation_journal_title=Am J Prev Med;  citation_year=2014;  citation_volume=47;  citation_issue=4;  citation_pages=375-381; " /><meta name="citation_reference" content="citation_title=Screening for prediabetes and type 2 diabetes: updated evidence report and systematic review for the US Preventive Services Task Force.; citation_author=Jonas  DE; citation_author=Crotty  K; citation_author=Yun  JD;  citation_journal_title=JAMA;  citation_year=2021; " /><meta name="citation_reference" content="citation_title=The ADDITION-Cambridge trial protocol: a cluster-randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients.; citation_author=Echouffo-Tcheugui  JB; citation_author=Simmons  RK; citation_author=Williams  KM;  citation_journal_title=BMC Public Health;  citation_year=2009;  citation_volume=9;  citation_pages=136" /><meta name="citation_reference" content="citation_title=Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial.; citation_author=Simmons  RK; citation_author=Echouffo-Tcheugui  JB; citation_author=Sharp  SJ;  citation_journal_title=Lancet;  citation_year=2012;  citation_volume=380;  citation_issue=9855;  citation_pages=1741-1748; " /><meta name="citation_reference" content="citation_title=Long-term effect of population screening for diabetes on cardiovascular morbidity, self-rated health, and health behavior.; citation_author=Echouffo-Tcheugui  JB; citation_author=Simmons  RK; citation_author=Prevost  AT;  citation_journal_title=Ann Fam Med;  citation_year=2015;  citation_volume=13;  citation_issue=2;  citation_pages=149-157; " /><meta name="citation_reference" content="citation_title=Effect of population screening for type 2 diabetes on mortality: long-term follow-up of the Ely cohort.; citation_author=Simmons  RK; citation_author=Rahman  M; citation_author=Jakes  RW;  citation_journal_title=Diabetologia;  citation_year=2011;  citation_volume=54;  citation_issue=2;  citation_pages=312-319; " /><meta name="citation_reference" content="citation_title=How much does screening bring forward the diagnosis of type 2 diabetes and reduce complications? twelve year follow-up of the Ely cohort.; citation_author=Rahman  M; citation_author=Simmons  RK; citation_author=Hennings  SH; citation_author=Wareham  NJ; citation_author=Griffin  SJ;  citation_journal_title=Diabetologia;  citation_year=2012;  citation_volume=55;  citation_issue=6;  citation_pages=1651-1659; " /><meta name="citation_reference" content="citation_title=Effect of screening for type 2 diabetes on population-level self-rated health outcomes and measures of cardiovascular risk: 13-year follow-up of the Ely cohort.; citation_author=Rahman  M; citation_author=Simmons  RK; citation_author=Hennings  SH; citation_author=Wareham  NJ; citation_author=Griffin  SJ;  citation_journal_title=Diabet Med;  citation_year=2012;  citation_volume=29;  citation_issue=7;  citation_pages=886-892; " /><meta name="citation_reference" content="citation_title=Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial.; citation_author=Griffin  SJ; citation_author=Borch-Johnsen  K; citation_author=Davies  MJ;  citation_journal_title=Lancet;  citation_year=2011;  citation_volume=378;  citation_issue=9786;  citation_pages=156-167; " /><meta name="citation_reference" content="citation_title=Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? findings from the ADDITION-Europe cluster-randomized trial.; citation_author=Simmons  RK; citation_author=Sharp  SJ; citation_author=Sandbæk  A;  citation_journal_title=Diabet Med;  citation_year=2012;  citation_volume=29;  citation_issue=11;  citation_pages=e409-e416; " /><meta name="citation_reference" content="citation_title=A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study.; citation_author=Simmons  RK; citation_author=Borch-Johnsen  K; citation_author=Lauritzen  T;  citation_journal_title=Health Technol Assess;  citation_year=2016;  citation_volume=20;  citation_issue=64;  citation_pages=1-86; " /><meta name="citation_reference" content="citation_title=Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial.; citation_author=Griffin  SJ; citation_author=Rutten  GEHM; citation_author=Khunti  K;  citation_journal_title=Lancet Diabetes Endocrinol;  citation_year=2019;  citation_volume=7;  citation_issue=12;  citation_pages=925-937; " /><meta name="citation_reference" content="citation_title=Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.; citation_author=Li  G; citation_author=Zhang  P; citation_author=Wang  J;  citation_journal_title=Lancet Diabetes Endocrinol;  citation_year=2014;  citation_volume=2;  citation_issue=6;  citation_pages=474-480; " /><meta name="citation_reference" content="citation_title=Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study.; citation_author=Da Qing Diabetes Prevention Study Group; citation_author=Gong  Q; citation_author=Zhang  P; citation_author=Wang  J;  citation_journal_title=Lancet Diabetes Endocrinol;  citation_year=2019;  citation_volume=7;  citation_issue=6;  citation_pages=452-461; " /><meta name="citation_reference" content="citation_title=Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).; citation_author=UK Prospective Diabetes Study (UKPDS) Group;  citation_journal_title=Lancet;  citation_year=1998;  citation_volume=352;  citation_issue=9131;  citation_pages=837-853; " /><meta name="citation_reference" content="citation_title=10-Year follow-up of intensive glucose control in type 2 diabetes.; citation_author=Holman  RR; citation_author=Paul  SK; citation_author=Bethel  MA; citation_author=Matthews  DR; citation_author=Neil  HA;  citation_journal_title=N Engl J Med;  citation_year=2008;  citation_volume=359;  citation_issue=15;  citation_pages=1577-1589; " /><meta name="citation_reference" content="citation_title=Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34).; citation_author=UK Prospective Diabetes Study (UKPDS) Group;  citation_journal_title=Lancet;  citation_year=1998;  citation_volume=352;  citation_issue=9131;  citation_pages=854-865; " /><meta name="citation_reference" content="citation_title=Effectiveness of the Diabetes Education and Self Management for Ongoing and Newly Diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial.; citation_author=Diabetes Education and Self Management for Ongoing and Newly Diagnosed Collaborative; citation_author=Davies  MJ; citation_author=Heller  S; citation_author=Skinner  TC;  citation_journal_title=BMJ;  citation_year=2008;  citation_volume=336;  citation_issue=7642;  citation_pages=491-495; " /><meta name="citation_reference" content="citation_title=Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care.; citation_author=Khunti  K; citation_author=Gray  LJ; citation_author=Skinner  T;  citation_journal_title=BMJ;  citation_year=2012;  citation_volume=344; " /><meta name="citation_reference" content="citation_title=Primary prevention of macroangiopathy in patients with short-duration type 2 diabetes by intensified multifactorial intervention: seven-year follow-up of diabetes complications in Chinese.; citation_author=Yang  Y; citation_author=Yao  JJ; citation_author=Du  JL;  citation_journal_title=Diabetes Care;  citation_year=2013;  citation_volume=36;  citation_issue=4;  citation_pages=978-984; " /><meta name="citation_reference" content="citation_title=PREVENT-DM comparative effectiveness trial of lifestyle intervention and metformin.; citation_author=O’Brien  MJ; citation_author=Perez  A; citation_author=Scanlan  AB;  citation_journal_title=Am J Prev Med;  citation_year=2017;  citation_volume=52;  citation_issue=6;  citation_pages=788-797; " /><meta name="citation_reference" content="citation_title=Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention Program.; citation_author=Diabetes Prevention Program Research Group; citation_author=Ratner  R; citation_author=Goldberg  R; citation_author=Haffner  S;  citation_journal_title=Diabetes Care;  citation_year=2005;  citation_volume=28;  citation_issue=4;  citation_pages=888-894; " /><meta name="citation_reference" content="citation_title=Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety: a randomised controlled trial in British general practice.; citation_author=Park  P; citation_author=Simmons  RK; citation_author=Prevost  AT; citation_author=Griffin  SJ;  citation_journal_title=BMC Public Health;  citation_year=2008;  citation_volume=8;  citation_pages=350" /><meta name="citation_reference" content="citation_title=Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial.; citation_author=Eborall  HC; citation_author=Griffin  SJ; citation_author=Prevost  AT; citation_author=Kinmonth  AL; citation_author=French  DP; citation_author=Sutton  S;  citation_journal_title=BMJ;  citation_year=2007;  citation_volume=335;  citation_issue=7618;  citation_pages=486" /><meta name="citation_reference" content="citation_title=Predictors of anxiety and depression among people attending diabetes screening: a prospective cohort study embedded in the ADDITION (Cambridge) randomized control trial.; citation_author=Paddison  CA; citation_author=Eborall  HC; citation_author=French  DP;  citation_journal_title=Br J Health Psychol;  citation_year=2011;  citation_volume=16;  citation_issue=pt 1;  citation_pages=213-226; " /><meta name="citation_reference" content="Metformin [package insert]. Bristol Myers Squibb. Accessed June 29, 2021. https://packageinserts.bms.com/pi/pi_glucophage.pdf " /><meta name="citation_reference" content="citation_title=Classification and diagnosis of diabetes: standards of medical care in diabetes—2018.; citation_author=American Diabetes Association;  citation_journal_title=Diabetes Care;  citation_year=2018;  citation_volume=41;  citation_pages=S13-S27; " /><meta name="citation_reference" content="citation_title=American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for developing a diabetes mellitus comprehensive care plan—2015.; citation_author=Handelsman  Y; citation_author=Bloomgarden  ZT; citation_author=Grunberger  G;  citation_journal_title=Endocr Pract;  citation_year=2015;  citation_volume=21;  citation_pages=1-87; " /><meta name="citation_fulltext_world_readable" content="" /><meta name="citation_pdf_url" content="https://jamanetwork.com/journals/jama/articlepdf/2783414/jama_davidson_2021_us_210018_1634939301.84191.pdf" />

    
        <title>Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement | Diabetes | JAMA | JAMA Network</title>

    <meta name="description" content="This 2021 Recommendation Statement from the US Preventive Services Task Force recommends screening for prediabetes and type 2 diabetes in adults aged 35">


    <link rel="canonical" href="https://jamanetwork.com/journals/jama/fullarticle/2783414" />









    
    <script src="//cdn.jamanetwork.com/UI/app/dist/head.min.js?v=638488852268208351"></script>
     
     <script src="https://r451.jamanetwork.com/script.js"></script>
        <div class="widget-WidgetLoader widget-instance-AMA_AdTag_HeaderScript">
        
    <meta class="SCM-SharedWidgets-AsyncHeaderAdLoader" data-url="/AMA/AdTag/AMA_AdTag_HeaderScript" data-params="{&quot;parameters&quot;:{&quot;siteName&quot;:&quot;jama&quot;,&quot;siteId&quot;:3,&quot;journalId&quot;:67,&quot;adDisplay&quot;:0,&quot;adSection&quot;:&quot;scholarly&quot;,&quot;adPosition&quot;:&quot;&quot;,&quot;fromGoogle&quot;:false},&quot;dynamicParameters&quot;:{&quot;localParams&quot;:&quot;[REPLACE_WITH_LOCAL]&quot;}}">
 
    </div>
</head>

<body data-sitename="jama" class="pg_article " data-thm="jama">
    
    <script>
        
        var App = App || {};
        App.suppressAds = App.suppressAds || !!document.getElementsByClassName('suppress-ads').length;
        App.suppressGtm = App.suppressGtm || !!document.getElementsByClassName('suppress-gtm').length;
    </script>

    

        <div id="ad-interstitial" class="ad-interstitial">
            <script>
      googletag.cmd.push(function() {
        if (App.suppressAds) { return; }
        App.Ads.slots[13] = googletag.defineOutOfPageSlot(App.Ads.adPath + '/scholarly', 'ad-interstitial')
          .setTargeting('pos', ['interstitial'])
          .addService(googletag.pubads());
        googletag.display('ad-interstitial');
        googletag.pubads().refresh([App.Ads.slots[13]], {changeCorrelator: false});
      });
            </script>
        </div>




    
    <a class="accessible js-skip-to-navigation" href="#skip-to-navigation">[Skip to Navigation]</a>

    <!-- Google Tag Manager --><noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-WNKSNP" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-WNKSNP');</script><!-- End Google Tag Manager -->

    
    
    <span class="hide tagmanagervalue" data-attribute="productName" data-value="JAMA" data-type="string"></span>
    <form method="post" action="./2783414" id="webform" class="m0">
<input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="to2URXfEcyPf+XIkA6YOCHo49IvEz6635ANRut8vvo2dXi5EW26DB1Pvw3PBRW4HBqcTOvUoZ6XEgpvDCkUdAa8GGBM=" />

<input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="2173C2F0" />
<input type="hidden" name="__EVENTVALIDATION" id="__EVENTVALIDATION" value="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" />
        
        <input id="hdnSiteID" type="hidden" value="3" />
        <input id="hdnDomain" type="hidden" value=".jamanetwork.com" />

        
        

        
        

    <section class="master-header">
        


<script type='text/javascript'>
    var App = App || {};
    App.LoginUserInfo = {
        isInstLoggedIn: [0],
        currentSessionId: 'rgv3uwi3tesln42d1mkwp5z3'
    };
</script>



<input name="ctl00$ctl00$BodyContent$Header$hfGlobalSearchSiteURL" type="hidden" id="hfGlobalSearchSiteURL" value="https://jamanetwork.com/" />

<input name="ctl00$ctl00$BodyContent$Header$hfAppIsPaidUser" type="hidden" id="hfAppIsPaidUser" value="false" />
<input name="ctl00$ctl00$BodyContent$Header$hfAppIsMember" type="hidden" id="hfAppIsMember" value="false" />
<input name="ctl00$ctl00$BodyContent$Header$hfAppSubscribedTo" type="hidden" id="hfAppSubscribedTo" />
<input name="ctl00$ctl00$BodyContent$Header$hfAppIsIndividual" type="hidden" id="hfAppIsIndividual" value="false" />
<input name="ctl00$ctl00$BodyContent$Header$hfAppHasAccess" type="hidden" id="hfAppHasAccess" value="false" />
<input name="ctl00$ctl00$BodyContent$Header$hfAppIsReferredFromGoogle" type="hidden" id="hfAppIsReferredFromGoogle" value="False" />
<input name="ctl00$ctl00$BodyContent$Header$hfSolrAutoSuggestMinimumCharactersLength" type="hidden" id="hfSolrAutoSuggestMinimumCharactersLength" value="2" />
<input name="ctl00$ctl00$BodyContent$Header$hfSolrJournalName" type="hidden" id="hfSolrJournalName" value="JAMA" />
<input name="ctl00$ctl00$BodyContent$Header$hfSolrJournalID" type="hidden" id="hfSolrJournalID" value="J67" />
<input name="ctl00$ctl00$BodyContent$Header$hfAppIsLucy" type="hidden" id="hfAppIsLucy" value="false" />


<div class="header-wrap">
    <header class="header">
            <div class="widget-GdprCookieBanner widget-instance-GdprCookieBanner">
        <div class="gdpr-cookie-wrapper js-gdpr-banner">
	<div class="gdpr-cookie-body">
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our <a href="https://jamanetwork.com/pages/privacy-policy#cookies">Cookie Policy</a>&nbsp;<span class="pipe">|</span>&nbsp;<a href="javascript:;" class="js-gdpr-cookie-acceptLink at-acceptgdpr">Continue</a>	</div>
            <input id="hdnDomain" type="hidden" value=".jamanetwork.com" />

    <input id="hdnDomainGdpr" type="hidden" value=".jamanetwork.com" />
    <input id="hdnClientIdGdpr" type="hidden" value="3" />

</div> 
    </div>

        <div class="network-bar">
            <a class="jama-network" href="/" title="JAMA Network Home">
                <img alt="JAMA Network Home" class="title-image" width="443" height="52" src="//cdn.jamanetwork.com/UI/app/svg/Jama_Network_Logo.svg">
            </a>
            
        </div>

        <a class="nav-toggler" href="#nav">
            <div class="nav-toggler-indicator">
                <span class="indicator-stroke"></span>
                <span class="indicator-stroke"></span>
                <span class="indicator-stroke"></span>
                <span class="indicator-stroke"></span>
            </div>
            <div class="nav-toggler-site">
                <span id="BodyContent_Header_siteFullNamenav" class="nav-toggler-microsite"><span class='network'>JAMA</span></span>
            </div>
        </a>
        <nav id="nav" class="nav hide" >
            <div class="nav-journal-level sb-nav-journal-level">
                <a href="https://jamanetwork.com/journals/jama" id="BodyContent_Header_rptMicrositeHeaders_aItemResourceList_0" class="home">Home</a><a href="https://jamanetwork.com/journals/jama/newonline" id="BodyContent_Header_rptMicrositeHeaders_aItemResourceList_1" class="new-online">New Online</a><a href="https://jamanetwork.com/journals/jama/currentissue" id="BodyContent_Header_rptMicrositeHeaders_aItemResourceList_2" class="current-issue">Current Issue</a><a href="https://jamanetwork.com/journals/jama/pages/for-authors" id="BodyContent_Header_rptMicrositeHeaders_aItemResourceList_3" class="for-authors">For Authors</a>
            </div>
            <div class="nav-journals">
                    <div class="widget-SelfServeContent widget-instance-HamburgerPublicationMenu">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="HamburgerPublicationMenu" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<style type="text/css">
    .nav-journals {margin-bottom: 1em;}
    .nav-heading {color: #B9B9B9;border-bottom: 1px solid #242424;border-top: 1px solid #242424;font-size: 1.15em;font-weight: 400;margin: 0;padding: .7em .75em;text-transform: uppercase;}
    a.no-bullet:before {content:none !important;}
    .nav-heading {font-size: 1.15em;margin-bottom:0;padding-left: 38px;}
    .nav-journals a.theme-jama {background-color: #242424;border-bottom: 1px solid #fff;border-top: 1px solid #fff;color: #fff;font-size: 1.15em;margin-bottom: 8px;padding: 11px 0 9px 37px;}
    .nav-journals a.theme-jama::before {background: unset;content: "\e91b";display: none;font-family: ama_icons !important;font-size: 1.25em;line-height: 1;}
    .nav-journals a.theme-jama-network-open {border-bottom:0;}
    .nav .widget-instance-HamburgerPublicationMenu a {padding-left: 36px;}
    .fake-ribbon {border-left: 8px solid #BE1E32;}
    .fake-ribbon a:before {content:none;}
    .nav .widget-instance-HamburgerPublicationMenu .fake-ribbon a {padding-left:30px;}
</style>
<h2 class="nav-heading">Journals</h2>
<a href="/journals/jama" class="theme-jama">JAMA</a>
<a href="/journals/jamanetworkopen" class="theme-jama-network-open">JAMA Network Open</a>
<a href="/journals/jamacardiology" class="theme-jama-cardiology">JAMA Cardiology</a>
<a href="/journals/jamadermatology" class="theme-jama-dermatology">JAMA Dermatology</a>
<a href="/journals/jama-health-forum" class="theme-jama-health-forum">JAMA Health Forum</a>
<a href="/journals/jamainternalmedicine" class="theme-jama-internal-medicine">JAMA Internal Medicine</a>
<a href="/journals/jamaneurology" class="theme-jama-neurology">JAMA Neurology</a>
<a href="/journals/jamaoncology" class="theme-jama-oncology">JAMA Oncology</a>
<a href="/journals/jamaophthalmology" class="theme-jama-ophthalmology">JAMA Ophthalmology </a>
<a href="/journals/jamaotolaryngology" class="theme-jama-otolaryngology-head-neck-surgery">JAMA Otolaryngology–Head &amp; Neck Surgery</a>
<a href="/journals/jamapediatrics" class="theme-jama-pediatrics">JAMA Pediatrics</a>
<a href="/journals/jamapsychiatry" class="theme-jama-psychiatry">JAMA Psychiatry</a>
<a href="/journals/jamasurgery" class="theme-jama-surgery">JAMA Surgery</a>
<a href="/journals/archneurpsyc" class="theme-archives-of-neurology-psychiatry-1919-1959-">Archives of Neurology &amp; Psychiatry (1919-1959)</a>
<h2 class="nav-heading">Podcasts</h2>
<a href="/journals/jama/pages/jama-clinical-reviews">Clinical Reviews</a>
<a href="/journals/jama/pages/jama-editors-summary">Editors' Summary</a>
<a href="/journals/jama/pages/jama-medical-news">Medical News</a>
<a href="/journals/jama/pages/jama-author-interviews">Author Interviews</a>
<a href="/pages/audio" class="no-bullet">More</a>


</div>

 
    </div>
    
            </div>
            <div class="nav-network-other">
                <a href="https://edhub.ama-assn.org/jn-learning" id="BodyContent_Header_rptOtherResources_aItemResourceList_0" class="is-b link-jn-learning-cme" target="_blank">JN Learning / CME</a><a href="https://store.jamanetwork.com/index.aspx?productcode=64" id="BodyContent_Header_rptOtherResources_aItemResourceList_1" class="is-b link-subscribe" target="_blank">Subscribe</a><a href="https://careers.jamanetwork.com/" id="BodyContent_Header_rptOtherResources_aItemResourceList_2" class="is-b link-jobs" target="_blank">Jobs</a><a href="https://jamanetwork.com/pages/resources-for-librarians" id="BodyContent_Header_rptOtherResources_aItemResourceList_3" class="is-b link-institutions-librarians">Institutions / Librarians</a><a href="https://jamanetwork.com/pages/reprints-and-permissions" id="BodyContent_Header_rptOtherResources_aItemResourceList_4" class="is-b link-reprints-permissions" rel="nofollow">Reprints &amp; Permissions</a>
            </div>
            <div class="white text-xxs">
                <div class="p05 ml4 mr3 mb1 mt10 flex hamburger-menu-legal">
                    <a href="/pages/conditions-of-use" class="p0" rel="nofollow">Terms of Use</a>
                    <span class="pl1 pr1">| </span>
                    <a href="/pages/privacy-policy" class="p0" rel="nofollow">Privacy Policy</a>
                    <span class="pl1 pr1">| </span>
                    <a href="/pages/accessibility-statement" class="p0" rel="nofollow">Accessibility Statement</a>
                </div>
                <div class="ta-c">
                    <span class="pb1">2024 American Medical Association. All Rights Reserved</span>
                </div>
            </div>
        </nav>

        

        
        <a class="toolbar-search-trigger is-b" data-mobile-tog-target=".site-search"></a>

        
        <div id="site-search" role="search" class="site-search">
            <div class="site-search-bar">
                
                <div role="search">
                    <select name="ctl00$ctl00$BodyContent$Header$ddlForSearch" id="BodyContent_Header_ddlForSearch" Name="dropDownList" class="cs-select cs-skin-border" title="Search Site Selector" role="options" aria-labelledby="searchLabel">
	<option value="J*">Search All</option>
	<option value="3">JAMA</option>
	<option value="214">JAMA Network Open</option>
	<option value="192">JAMA Cardiology</option>
	<option value="12">JAMA Dermatology</option>
	<option value="261">JAMA Forum Archive</option>
	<option value="193">JAMA Health Forum</option>
	<option value="15">JAMA Internal Medicine</option>
	<option value="16">JAMA Neurology</option>
	<option value="159">JAMA Oncology</option>
	<option value="17">JAMA Ophthalmology</option>
	<option value="18">JAMA Otolaryngology–Head &amp; Neck Surgery</option>
	<option value="19">JAMA Pediatrics</option>
	<option value="14">JAMA Psychiatry</option>
	<option value="20">JAMA Surgery</option>
	<option value="23">Archives of Neurology &amp; Psychiatry</option>

</select>
                </div>
                
                <div class="search-input-container">
                    <input type="search" name="textbox" autocomplete="off" role="textbox" id="search-term" aria-labelledby="searchLabel" class="search-term at-microsite-search-term" placeholder="Enter Search Term" maxlength="255" title="Enter Search Term">
                  
                    <ul id="umbrellaSiteAutoCompleteResults" class="term-list hidden"></ul>
                    
                    <label style="display:none" for="umbrellaSiteSearchInputHint" id="searchLabel">Input Search Term</label>
                      <input class="searchTerm search-input" name="textbox" role="textbox" type="text" id="umbrellaSiteSearchInputHint" aria-labelledby="searchLabel" title="Input Search Term" autocomplete="off">
                </div>
                <!-- /.search-input-container -->
                
                <a name="button" role="button" class="search-button is-b" alt="search button" href="javascript:;"></a>
            </div>
        </div>
        
        <div id="BodyContent_Header_GlobalSignIn_auth" class="auth">
            <a class="auth--trigger is-b is-a" href="javascript:;">
                <span id="BodyContent_Header_GlobalSignIn_spnUserFullName" class="user-full-name">Sign In</span>
            </a>

            <div class="auth--dropdown js-signIn-dropdown">
                
                <div class="auth--option auth--ind">
                    
                    <div id="BodyContent_Header_GlobalSignIn_divUserFullName" class="auth--ind-user"></div>                    
                    
                    <div id="BodyContent_Header_GlobalSignIn_divIndSignIn" class="auth--ind-auth">
                        <div class="auth--title">Individual Sign In</div>
                        <a href="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2783414" id="BodyContent_Header_GlobalSignIn_oauthSignInLink" rel="nofollow" class="auth--ind-sign-in">Sign in</a><a href="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2783414" id="BodyContent_Header_GlobalSignIn_oauthSignUpLink" rel="nofollow" class="auth--ind-create">Create an Account</a>
                    </div>
                </div>

                
                <div id="BodyContent_Header_GlobalSignIn_divInstSignIn" class="auth--option auth--inst">

                    
                    
                    <div class="auth--inst-auth">
                        <div class="auth--title">Access through your institution</div>
                        <a href="/signinshibboleth?returnUrl=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2783414" id="BodyContent_Header_GlobalSignIn_institutionSignIn" rel="nofollow" class="auth--shib">Sign In</a>
                    </div>
                    </div>
 
                                               
                <div id="BodyContent_Header_GlobalSignIn_divPurchaseOptions" class="auth--option auth--purchase">
                    <div class="auth--title">Purchase Options:</div>
                    
                    <a id="BodyContent_Header_GlobalSignIn_lnkSubscribeJournal" class="auth--subscribe" rel="nofollow" href="https://store.jamanetwork.com/index.aspx?productcode=64">Subscribe to the JAMA journal</a>
                </div>

                
                

                
            </div>
        </div>




    </header>
</div>


<div class="editors-choice-header">
</div>

<div id="BodyContent_Header_divAds" class="header-ad-wrap sb-background-primary-dark">
        <div class="leader-ad desktop-only">
            
                <div class="widget-WidgetLoader widget-instance-AMA_AdTag_LeaderboardAd">
        
    <div class="SCM-SharedWidgets-AsyncAdLoader" data-url="/AMA/AdTag/AMA_AdTag_LeaderboardAd" data-params="{&quot;parameters&quot;:{&quot;siteName&quot;:&quot;jama&quot;,&quot;siteId&quot;:3,&quot;journalId&quot;:67,&quot;adDisplay&quot;:1,&quot;adSection&quot;:&quot;scholarly&quot;,&quot;adPosition&quot;:&quot;atf&quot;,&quot;fromGoogle&quot;:false},&quot;dynamicParameters&quot;:{&quot;localParams&quot;:&quot;[REPLACE_WITH_LOCAL]&quot;}}"></div>
 
    </div>

        </div>
    </div>

<!-- /.header-ad-wrap -->


    </section>


    <section class="master-main">
        
    <div class="social-share hide" data-share-journal="JAMA_current" data-share-title="USPSTF Recommendation: Screening for Prediabetes and Type 2 Diabetes"></div>

        <div class="widget-UserContentAccessWrite widget-instance-AMA_LocalStorage_Article">
        <div class="SCM-SharedWidgets-LocalStorage-UserContentAccessWrite" data-values='{"id":"2783414","type":"Article","date":"5/5/2024 9:16:23 AM"}'></div>
 
    </div>
    <div class="widget-ArticleToggleView widget-instance-AMA_ArticleToggleView">
        
    <div class="widget-ArticleFullView widget-instance-AMA_ArticleFullView">
        
<script>
    (function () {
        var bodyElem = document.querySelector('body');
        var className = 'split-screen';

        if (bodyElem.classList) {
            bodyElem.classList.add(className);
        } else {
            el.className += ' ' + className;
        }
    })();
</script>


<div id="resources-panel" class="resources-panel">
                <span class="hide tagmanagervalue" data-attribute="template" data-value="splitscreen" data-type="string"></span>


    <div class="tab-nav">
        <a class="tab-nav-trigger tab-nav-full-text tablet-down" href="#full-text-tab">
            <i class="icon-full_text"><span class="sr-t">full text icon</span></i>
            <div class="tab-nav-tab-name">Full Text</div>
        </a>
        <a class="tab-nav-trigger tab-nav-contents target-tab-active" href="#contents-tab">
            <i class="icon-contents"><span class="sr-t">contents icon</span></i>
            <div class="tab-nav-tab-name">Contents</div>
        </a>
        <a class="tab-nav-trigger tab-nav-figure-table" href="#figure-table-tab">
            <i class="icon-figures"><span class="sr-t">figure icon</span></i>
            <div class="tab-nav-tab-name">Figures / <br> Tables</div>
        </a>
        <a class="tab-nav-trigger tab-nav-multimedia" href="#multimedia-tab">
            <i class="icon-multimedia"><span class="sr-t">multimedia icon</span></i>
            <div class="tab-nav-tab-name">Multimedia</div>
        </a>
        <a class="tab-nav-trigger tab-nav-supplemental" href="#supplemental-tab">
            <i class="icon-attach"><span class="sr-t">attach icon</span></i>
            <div class="tab-nav-tab-name">Supplemental <br> Content</div>
        </a>
        <a class="tab-nav-trigger tab-nav-references" href="#references-tab">
            <i class="icon-references"><span class="sr-t">references icon</span></i>
            <div class="tab-nav-tab-name">References</div>
        </a>
        <a class="tab-nav-trigger tab-nav-related" href="#related-tab">
            <i class="icon-related"><span class="sr-t">related icon</span></i>
            <div class="tab-nav-tab-name">Related</div>
        </a>
        <a class="tab-nav-trigger tab-nav-comments" href="#comments-tab">
            <i class="icon-user-comments"><span class="sr-t">comments icon</span></i>
            <div class="tab-nav-tab-name">Comments</div>
        </a>
    </div>



    <div class="resource-tabs">
        <div id="contents-tab" class="resource-tab js-resource-tab contents-tab tab-active">
            <div class="contents-tab-contents">
            <a id="pdf-link" class="toolbar-tool toolbar-pdf al-link pdfaccess" data-article-id="2783414" data-article-url="/journals/jama/articlepdf/2783414/jama_davidson_2021_us_210018_1634939301.84191.pdf" data-ajax-url="/Content/CheckPdfAccess"><span class="toolbar-pdf-text"><span class="toolbar-link-text-extra">Download </span><span class="toolbar-link-text">PDF</span></span>
            </a>
    <div class="widget-ArticleJumpLinks widget-instance-AMA_ArticleJumpLinks_Widget">
            <a href="#top" class="section-jump-link contents-tab-jump-link top-of-article" data-tab-toggle=".tab-nav-full-text">Top of Article</a>
    <ul class="section-jump-links bullet ml2 pl1">
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#248067107" data-tab-toggle=".tab-nav-full-text">Abstract</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#248067113" data-tab-toggle=".tab-nav-full-text">Summary of Recommendation</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#248067116" data-tab-toggle=".tab-nav-full-text">Importance</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#248067119" data-tab-toggle=".tab-nav-full-text">USPSTF Assessment of Magnitude of Net Benefit</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#248067124" data-tab-toggle=".tab-nav-full-text">Practice Considerations</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#248067144" data-tab-toggle=".tab-nav-full-text">Update of Previous USPSTF Recommendation</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#248067146" data-tab-toggle=".tab-nav-full-text">Supporting Evidence</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#248067169" data-tab-toggle=".tab-nav-full-text">Research Needs and Gaps</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#248067172" data-tab-toggle=".tab-nav-full-text">Recommendations of Others</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#248067174" data-tab-toggle=".tab-nav-full-text">Article Information</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="#248067175" data-tab-toggle=".tab-nav-full-text">References</a></li>
    </ul>
 
    </div>
    <div class="widget-SelfServeContent widget-instance-AMA_Contents_Tab_SelfServe">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="v2_article_content_tab" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="bc_right_rail_article_promo"><!-- Content Goes Here --></div>


</div>

 
    </div>

            </div>
            <div class="contents-tab-ad">
                <div id="split-screen-contab"></div>
            </div>
        </div>

        
        <div id="figure-table-tab" class="resource-tab js-resource-tab figure-table-tab need-jobs-ad">
    <div class="widget-ArticleFiguresAndTables widget-instance-AMA_Article_Figures_Tab">
        <div class="figure-table-wrapper inline thm-bd-top"><div class="inline-graphic"><a id="jus210018fa" class="figure-anchor"> </a><a href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938758/jus210018fa_1634939302.09698.png?Expires=1717900123&amp;Signature=aHR-OwCDQoSuGGPUuOgmVdHtNLH8r9AVAv3zLvve0hfMrW4DFWIGFDGb4Dqo-r2uHIx6cwkpKCbyIyHI0duETb4O7-aHPRGzLO6~7Wda48XrCfrtHcArr0Zk68EMRA~pQf5wc73-JR6z4x2FeTcu6VwibwNvWFEZ7z1nqP7N7NXi2eOLiecifwXV06FxX2BeB~iUwDJpvGOVGWSXdIH~vZQmxU5ofiWJHUHSitLF3lMUXblz2kNtxB5OWgm91ylPF4irN~RJnpzkXvSpJ7OYyCk8RT2Zuf0xPru2AKpaWSe3wgqHJOgXZ27FGHf3gnhpmApXCrSsSW0In6F7hcl11g__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" path-from-xml="jus210018fa" rel="nofollow"><img data-original="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938758/m_jus210018fa_1634939302.09698.png?Expires=1717900123&amp;Signature=lV~qe2DO~z7bCyxXBhsBfrBh6TWGb-UxGSJ7pyegXKD3ffj-Y9TLQ2ZC1ZYqfnVJ6ByETXWcrrQpeaClv8NwgVCGW-HVc2QQJbaQs6TCS2yw-rTmvjbsscs8AbR8tiwCF-p2ajgocNttxf9WVAldG4PFchLl8vMmyEpl6iCji6HdwXgI4rYH0-RZEf3EP7Mycj7M25PnwddiuybEPWBc1~WMTR-Mxa61-m6Vy9eIUeRWs8hQO0ZMVC2dJSuKjmEdMOVTEumYvs9LzyoVQ-r0ZOcfTh66SiK2XWr4uA3gWd5Lsfpur~JoZTNGYeNRTfYh28vSVx-eTK4lS0Z59ZMhBQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" alt="See the Figure for a more detailed summary of the recommendations for clinicians. USPSTF indicates US Preventive Services Task Force." class="content-img lazy" path-from-xml="jus210018fa" /></a></div><div class="figure-caption clip-last-child"><p class="para">See the Figure for a more detailed summary of the recommendations for clinicians. USPSTF indicates US Preventive Services Task Force.</p></div></div><div class="figure-table-wrapper thm-bd-top"><div class="figure-label">Figure.  Clinician Summary: Screening for Prediabetes and Type 2 Diabetes</div><a id="jus210018f1" class="figure-table-anchor"> </a><div class="figure-table-links right"><a class="view-large figure-table-link is-b desktop-only" path-from-xml="jus210018f1" href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938758/jus210018f1_1634939302.12692.png?Expires=1717900123&amp;Signature=AlDOxc7jDQvyaojUy~E1QWrZM4FjXRkX8DUgAeNSIbls-obL4KPoicvAYTLCHSAxx0IFP~c3~F5axY2b39-dTdhbcz-pPBYiKEI4mpLJlqct1Z3DeoIxpuNJd94SxrvHEeNYYzMkyn15aRPcRjkdcqYI14BzTmT68JOVYGvXqghK4lsn6z6V97hRaVT8lRCVI73~jlxwURV6Ob4Nz7T5kgsOc2xnBAfDCfikqXdZX46x9rs0sDUBr72UH4UvA80fFkBXluQy3I-QhB3wlJxOqlkVQOdVeDXC-2AdzNzJZFcL~16Gi3dxYHCR9mz9x2IYU~FPPjt9UNFTrcQ676AIPg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" rel="nofollow"><span class="view-large-text">View Large</span></a><a class="download-ppt figure-table-link is-b stats-download-figure-table" path-from-xml="jus210018f1" href="/downloadimage.aspx?image=https://cdn.jamanetwork.com/ama/content_public/journal/jama/938758/jus210018f1_1634939302.12692.png?Expires=1717900123&Signature=AlDOxc7jDQvyaojUy~E1QWrZM4FjXRkX8DUgAeNSIbls-obL4KPoicvAYTLCHSAxx0IFP~c3~F5axY2b39-dTdhbcz-pPBYiKEI4mpLJlqct1Z3DeoIxpuNJd94SxrvHEeNYYzMkyn15aRPcRjkdcqYI14BzTmT68JOVYGvXqghK4lsn6z6V97hRaVT8lRCVI73~jlxwURV6Ob4Nz7T5kgsOc2xnBAfDCfikqXdZX46x9rs0sDUBr72UH4UvA80fFkBXluQy3I-QhB3wlJxOqlkVQOdVeDXC-2AdzNzJZFcL~16Gi3dxYHCR9mz9x2IYU~FPPjt9UNFTrcQ676AIPg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=248067123&ar=2783414&imagename=&siteId=3" rel="nofollow"><span class="download-ppt-text">Download</span></a><a class="figure-table-twitter figure-table-link figure-table-social addthis_button_twitter is-b" rel="nofollow"><span class="share-text"> </span></a><a class="figure-table-facebook figure-table-link figure-table-social addthis_button_facebook is-b" rel="nofollow"><span class="share-text"> </span></a></div><div class="figure-table cf cb"><div class="figure-table-image"><a href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938758/jus210018f1_1634939302.12692.png?Expires=1717900123&amp;Signature=AlDOxc7jDQvyaojUy~E1QWrZM4FjXRkX8DUgAeNSIbls-obL4KPoicvAYTLCHSAxx0IFP~c3~F5axY2b39-dTdhbcz-pPBYiKEI4mpLJlqct1Z3DeoIxpuNJd94SxrvHEeNYYzMkyn15aRPcRjkdcqYI14BzTmT68JOVYGvXqghK4lsn6z6V97hRaVT8lRCVI73~jlxwURV6Ob4Nz7T5kgsOc2xnBAfDCfikqXdZX46x9rs0sDUBr72UH4UvA80fFkBXluQy3I-QhB3wlJxOqlkVQOdVeDXC-2AdzNzJZFcL~16Gi3dxYHCR9mz9x2IYU~FPPjt9UNFTrcQ676AIPg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" path-from-xml="jus210018f1" rel="nofollow"><img data-original="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938758/m_jus210018f1_1634939302.12692.png?Expires=1717900123&amp;Signature=OTkpiPZw8o6nzsjYudS1epyCO3JG8ouOGZdHMLImJ3VnAdB-nk42nqEiFiNAew4C8SfQleMDQ2IYFFFW6QaWxWW3O97oMwpnfJ976as39kmvFfy8w8fVkpHsuOvCTTz2J6kbWMYkPf22SOKm-4NlNk938j929vk50U-6m6-Z1vzkZiPSS12fbt9BrZ36atp8cYXMTI-4rwRL3z6HdW9411sdwViaOCUJzi79TkC36h~z6tRH-NdfjTCeOHj1ZvvhZL8KNuSQipXxPYzwpLTDHseF4I9uxWJVl4N6SLdU7GxPR~zaXnttNpXKyTC6iX4XujJEVFo3KMjftGhEHLvbsg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" alt="Clinician Summary: Screening for Prediabetes and Type 2 Diabetes" class="content-img lazy" path-from-xml="jus210018f1" /></a></div></div><div class="figure-caption clip-last-child"><p class="para">BMI indicates body mass index (calculated as weight in kilograms divided by height in meters squared); HbA<sub>1c</sub>, hemoglobin A<sub>1c</sub>; USPSTF, US Preventive Services Task Force.</p></div></div> 
    </div>
    <div class="widget-ArticleFiguresAndTables widget-instance-AMA_Article_Tables_Tab">
        <div class="figure-table-wrapper thm-bd-top"><div class="table-label">Table.  Summary of USPSTF Rationale</div><a class="figure-table-anchor" id="jus210018t1"> </a><div class="figure-table-links right"><a class="view-large figure-table-link is-b desktop-only" path-from-xml="jus210018t1" href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938758/jus210018t1_1634939302.11693.png?Expires=1717900123&amp;Signature=HENfOct9hThTLl1pud9rGvvA-4jPKHPYu3-43hEjh3rBZ5COOOukZqJwjUDDXaP~kghraL4-pVZ0jMb4ADbBGvioxXZPPAoj3347lRsmd3HyV~9bpbxBxHO8n1vxfQcjSNKEpQYvOYUen2tb6SuZUcjfjMYXnIP24Gois1MqbHxLBGfyNa4msfe46xZcC-gezm0Qw4g~WqEn0Y~T5fWUaUH8uy5ITO-bAlmovjkS58IvteFd~llc0VK864rWtV94NPnKBKkHAxXUEf97g67GXwvS9Sl6gL~ZsiPZSCajUqr9fmvwRnpcGtPXxykAhOsNwTabG11ovuEky7EyMKVopg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" rel="nofollow"><span class="view-large-text">View Large</span></a><a class="download-ppt figure-table-link is-b stats-download-figure-table" path-from-xml="jus210018t1" href="/downloadimage.aspx?image=https://cdn.jamanetwork.com/ama/content_public/journal/jama/938758/jus210018t1_1634939302.11693.png?Expires=1717900123&Signature=HENfOct9hThTLl1pud9rGvvA-4jPKHPYu3-43hEjh3rBZ5COOOukZqJwjUDDXaP~kghraL4-pVZ0jMb4ADbBGvioxXZPPAoj3347lRsmd3HyV~9bpbxBxHO8n1vxfQcjSNKEpQYvOYUen2tb6SuZUcjfjMYXnIP24Gois1MqbHxLBGfyNa4msfe46xZcC-gezm0Qw4g~WqEn0Y~T5fWUaUH8uy5ITO-bAlmovjkS58IvteFd~llc0VK864rWtV94NPnKBKkHAxXUEf97g67GXwvS9Sl6gL~ZsiPZSCajUqr9fmvwRnpcGtPXxykAhOsNwTabG11ovuEky7EyMKVopg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=248067121&ar=2783414&imagename=&siteId=3" rel="nofollow"><span class="download-ppt-text">Download</span></a><a class="figure-table-twitter figure-table-link figure-table-social addthis_button_twitter is-b" rel="nofollow"><span class="share-text"> </span></a><a class="figure-table-facebook figure-table-link figure-table-social addthis_button_facebook is-b" rel="nofollow"><span class="share-text"> </span></a></div><div class="figure-table cf cb"><div class="figure-table-image"><a href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938758/jus210018t1_1634939302.11693.png?Expires=1717900123&amp;Signature=HENfOct9hThTLl1pud9rGvvA-4jPKHPYu3-43hEjh3rBZ5COOOukZqJwjUDDXaP~kghraL4-pVZ0jMb4ADbBGvioxXZPPAoj3347lRsmd3HyV~9bpbxBxHO8n1vxfQcjSNKEpQYvOYUen2tb6SuZUcjfjMYXnIP24Gois1MqbHxLBGfyNa4msfe46xZcC-gezm0Qw4g~WqEn0Y~T5fWUaUH8uy5ITO-bAlmovjkS58IvteFd~llc0VK864rWtV94NPnKBKkHAxXUEf97g67GXwvS9Sl6gL~ZsiPZSCajUqr9fmvwRnpcGtPXxykAhOsNwTabG11ovuEky7EyMKVopg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" path-from-xml="jus210018t1" rel="nofollow"><img data-original="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938758/m_jus210018t1_1634939302.11693.png?Expires=1717900123&amp;Signature=uzfDbiFdTZqW~Cq1d~k8FjzBwiHqw9sesBjx0cnLDqbgI~IWTZGYoykVJW0uUfu6IKwkhBSVFKGJfYaiTEZKKBye8dbSfjPPFWvA8nSPpcHXjvGQ62Umytpt1GnXvYX1-YWv2sh3UPuWtKfzk9YN4Y-GQBgaBZPshnoHVM3a~wmcPzfy~najRyYEbi6AG~tm8ToWAeda0BbmbXlWVCfk4z90UKZ4kqKqYetXT7e44KbfZyIPk1Zw-2yjThcV0n9lFBr-s8kkLfwBmLbDLzYxdB6TBpb57S0ZTRAOV7GDt9Pc1Q2Pw1OMUQir0aMOqx266-xv6fPINiILQIiXYMagUA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" alt="Summary of USPSTF Rationale" class="content-img lazy" path-from-xml="jus210018t1" /></a></div></div><div class="table-caption"></div></div> 
    </div>

        </div>

        
        <div id="multimedia-tab" class="resource-tab js-resource-tab multimedia-tab need-jobs-ad">
    <div class="widget-MultimediaInfo widget-instance-AMAv2MultimediaContent">
        

        <div class="multimedia-item audio ">
                    <div class="audio-group-duration">
            Audio Clinical Review (16:25)
        </div>
        <div><a class="audio-title" href="https://jamanetwork.com/learning/audio-player/18635651" target="_blank" aria-label="Linked Multimedia Button"><div class="multimedia-title">USPSTF Recommendation: Screening for Prediabetes and Type 2 Diabetes</div></a></div>
        <a class="audio-anchor"></a>
    <div class="widget-AudioPlayer widget-instance-AMA_MultimediaInfo_PlatformAudioPlayer_MultimediaInfo">
            <div class="audio-element-wrapper js-audio-element-wrapper">
                            <a class="audio-anchor" id="101001jama202111787"></a>
        <div id="audio-player-wrapper" class="js-audio-player-wrapper audio-player-wrapper">
            <audio class="js-audio-player" id="audio-player" type="audio/mp3" preload="none" src=https://traffic.libsyn.com/jamaclinicalreviews/uspstf_recommendation__screening_for_prediabetes_and_type_2_diabetes.mp3></audio>
            <div class="display-elements">
                <div class="audio-controls">
                    <a id="backward" class="js-btn-backward audio-back" href="javascript:;" aria-label="Back Button">
                        <img src="//cdn.jamanetwork.com/UI/app/svg/multimedia/Backward_15.svg" alt="Backward 15" />
                    </a>
                    <a id="play-pause" class="js-play-pause audio-play" href="javascript:;" aria-label="Play Button">
                        <img src="//cdn.jamanetwork.com/UI/app/svg/multimedia/Play.svg" alt="Play" />
                    </a>
                    <a id="play-pause" class="js-play-pause audio-pause" href="javascript:;" aria-label="Pause Button">
                        <img src="//cdn.jamanetwork.com/UI/app/svg/multimedia/Pause.svg" alt="Pause" />
                    </a>
                    <a id="forward" class="js-btn-forward audio-forward" href="javascript:;" aria-label="Fast Forward Button">
                        <img src="//cdn.jamanetwork.com/UI/app/svg/multimedia/Forward_15.svg" alt="Forward 15" />
                    </a>
                </div>
                <div class="js-progressBar-clickable progressBar-clickable">
                    <div class="js-progressBar progressBar">
                        <div class="js-loading-animation">
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                        </div>
                        <div class="js-timeBar timeBar thm-bg-col sb-background-pc" tabindex="0" aria-label="Progress Bar"></div>
                    </div>
                </div>
                <div class="audio-speed">
                    <a id="speed-1x" class="js-btn-speed" play-speed=1 href="javascript:;" aria-label="Speed Control Button">1x</a>
                </div>
                <div class="audio-time">
                    <span id="time" class="js-time js-timeAudioCurrent">0:00</span>
                    <span> / </span>
                    <span class="js-initialTime">0:00</span>
                    <span class="js-duration hide"></span>
                </div>
            </div>
        </div>
            <div class="linked-content-urls-wrapper">
                            <span><a class="thm-col sb-pc linked-content" target="_blank" href="https://jamanetwork.com/journals/jama/pages/jama-clinical-reviews" aria-label="Subscribe To Podcast Button">Subscribe to Podcast</a></span>

            </div>
        
    </div>
 
    </div>

        </div>
        <div class="video-border-top  thm-bg-col sb-background-pc"></div>
        <div class="multimedia-item brightcove extrinsic-video">
            <div class="multimedia-content-wrap">
                <a class="learning-link td-n" href="https://jamanetwork.com/learning/video-player/18668918" target="_blank">
                    <div class="multimedia-content">
<div class="multimedia-title"><div class='video-group'>Video</div> Screening for Prediabetes</div>                    </div>
                </a>
            </div>
            <a class="video-anchor"></a>
            <div class="brightcove-video relative" style="height: 0; padding-bottom: 56.25%;">
                <video data-video-id="6287188987001"
                       data-account="864352215001"
                       data-player="ByudjMUZ"
                       data-embed="default"
                       class="video-js"
                       controls style="width: 100%; height: 100%; position: absolute; top: 0px; bottom: 0px; right: 0px; left: 0px;"></video>
            </div>
                <div class="multimedia-caption-wrap">
                    <div class="multimedia-caption-container">
                        <div class="video-caption"><Content><p specific-use="short-description">In August 2021 JAMA published the US Preventive Services Task Force’s updated Recommendation Statement on Screening for Prediabetes and Type 2 Diabetes. The updated guidance differs from the 2015 recommendation in that the age to begin screening is lowered from 40 to 35, and it uses the term “prediabetes” to identify individuals who are at high risk for developing diabetes.           This...</p></Content></div>
                    </div>
                </div>
        </div>
        <script src="//players.brightcove.net/864352215001/ByudjMUZ_default/index.min.js"></script>

            <span class="hide tagmanagervalue" data-attribute="arrRelatedAudio" data-value="10.1001/jama.2021.11787" data-type="array"></span>
            <span class="hide tagmanagervalue" data-attribute="arrRelatedVideo" data-value="10.1001/jama.2021.24012" data-type="array"></span>





 
    </div>

        </div>

        
        <div id="supplemental-tab" class="resource-tab js-resource-tab supplemental-tab need-jobs-ad">
    <div class="widget-ArticleDataSupplements widget-instance-AMA_Data_Supplements_Tab">
            <div class="supplement">
        <a id="note-JUS210018-1" href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/938758/jus210018supp1_prod_1634939301.87695.pdf?Expires=1717900123&amp;Signature=B97hSlBu4Sur1PWwck39v-qoewr2k7e-is1bskAxgdtK-9TT-d1ygXQXrfY7m8FaS~JskUU90Weo~we3DQZePLYsXoPSHvBry0b1uGC1WimKN6D6qf8OjLny2ocT~98kcpbvY8pBVgGfPPrwkqIgImxIJY-FRt0Bn5X410EwSFEaWviV2LlMe2Y9Np57MGQKmJPswaaHNhskY2Uh79-ByY93e89KN1C8BXcIE76CpvMwfgw48L2dHAMnJJ7a~OuJiyfQyqCYSLbX3hhaVTIDbhdywt6UFASul1gdBXrF7tisqpYoFBG88BY1y4fhmb7e567L0vm~h1BizNKwro0jXw__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" class="supplement-link supplement-download stats-supplement-download" rel=&quot;nofollow&quot;>
            <div class="pdf supplement-type"></div>
                <div class="supplement-title"><span class="title-label">Supplement.</span><p class="para">US Preventive Services Task Force (USPSTF) Grades and Levels of Evidence</p></div>
        </a>        
    </div>

 
    </div>

        </div>

        
        <div id="references-tab" class="resource-tab js-resource-tab references-tab need-jobs-ad">
            <div class="references-wrap">
    <div class="widget-SectionDisplay widget-instance-AMA_References_Tab">
        
<div class="references"><div class="reference"><a class="reference-number" id="jus210018r1">1.</a><div class="reference-content">Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020. Accessed June 29, 2021. <a href="https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf">https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf</a></div></div><div class="reference"><a class="reference-number" id="jus210018r2">2.</a><div class="reference-content">Jonas
         D﻿, Crotty
         K﻿, Yun
         JD﻿, 
     et al. <i xmlns:helper="urn:XsltStringHelper"> Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: An Evidence Review for the U.S. Preventive Services Task Force. Evidence Synthesis No. 207</i>.  Agency for Healthcare Research and Quality; 2021. AHRQ publication 21-05276-EF-1.</div></div><div class="reference"><a class="reference-number" id="jus210018r3">3.</a><div class="reference-content">Glauber
         H﻿, Vollmer
         WM﻿, Nichols
         GA﻿.  A simple model for predicting two-year risk of diabetes development in individuals with prediabetes. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Perm J</i>. 2018;22:17-050.<a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/29309270" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=A%20simple%20model%20for%20predicting%20two-year%20risk%20of%20diabetes%20development%20in%20individuals%20with%20prediabetes.&amp;author=H%20Glauber&amp;author=WM%20Vollmer&amp;author=GA%20Nichols&amp;publication_year=2018&amp;journal=Perm%20J&amp;volume=22&amp;pages=17-050" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jus210018r4">4.</a><div class="reference-content">Leon
         BM﻿, Maddox
         TM﻿.  Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. ﻿ <i xmlns:helper="urn:XsltStringHelper"> World J Diabetes</i>. 2015;6(13):1246-1258. doi:<a href="http://dx.doi.org/10.4239/wjd.v6.i13.1246">10.4239/wjd.v6.i13.1246</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/26468341" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Diabetes%20and%20cardiovascular%20disease%3A%20epidemiology%2C%20biological%20mechanisms%2C%20treatment%20recommendations%20and%20future%20research.&amp;author=BM%20Leon&amp;author=TM%20Maddox&amp;publication_year=2015&amp;journal=World%20J%20Diabetes&amp;volume=6&amp;pages=1246-1258" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.4239/wjd.v6.i13.1246" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.4239/wjd.v6.i13.1246" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r5">5.</a><div class="reference-content">Portillo-Sanchez
         P﻿, Bril
         F﻿, Maximos
         M﻿, 
     et al.  High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels. ﻿ <i xmlns:helper="urn:XsltStringHelper"> J Clin Endocrinol Metab</i>. 2015;100(6):2231-2238. doi:<a href="http://dx.doi.org/10.1210/jc.2015-1966">10.1210/jc.2015-1966</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/25885947" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=High%20prevalence%20of%20nonalcoholic%20fatty%20liver%20disease%20in%20patients%20with%20type%202%20diabetes%20mellitus%20and%20normal%20plasma%20aminotransferase%20levels.&amp;author=P%20Portillo-Sanchez&amp;author=F%20Bril&amp;author=M%20Maximos&amp;publication_year=2015&amp;journal=J%20Clin%20Endocrinol%20Metab&amp;volume=100&amp;pages=2231-2238" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1210/jc.2015-1966" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1210/jc.2015-1966" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r6">6.</a><div class="reference-content">Younossi
         ZM﻿, Golabi
         P﻿, de Avila
         L﻿, 
     et al.  The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. ﻿ <i xmlns:helper="urn:XsltStringHelper"> J Hepatol</i>. 2019;71(4):793-801. doi:<a href="http://dx.doi.org/10.1016/j.jhep.2019.06.021">10.1016/j.jhep.2019.06.021</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/31279902" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=The%20global%20epidemiology%20of%20NAFLD%20and%20NASH%20in%20patients%20with%20type%202%20diabetes%3A%20a%20systematic%20review%20and%20meta-analysis.&amp;author=ZM%20Younossi&amp;author=P%20Golabi&amp;author=L%20de Avila&amp;publication_year=2019&amp;journal=J%20Hepatol&amp;volume=71&amp;pages=793-801" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/j.jhep.2019.06.021" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/j.jhep.2019.06.021" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r7">7.</a><div class="reference-content">Procedure Manual. US Preventive Services Task Force. Published May 2021. Accessed June 29, 2021. <a href="https://uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual">https://uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual</a></div></div><div class="reference"><a class="reference-number" id="jus210018r8">8.</a><div class="reference-content">Zheng
         Y﻿, Ley
         SH﻿, Hu
         FB﻿.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Nat Rev Endocrinol</i>. 2018;14(2):88-98. doi:<a href="http://dx.doi.org/10.1038/nrendo.2017.151">10.1038/nrendo.2017.151</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/29219149" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Global%20aetiology%20and%20epidemiology%20of%20type%202%20diabetes%20mellitus%20and%20its%20complications.&amp;author=Y%20Zheng&amp;author=SH%20Ley&amp;author=FB%20Hu&amp;publication_year=2018&amp;journal=Nat%20Rev%20Endocrinol&amp;volume=14&amp;pages=88-98" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1038/nrendo.2017.151" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1038/nrendo.2017.151" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r9">9.</a><div class="reference-content">Rubin
         KH﻿, Glintborg
         D﻿, Nybo
         M﻿, Abrahamsen
         B﻿, Andersen
         M﻿.  Development and risk factors of type 2 diabetes in a nationwide population of women with polycystic ovary syndrome. ﻿ <i xmlns:helper="urn:XsltStringHelper"> J Clin Endocrinol Metab</i>. 2017;102(10):3848-3857. doi:<a href="http://dx.doi.org/10.1210/jc.2017-01354">10.1210/jc.2017-01354</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/28938447" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Development%20and%20risk%20factors%20of%20type%202%20diabetes%20in%20a%20nationwide%20population%20of%20women%20with%20polycystic%20ovary%20syndrome.&amp;author=KH%20Rubin&amp;author=D%20Glintborg&amp;author=M%20Nybo&amp;author=B%20Abrahamsen&amp;author=M%20Andersen&amp;publication_year=2017&amp;journal=J%20Clin%20Endocrinol%20Metab&amp;volume=102&amp;pages=3848-3857" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1210/jc.2017-01354" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1210/jc.2017-01354" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r10">10.</a><div class="reference-content">Hill-Briggs
         F﻿, Adler
         NE﻿, Berkowitz
         SA﻿, 
     et al.  Social determinants of health and diabetes: a scientific review. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetes Care</i>. 2020;44(1):258-279. doi:<a href="http://dx.doi.org/10.2337/dci20-0053">10.2337/dci20-0053</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/33139407" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Social%20determinants%20of%20health%20and%20diabetes%3A%20a%20scientific%20review.&amp;author=F%20Hill-Briggs&amp;author=NE%20Adler&amp;author=SA%20Berkowitz&amp;publication_year=2020&amp;journal=Diabetes%20Care&amp;volume=44&amp;pages=258-279" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.2337/dci20-0053" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.2337/dci20-0053" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r11">11.</a><div class="reference-content">Diabetes and Asian Americans. Centers for Disease Control and Prevention. Accessed June 29, 2021. <a href="https://www.cdc.gov/diabetes/library/spotlights/diabetes-asian-americans.html">https://www.cdc.gov/diabetes/library/spotlights/diabetes-asian-americans.html</a></div></div><div class="reference"><a class="reference-number" id="jus210018r12">12.</a><div class="reference-content">Lee
         JW﻿, Brancati
         FL﻿, Yeh
         HC﻿.  Trends in the prevalence of type 2 diabetes in Asians versus Whites: results from the United States National Health Interview Survey, 1997-2008. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetes Care</i>. 2011;34(2):353-357. doi:<a href="http://dx.doi.org/10.2337/dc10-0746">10.2337/dc10-0746</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/21216863" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Trends%20in%20the%20prevalence%20of%20type%202%20diabetes%20in%20Asians%20versus%20Whites%3A%20results%20from%20the%20United%20States%20National%20Health%20Interview%20Survey%2C%201997-2008.&amp;author=JW%20Lee&amp;author=FL%20Brancati&amp;author=HC%20Yeh&amp;publication_year=2011&amp;journal=Diabetes%20Care&amp;volume=34&amp;pages=353-357" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.2337/dc10-0746" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.2337/dc10-0746" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r13">13.</a><div class="reference-content">Araneta
         MR﻿, Kanaya
         AM﻿, Hsu
         WC﻿, 
     et al.  Optimum BMI cut points to screen Asian Americans for type 2 diabetes. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetes Care</i>. 2015;38(5):814-820. doi:<a href="http://dx.doi.org/10.2337/dc14-2071">10.2337/dc14-2071</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/25665815" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Optimum%20BMI%20cut%20points%20to%20screen%20Asian%20Americans%20for%20type%202%20diabetes.&amp;author=MR%20Araneta&amp;author=AM%20Kanaya&amp;author=WC%20Hsu&amp;publication_year=2015&amp;journal=Diabetes%20Care&amp;volume=38&amp;pages=814-820" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.2337/dc14-2071" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.2337/dc14-2071" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r14">14.</a><div class="reference-content">American Diabetes Association.  Classification and diagnosis of diabetes: standards of medical care in diabetes—2020. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetes Care</i>. 2020;43(suppl 1):S14-S31. doi:<a href="http://dx.doi.org/10.2337/dc20-S002">10.2337/dc20-S002</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/31862745" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Classification%20and%20diagnosis%20of%20diabetes%3A%20standards%20of%20medical%20care%20in%20diabetes%E2%80%942020.&amp;publication_year=2020&amp;journal=Diabetes%20Care&amp;volume=43&amp;pages=S14-S31" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.2337/dc20-S002" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.2337/dc20-S002" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r15">15.</a><div class="reference-content">Takahashi
         O﻿, Farmer
         AJ﻿, Shimbo
         T﻿, Fukui
         T﻿, Glasziou
         PP﻿.  A1C to detect diabetes in healthy adults: when should we recheck? ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetes Care</i>. 2010;33(9):2016-2017. doi:<a href="http://dx.doi.org/10.2337/dc10-0588">10.2337/dc10-0588</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/20566678" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=A1C%20to%20detect%20diabetes%20in%20healthy%20adults%3A%20when%20should%20we%20recheck%3F&amp;author=O%20Takahashi&amp;author=AJ%20Farmer&amp;author=T%20Shimbo&amp;author=T%20Fukui&amp;author=PP%20Glasziou&amp;publication_year=2010&amp;journal=Diabetes%20Care&amp;volume=33&amp;pages=2016-2017" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.2337/dc10-0588" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.2337/dc10-0588" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r16">16.</a><div class="reference-content">Kahn
         R﻿, Alperin
         P﻿, Eddy
         D﻿, 
     et al.  Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet</i>. 2010;375(9723):1365-1374. doi:<a href="http://dx.doi.org/10.1016/S0140-6736(09)62162-0">10.1016/S0140-6736(09)62162-0</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/20356621" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Age%20at%20initiation%20and%20frequency%20of%20screening%20to%20detect%20type%202%20diabetes%3A%20a%20cost-effectiveness%20analysis.&amp;author=R%20Kahn&amp;author=P%20Alperin&amp;author=D%20Eddy&amp;publication_year=2010&amp;journal=Lancet&amp;volume=375&amp;pages=1365-1374" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S0140-6736(09)62162-0" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S0140-6736(09)62162-0" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r17">17.</a><div class="reference-content">Herman
         WH﻿, Ye
         W﻿, Griffin
         SJ﻿, 
     et al.  Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe). ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetes Care</i>. 2015;38(8):1449-1455. doi:<a href="http://dx.doi.org/10.2337/dc14-2459">10.2337/dc14-2459</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/25986661" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Early%20detection%20and%20treatment%20of%20type%202%20diabetes%20reduce%20cardiovascular%20morbidity%20and%20mortality%3A%20a%20simulation%20of%20the%20results%20of%20the%20Anglo-Danish-Dutch%20Study%20of%20Intensive%20Treatment%20in%20People%20With%20Screen-Detected%20Diabetes%20in%20Primary%20Care%20%28ADDITION-Europe%29.&amp;author=WH%20Herman&amp;author=W%20Ye&amp;author=SJ%20Griffin&amp;publication_year=2015&amp;journal=Diabetes%20Care&amp;volume=38&amp;pages=1449-1455" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.2337/dc14-2459" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.2337/dc14-2459" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r18">18.</a><div class="reference-content">Knowler
         WC﻿, Barrett-Connor
         E﻿, Fowler
         SE﻿, 
     et al; Diabetes Prevention Program Research Group.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. ﻿ <i xmlns:helper="urn:XsltStringHelper"> N Engl J Med</i>. 2002;346(6):393-403. doi:<a href="http://dx.doi.org/10.1056/NEJMoa012512">10.1056/NEJMoa012512</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/11832527" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Reduction%20in%20the%20incidence%20of%20type%202%20diabetes%20with%20lifestyle%20intervention%20or%20metformin.&amp;author=WC%20Knowler&amp;author=E%20Barrett-Connor&amp;author=SE%20Fowler&amp;publication_year=2002&amp;journal=N%20Engl%20J%20Med&amp;volume=346&amp;pages=393-403" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jus210018r19">19.</a><div class="reference-content">Diabetes Prevention Program Research Group.  Long-term effects of metformin on diabetes prevention: identification of subgroups that benefited most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetes Care</i>. 2019;42(4):601-608. doi:<a href="http://dx.doi.org/10.2337/dc18-1970">10.2337/dc18-1970</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/30877090" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Long-term%20effects%20of%20metformin%20on%20diabetes%20prevention%3A%20identification%20of%20subgroups%20that%20benefited%20most%20in%20the%20Diabetes%20Prevention%20Program%20and%20Diabetes%20Prevention%20Program%20Outcomes%20Study.&amp;publication_year=2019&amp;journal=Diabetes%20Care&amp;volume=42&amp;pages=601-608" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.2337/dc18-1970" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.2337/dc18-1970" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r20">20.</a><div class="reference-content">Curry
         SJ﻿, Krist
         AH﻿, Owens
         DK﻿, 
     et al; US Preventive Services Task Force.  Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force recommendation statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2018;320(11):1163-1171. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2018.13022">10.1001/jama.2018.13022</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/30326502" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Behavioral%20weight%20loss%20interventions%20to%20prevent%20obesity-related%20morbidity%20and%20mortality%20in%20adults%3A%20US%20Preventive%20Services%20Task%20Force%20recommendation%20statement.&amp;author=SJ%20Curry&amp;author=AH%20Krist&amp;author=DK%20Owens&amp;publication_year=2018&amp;journal=JAMA&amp;volume=320&amp;pages=1163-1171" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jus210018r21">21.</a><div class="reference-content">Siu
         AL﻿; US Preventive Services Task Force.  Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Ann Intern Med</i>. 2015;163(11):861-868. doi:<a href="http://dx.doi.org/10.7326/M15-2345">10.7326/M15-2345</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/26501513" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Screening%20for%20abnormal%20blood%20glucose%20and%20type%202%20diabetes%20mellitus%3A%20U.S.%20Preventive%20Services%20Task%20Force%20recommendation%20statement.&amp;author=AL%20Siu&amp;publication_year=2015&amp;journal=Ann%20Intern%20Med&amp;volume=163&amp;pages=861-868" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.7326/M15-2345" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.7326/M15-2345" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r22">22.</a><div class="reference-content">Chung
         S﻿, Azar
         KM﻿, Baek
         M﻿, Lauderdale
         DS﻿, Palaniappan
         LP﻿.  Reconsidering the age thresholds for type II diabetes screening in the U.S. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Am J Prev Med</i>. 2014;47(4):375-381. doi:<a href="http://dx.doi.org/10.1016/j.amepre.2014.05.012">10.1016/j.amepre.2014.05.012</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/25131213" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Reconsidering%20the%20age%20thresholds%20for%20type%20II%20diabetes%20screening%20in%20the%20U.S.&amp;author=S%20Chung&amp;author=KM%20Azar&amp;author=M%20Baek&amp;author=DS%20Lauderdale&amp;author=LP%20Palaniappan&amp;publication_year=2014&amp;journal=Am%20J%20Prev%20Med&amp;volume=47&amp;pages=375-381" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/j.amepre.2014.05.012" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/j.amepre.2014.05.012" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r23">23.</a><div class="reference-content">Jonas
         DE﻿, Crotty
         K﻿, Yun
         JD﻿, 
     et al.  Screening for prediabetes and type 2 diabetes: updated evidence report and systematic review for the US Preventive Services Task Force. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. Published August 24, 2021. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2021.10403">10.1001/jama.2021.10403</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Screening%20for%20prediabetes%20and%20type%202%20diabetes%3A%20updated%20evidence%20report%20and%20systematic%20review%20for%20the%20US%20Preventive%20Services%20Task%20Force.&amp;author=DE%20Jonas&amp;author=K%20Crotty&amp;author=JD%20Yun&amp;publication_year=2021&amp;journal=JAMA&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jus210018r24">24.</a><div class="reference-content">Echouffo-Tcheugui
         JB﻿, Simmons
         RK﻿, Williams
         KM﻿, 
     et al.  The ADDITION-Cambridge trial protocol: a cluster-randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients. ﻿ <i xmlns:helper="urn:XsltStringHelper"> BMC Public Health</i>. 2009;9:136. doi:<a href="http://dx.doi.org/10.1186/1471-2458-9-136">10.1186/1471-2458-9-136</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/19435491" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=The%20ADDITION-Cambridge%20trial%20protocol%3A%20a%20cluster-randomised%20controlled%20trial%20of%20screening%20for%20type%202%20diabetes%20and%20intensive%20treatment%20for%20screen-detected%20patients.&amp;author=JB%20Echouffo-Tcheugui&amp;author=RK%20Simmons&amp;author=KM%20Williams&amp;publication_year=2009&amp;journal=BMC%20Public%20Health&amp;volume=9&amp;pages=136" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1186/1471-2458-9-136" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1186/1471-2458-9-136" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r25">25.</a><div class="reference-content">Simmons
         RK﻿, Echouffo-Tcheugui
         JB﻿, Sharp
         SJ﻿, 
     et al.  Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet</i>. 2012;380(9855):1741-1748. doi:<a href="http://dx.doi.org/10.1016/S0140-6736(12)61422-6">10.1016/S0140-6736(12)61422-6</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/23040422" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Screening%20for%20type%202%20diabetes%20and%20population%20mortality%20over%2010%20years%20%28ADDITION-Cambridge%29%3A%20a%20cluster-randomised%20controlled%20trial.&amp;author=RK%20Simmons&amp;author=JB%20Echouffo-Tcheugui&amp;author=SJ%20Sharp&amp;publication_year=2012&amp;journal=Lancet&amp;volume=380&amp;pages=1741-1748" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S0140-6736(12)61422-6" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S0140-6736(12)61422-6" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r26">26.</a><div class="reference-content">Echouffo-Tcheugui
         JB﻿, Simmons
         RK﻿, Prevost
         AT﻿, 
     et al.  Long-term effect of population screening for diabetes on cardiovascular morbidity, self-rated health, and health behavior. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Ann Fam Med</i>. 2015;13(2):149-157. doi:<a href="http://dx.doi.org/10.1370/afm.1737">10.1370/afm.1737</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/25755036" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Long-term%20effect%20of%20population%20screening%20for%20diabetes%20on%20cardiovascular%20morbidity%2C%20self-rated%20health%2C%20and%20health%20behavior.&amp;author=JB%20Echouffo-Tcheugui&amp;author=RK%20Simmons&amp;author=AT%20Prevost&amp;publication_year=2015&amp;journal=Ann%20Fam%20Med&amp;volume=13&amp;pages=149-157" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1370/afm.1737" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1370/afm.1737" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r27">27.</a><div class="reference-content">Simmons
         RK﻿, Rahman
         M﻿, Jakes
         RW﻿, 
     et al.  Effect of population screening for type 2 diabetes on mortality: long-term follow-up of the Ely cohort. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetologia</i>. 2011;54(2):312-319. doi:<a href="http://dx.doi.org/10.1007/s00125-010-1949-8">10.1007/s00125-010-1949-8</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/20978739" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Effect%20of%20population%20screening%20for%20type%202%20diabetes%20on%20mortality%3A%20long-term%20follow-up%20of%20the%20Ely%20cohort.&amp;author=RK%20Simmons&amp;author=M%20Rahman&amp;author=RW%20Jakes&amp;publication_year=2011&amp;journal=Diabetologia&amp;volume=54&amp;pages=312-319" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1007/s00125-010-1949-8" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1007/s00125-010-1949-8" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r28">28.</a><div class="reference-content">Rahman
         M﻿, Simmons
         RK﻿, Hennings
         SH﻿, Wareham
         NJ﻿, Griffin
         SJ﻿.  How much does screening bring forward the diagnosis of type 2 diabetes and reduce complications? twelve year follow-up of the Ely cohort. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetologia</i>. 2012;55(6):1651-1659. doi:<a href="http://dx.doi.org/10.1007/s00125-011-2441-9">10.1007/s00125-011-2441-9</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/22237689" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=How%20much%20does%20screening%20bring%20forward%20the%20diagnosis%20of%20type%202%20diabetes%20and%20reduce%20complications%3F%20twelve%20year%20follow-up%20of%20the%20Ely%20cohort.&amp;author=M%20Rahman&amp;author=RK%20Simmons&amp;author=SH%20Hennings&amp;author=NJ%20Wareham&amp;author=SJ%20Griffin&amp;publication_year=2012&amp;journal=Diabetologia&amp;volume=55&amp;pages=1651-1659" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1007/s00125-011-2441-9" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1007/s00125-011-2441-9" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r29">29.</a><div class="reference-content">Rahman
         M﻿, Simmons
         RK﻿, Hennings
         SH﻿, Wareham
         NJ﻿, Griffin
         SJ﻿.  Effect of screening for type 2 diabetes on population-level self-rated health outcomes and measures of cardiovascular risk: 13-year follow-up of the Ely cohort. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabet Med</i>. 2012;29(7):886-892. doi:<a href="http://dx.doi.org/10.1111/j.1464-5491.2012.03570.x">10.1111/j.1464-5491.2012.03570.x</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/22283392" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Effect%20of%20screening%20for%20type%202%20diabetes%20on%20population-level%20self-rated%20health%20outcomes%20and%20measures%20of%20cardiovascular%20risk%3A%2013-year%20follow-up%20of%20the%20Ely%20cohort.&amp;author=M%20Rahman&amp;author=RK%20Simmons&amp;author=SH%20Hennings&amp;author=NJ%20Wareham&amp;author=SJ%20Griffin&amp;publication_year=2012&amp;journal=Diabet%20Med&amp;volume=29&amp;pages=886-892" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1111/dme.2012.29.issue-7" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1111/dme.2012.29.issue-7" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r30">30.</a><div class="reference-content">Griffin
         SJ﻿, Borch-Johnsen
         K﻿, Davies
         MJ﻿, 
     et al.  Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet</i>. 2011;378(9786):156-167. doi:<a href="http://dx.doi.org/10.1016/S0140-6736(11)60698-3">10.1016/S0140-6736(11)60698-3</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/21705063" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Effect%20of%20early%20intensive%20multifactorial%20therapy%20on%205-year%20cardiovascular%20outcomes%20in%20individuals%20with%20type%202%20diabetes%20detected%20by%20screening%20%28ADDITION-Europe%29%3A%20a%20cluster-randomised%20trial.&amp;author=SJ%20Griffin&amp;author=K%20Borch-Johnsen&amp;author=MJ%20Davies&amp;publication_year=2011&amp;journal=Lancet&amp;volume=378&amp;pages=156-167" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S0140-6736(11)60698-3" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S0140-6736(11)60698-3" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r31">31.</a><div class="reference-content">Simmons
         RK﻿, Sharp
         SJ﻿, Sandbæk
         A﻿, 
     et al.  Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? findings from the ADDITION-Europe cluster-randomized trial. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabet Med</i>. 2012;29(11):e409-e416. doi:<a href="http://dx.doi.org/10.1111/j.1464-5491.2012.03759.x">10.1111/j.1464-5491.2012.03759.x</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/22823477" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Does%20early%20intensive%20multifactorial%20treatment%20reduce%20total%20cardiovascular%20burden%20in%20individuals%20with%20screen-detected%20diabetes%3F%20findings%20from%20the%20ADDITION-Europe%20cluster-randomized%20trial.&amp;author=RK%20Simmons&amp;author=SJ%20Sharp&amp;author=A%20Sandbæk&amp;publication_year=2012&amp;journal=Diabet%20Med&amp;volume=29&amp;pages=e409-e416" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1111/dme.2012.29.issue-11" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1111/dme.2012.29.issue-11" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r32">32.</a><div class="reference-content">Simmons
         RK﻿, Borch-Johnsen
         K﻿, Lauritzen
         T﻿, 
     et al.  A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Health Technol Assess</i>. 2016;20(64):1-86. doi:<a href="http://dx.doi.org/10.3310/hta20640">10.3310/hta20640</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/27583404" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=A%20randomised%20trial%20of%20the%20effect%20and%20cost-effectiveness%20of%20early%20intensive%20multifactorial%20therapy%20on%205-year%20cardiovascular%20outcomes%20in%20individuals%20with%20screen-detected%20type%202%20diabetes%3A%20the%20Anglo-Danish-Dutch%20Study%20of%20Intensive%20Treatment%20in%20People%20With%20Screen-Detected%20Diabetes%20in%20Primary%20Care%20%28ADDITION-Europe%29%20study.&amp;author=RK%20Simmons&amp;author=K%20Borch-Johnsen&amp;author=T%20Lauritzen&amp;publication_year=2016&amp;journal=Health%20Technol%20Assess&amp;volume=20&amp;pages=1-86" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.3310/hta20640" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.3310/hta20640" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r33">33.</a><div class="reference-content">Griffin
         SJ﻿, Rutten
         GEHM﻿, Khunti
         K﻿, 
     et al.  Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet Diabetes Endocrinol</i>. 2019;7(12):925-937. doi:<a href="http://dx.doi.org/10.1016/S2213-8587(19)30349-3">10.1016/S2213-8587(19)30349-3</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/31748169" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Long-term%20effects%20of%20intensive%20multifactorial%20therapy%20in%20individuals%20with%20screen-detected%20type%202%20diabetes%20in%20primary%20care%3A%2010-year%20follow-up%20of%20the%20ADDITION-Europe%20cluster-randomised%20trial.&amp;author=SJ%20Griffin&amp;author=GEHM%20Rutten&amp;author=K%20Khunti&amp;publication_year=2019&amp;journal=Lancet%20Diabetes%20Endocrinol&amp;volume=7&amp;pages=925-937" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S2213-8587(19)30349-3" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S2213-8587(19)30349-3" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r34">34.</a><div class="reference-content">Li
         G﻿, Zhang
         P﻿, Wang
         J﻿, 
     et al.  Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet Diabetes Endocrinol</i>. 2014;2(6):474-480. doi:<a href="http://dx.doi.org/10.1016/S2213-8587(14)70057-9">10.1016/S2213-8587(14)70057-9</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/24731674" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Cardiovascular%20mortality%2C%20all-cause%20mortality%2C%20and%20diabetes%20incidence%20after%20lifestyle%20intervention%20for%20people%20with%20impaired%20glucose%20tolerance%20in%20the%20Da%20Qing%20Diabetes%20Prevention%20Study%3A%20a%2023-year%20follow-up%20study.&amp;author=G%20Li&amp;author=P%20Zhang&amp;author=J%20Wang&amp;publication_year=2014&amp;journal=Lancet%20Diabetes%20Endocrinol&amp;volume=2&amp;pages=474-480" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S2213-8587(14)70057-9" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S2213-8587(14)70057-9" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r35">35.</a><div class="reference-content">Gong
         Q﻿, Zhang
         P﻿, Wang
         J﻿, 
     et al; Da Qing Diabetes Prevention Study Group.  Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet Diabetes Endocrinol</i>. 2019;7(6):452-461. doi:<a href="http://dx.doi.org/10.1016/S2213-8587(19)30093-2">10.1016/S2213-8587(19)30093-2</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/31036503" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Morbidity%20and%20mortality%20after%20lifestyle%20intervention%20for%20people%20with%20impaired%20glucose%20tolerance%3A%2030-year%20results%20of%20the%20Da%20Qing%20Diabetes%20Prevention%20Outcome%20Study.&amp;author=Q%20Gong&amp;author=P%20Zhang&amp;author=J%20Wang&amp;publication_year=2019&amp;journal=Lancet%20Diabetes%20Endocrinol&amp;volume=7&amp;pages=452-461" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S2213-8587(19)30093-2" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S2213-8587(19)30093-2" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r36">36.</a><div class="reference-content">UK Prospective Diabetes Study (UKPDS) Group.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet</i>. 1998;352(9131):837-853. doi:<a href="http://dx.doi.org/10.1016/S0140-6736(98)07019-6">10.1016/S0140-6736(98)07019-6</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/9742976" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Intensive%20blood-glucose%20control%20with%20sulphonylureas%20or%20insulin%20compared%20with%20conventional%20treatment%20and%20risk%20of%20complications%20in%20patients%20with%20type%202%20diabetes%20%28UKPDS%2033%29.&amp;publication_year=1998&amp;journal=Lancet&amp;volume=352&amp;pages=837-853" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S0140-6736(98)07019-6" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S0140-6736(98)07019-6" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r37">37.</a><div class="reference-content">Holman
         RR﻿, Paul
         SK﻿, Bethel
         MA﻿, Matthews
         DR﻿, Neil
         HA﻿.  10-Year follow-up of intensive glucose control in type 2 diabetes. ﻿ <i xmlns:helper="urn:XsltStringHelper"> N Engl J Med</i>. 2008;359(15):1577-1589. doi:<a href="http://dx.doi.org/10.1056/NEJMoa0806470">10.1056/NEJMoa0806470</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/18784090" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=10-Year%20follow-up%20of%20intensive%20glucose%20control%20in%20type%202%20diabetes.&amp;author=RR%20Holman&amp;author=SK%20Paul&amp;author=MA%20Bethel&amp;author=DR%20Matthews&amp;author=HA%20Neil&amp;publication_year=2008&amp;journal=N%20Engl%20J%20Med&amp;volume=359&amp;pages=1577-1589" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1056/NEJMoa0806470" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1056/NEJMoa0806470" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r38">38.</a><div class="reference-content">UK Prospective Diabetes Study (UKPDS) Group.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet</i>. 1998;352(9131):854-865. doi:<a href="http://dx.doi.org/10.1016/S0140-6736(98)07037-8">10.1016/S0140-6736(98)07037-8</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/9742977" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Effect%20of%20intensive%20blood-glucose%20control%20with%20metformin%20on%20complications%20in%20overweight%20patients%20with%20type%202%20diabetes%20%28UKPDS%2034%29.&amp;publication_year=1998&amp;journal=Lancet&amp;volume=352&amp;pages=854-865" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S0140-6736(98)07037-8" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S0140-6736(98)07037-8" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r39">39.</a><div class="reference-content">Davies
         MJ﻿, Heller
         S﻿, Skinner
         TC﻿, 
     et al; Diabetes Education and Self Management for Ongoing and Newly Diagnosed Collaborative.  Effectiveness of the Diabetes Education and Self Management for Ongoing and Newly Diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. ﻿ <i xmlns:helper="urn:XsltStringHelper"> BMJ</i>. 2008;336(7642):491-495. doi:<a href="http://dx.doi.org/10.1136/bmj.39474.922025.BE">10.1136/bmj.39474.922025.BE</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/18276664" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Effectiveness%20of%20the%20Diabetes%20Education%20and%20Self%20Management%20for%20Ongoing%20and%20Newly%20Diagnosed%20%28DESMOND%29%20programme%20for%20people%20with%20newly%20diagnosed%20type%202%20diabetes%3A%20cluster%20randomised%20controlled%20trial.&amp;author=MJ%20Davies&amp;author=S%20Heller&amp;author=TC%20Skinner&amp;publication_year=2008&amp;journal=BMJ&amp;volume=336&amp;pages=491-495" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1136/bmj.39474.922025.BE" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1136/bmj.39474.922025.BE" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r40">40.</a><div class="reference-content">Khunti
         K﻿, Gray
         LJ﻿, Skinner
         T﻿, 
     et al.  Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care. ﻿ <i xmlns:helper="urn:XsltStringHelper"> BMJ</i>. 2012;344:e2333. doi:<a href="http://dx.doi.org/10.1136/bmj.e2333">10.1136/bmj.e2333</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/22539172" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Effectiveness%20of%20a%20diabetes%20education%20and%20self%20management%20programme%20%28DESMOND%29%20for%20people%20with%20newly%20diagnosed%20type%202%20diabetes%20mellitus%3A%20three%20year%20follow-up%20of%20a%20cluster%20randomised%20controlled%20trial%20in%20primary%20care.&amp;author=K%20Khunti&amp;author=LJ%20Gray&amp;author=T%20Skinner&amp;publication_year=2012&amp;journal=BMJ&amp;volume=344&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jus210018r41">41.</a><div class="reference-content">Yang
         Y﻿, Yao
         JJ﻿, Du
         JL﻿, 
     et al.  Primary prevention of macroangiopathy in patients with short-duration type 2 diabetes by intensified multifactorial intervention: seven-year follow-up of diabetes complications in Chinese. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetes Care</i>. 2013;36(4):978-984. doi:<a href="http://dx.doi.org/10.2337/dc12-0227">10.2337/dc12-0227</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/23230099" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Primary%20prevention%20of%20macroangiopathy%20in%20patients%20with%20short-duration%20type%202%20diabetes%20by%20intensified%20multifactorial%20intervention%3A%20seven-year%20follow-up%20of%20diabetes%20complications%20in%20Chinese.&amp;author=Y%20Yang&amp;author=JJ%20Yao&amp;author=JL%20Du&amp;publication_year=2013&amp;journal=Diabetes%20Care&amp;volume=36&amp;pages=978-984" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.2337/dc12-0227" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.2337/dc12-0227" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r42">42.</a><div class="reference-content">O’Brien
         MJ﻿, Perez
         A﻿, Scanlan
         AB﻿, 
     et al.  PREVENT-DM comparative effectiveness trial of lifestyle intervention and metformin. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Am J Prev Med</i>. 2017;52(6):788-797. doi:<a href="http://dx.doi.org/10.1016/j.amepre.2017.01.008">10.1016/j.amepre.2017.01.008</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/28237635" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=PREVENT-DM%20comparative%20effectiveness%20trial%20of%20lifestyle%20intervention%20and%20metformin.&amp;author=MJ%20O’Brien&amp;author=A%20Perez&amp;author=AB%20Scanlan&amp;publication_year=2017&amp;journal=Am%20J%20Prev%20Med&amp;volume=52&amp;pages=788-797" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/j.amepre.2017.01.008" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/j.amepre.2017.01.008" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r43">43.</a><div class="reference-content">Ratner
         R﻿, Goldberg
         R﻿, Haffner
         S﻿, 
     et al; Diabetes Prevention Program Research Group.  Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention Program. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetes Care</i>. 2005;28(4):888-894. doi:<a href="http://dx.doi.org/10.2337/diacare.28.4.888">10.2337/diacare.28.4.888</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/15793191" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Impact%20of%20intensive%20lifestyle%20and%20metformin%20therapy%20on%20cardiovascular%20disease%20risk%20factors%20in%20the%20Diabetes%20Prevention%20Program.&amp;author=R%20Ratner&amp;author=R%20Goldberg&amp;author=S%20Haffner&amp;publication_year=2005&amp;journal=Diabetes%20Care&amp;volume=28&amp;pages=888-894" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jus210018r44">44.</a><div class="reference-content">Park
         P﻿, Simmons
         RK﻿, Prevost
         AT﻿, Griffin
         SJ﻿.  Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety: a randomised controlled trial in British general practice. ﻿ <i xmlns:helper="urn:XsltStringHelper"> BMC Public Health</i>. 2008;8:350. doi:<a href="http://dx.doi.org/10.1186/1471-2458-8-350">10.1186/1471-2458-8-350</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/18840266" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Screening%20for%20type%202%20diabetes%20is%20feasible%2C%20acceptable%2C%20but%20associated%20with%20increased%20short-term%20anxiety%3A%20a%20randomised%20controlled%20trial%20in%20British%20general%20practice.&amp;author=P%20Park&amp;author=RK%20Simmons&amp;author=AT%20Prevost&amp;author=SJ%20Griffin&amp;publication_year=2008&amp;journal=BMC%20Public%20Health&amp;volume=8&amp;pages=350" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1186/1471-2458-8-350" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1186/1471-2458-8-350" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r45">45.</a><div class="reference-content">Eborall
         HC﻿, Griffin
         SJ﻿, Prevost
         AT﻿, Kinmonth
         AL﻿, French
         DP﻿, Sutton
         S﻿.  Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial. ﻿ <i xmlns:helper="urn:XsltStringHelper"> BMJ</i>. 2007;335(7618):486. doi:<a href="http://dx.doi.org/10.1136/bmj.39303.723449.55">10.1136/bmj.39303.723449.55</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/17761995" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Psychological%20impact%20of%20screening%20for%20type%202%20diabetes%3A%20controlled%20trial%20and%20comparative%20study%20embedded%20in%20the%20ADDITION%20%28Cambridge%29%20randomised%20controlled%20trial.&amp;author=HC%20Eborall&amp;author=SJ%20Griffin&amp;author=AT%20Prevost&amp;author=AL%20Kinmonth&amp;author=DP%20French&amp;author=S%20Sutton&amp;publication_year=2007&amp;journal=BMJ&amp;volume=335&amp;pages=486" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1136/bmj.39303.723449.55" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1136/bmj.39303.723449.55" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r46">46.</a><div class="reference-content">Paddison
         CA﻿, Eborall
         HC﻿, French
         DP﻿, 
     et al.  Predictors of anxiety and depression among people attending diabetes screening: a prospective cohort study embedded in the ADDITION (Cambridge) randomized control trial. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Br J Health Psychol</i>. 2011;16(pt 1):213-226. doi:<a href="http://dx.doi.org/10.1348/135910710X495366">10.1348/135910710X495366</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/21226792" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Predictors%20of%20anxiety%20and%20depression%20among%20people%20attending%20diabetes%20screening%3A%20a%20prospective%20cohort%20study%20embedded%20in%20the%20ADDITION%20%28Cambridge%29%20randomized%20control%20trial.&amp;author=CA%20Paddison&amp;author=HC%20Eborall&amp;author=DP%20French&amp;publication_year=2011&amp;journal=Br%20J%20Health%20Psychol&amp;volume=16&amp;pages=213-226" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jus210018r47">47.</a><div class="reference-content">Metformin [package insert]. Bristol Myers Squibb. Accessed June 29, 2021. <a href="https://packageinserts.bms.com/pi/pi_glucophage.pdf">https://packageinserts.bms.com/pi/pi_glucophage.pdf</a></div></div><div class="reference"><a class="reference-number" id="jus210018r48">48.</a><div class="reference-content">American Diabetes Association.  Classification and diagnosis of diabetes: standards of medical care in diabetes—2018. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetes Care</i>. 2018;41(suppl 1):S13-S27. doi:<a href="http://dx.doi.org/10.2337/dc18-S002">10.2337/dc18-S002</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/29222373" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Classification%20and%20diagnosis%20of%20diabetes%3A%20standards%20of%20medical%20care%20in%20diabetes%E2%80%942018.&amp;publication_year=2018&amp;journal=Diabetes%20Care&amp;volume=41&amp;pages=S13-S27" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.2337/dc18-S002" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.2337/dc18-S002" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r49">49.</a><div class="reference-content">Handelsman
         Y﻿, Bloomgarden
         ZT﻿, Grunberger
         G﻿, 
     et al.  American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for developing a diabetes mellitus comprehensive care plan—2015. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Endocr Pract</i>. 2015;21(suppl 1):1-87. doi:<a href="http://dx.doi.org/10.4158/EP15672.GLSUPPL">10.4158/EP15672.GLSUPPL</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/25869408" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=American%20Association%20of%20Clinical%20Endocrinologists%20and%20American%20College%20of%20Endocrinology%20clinical%20practice%20guidelines%20for%20developing%20a%20diabetes%20mellitus%20comprehensive%20care%20plan%E2%80%942015.&amp;author=Y%20Handelsman&amp;author=ZT%20Bloomgarden&amp;author=G%20Grunberger&amp;publication_year=2015&amp;journal=Endocr%20Pract&amp;volume=21&amp;pages=1-87" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.4158/EP15672.GLSUPPL" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.4158/EP15672.GLSUPPL" xmlns:helper="urn:XsltStringHelper"> </span></div></div></div> 
    </div>

            </div>
        </div>

        
        <div id="related-tab" class="resource-tab js-resource-tab related-tab need-jobs-ad">
    <div class="widget-ArticleLinks widget-instance-AMA_See_Also_Related_Content">
        
    <ul class="article-links related-content">

            <li class="article-link related-article odd">
                <a href="https://jamanetwork.com/journals/jama/fullarticle/2783415" class="td-n">
                        <div class="related-article-title">USPSTF Report: Screening for Prediabetes and Type 2 Diabetes</div>
                                            <div class="related-journal-name">JAMA</div>
                    <div class="related-article-type">US Preventive Services Task Force</div>
                    <div class="related-article-date">August 24, 2021</div>
                    <div class="related-article-excerpt">This systematic review to support the 2021 US Preventive Services Task Force Recommendation Statement on screening for diabetes summarizes published evidence on the benefits and harms of screening for and treatment of prediabetes and type 2 diabetes in asymptomatic persons.</div>
                    <div class="related-article-authors">Daniel E. Jonas, MD, MPH; Karen Crotty, PhD, MPH; Jonathan D. Y. Yun, MD, MPH; Jennifer Cook Middleton, PhD; Cynthia Feltner, MD, MPH; Sian Taylor-Phillips, PhD, MPhys, MSc; Colleen Barclay, MPH; Andrea Dotson, MD, MSPH; Claire Baker; Casey P. Balio, PhD; Christiane E. Voisin, MSLS; Russell P. Harris, MD, MPH</div>
                </a>
            </li>
            <li class="article-link related-article even">
                <a href="https://jamanetwork.com/journals/jama/fullarticle/2783444" class="td-n">
                        <div class="related-article-title">New USPSTF Recommendations for Screening for Prediabetes and Type 2 Diabetes</div>
                                            <div class="related-journal-name">JAMA</div>
                    <div class="related-article-type">Editorial</div>
                    <div class="related-article-date">August 24, 2021</div>
                    <div class="related-article-excerpt"></div>
                    <div class="related-article-authors">Edward W. Gregg, PhD; Tannaz Moin, MD, MBA, MSHS</div>
                </a>
            </li>
            <li class="article-link related-article odd">
                <a href="https://jamanetwork.com/journals/jama/fullarticle/2783419" class="td-n">
                        <div class="related-article-title">Patient Information: Screening for Prediabetes and Type 2 Diabetes</div>
                                            <div class="related-journal-name">JAMA</div>
                    <div class="related-article-type">JAMA Patient Page</div>
                    <div class="related-article-date">August 24, 2021</div>
                    <div class="related-article-excerpt">This JAMA Patient Page summarizes the US Preventive Services Task Force’s recent recommendations on screening for prediabetes and type 2 diabetes.</div>
                    <div class="related-article-authors">Jill Jin, MD, MPH</div>
                </a>
            </li>
            <li class="article-link related-article even">
                <a href="https://jamanetwork.com/journals/jama/fullarticle/2785526" class="td-n">
                        <div class="related-article-title">Unclear Diagnostic Testing Standard</div>
                                            <div class="related-journal-name">JAMA</div>
                    <div class="related-article-type">Correction</div>
                    <div class="related-article-date">October 26, 2021</div>
                    <div class="related-article-excerpt"></div>
                    <div class="related-article-authors"></div>
                </a>
            </li>
            <li class="article-link related-article odd">
                <a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2783521" class="td-n">
                        <div class="related-article-title">Updated USPSTF Screening Recommendations for Diabetes</div>
                                            <div class="related-journal-name">JAMA Internal Medicine</div>
                    <div class="related-article-type">Editorial</div>
                    <div class="related-article-date">October 1, 2021</div>
                    <div class="related-article-excerpt"></div>
                    <div class="related-article-authors">Richard W. Grant, MD, MPH; Anjali Gopalan, MD, MS; Marc G. Jaffe, MD</div>
                </a>
            </li>
    </ul>
 
    </div>
    <div class="widget-EditorsChoice widget-instance-AMA_EditorsChoice_Links">
        
 
    </div>
    <div class="widget-RelatedTopics widget-instance-AMA_Related_Topics">
        
        <div class="related-topics-block">
            <h4 class="related-topics-heading topic-suggestions-heading sb-sc">
See More About            </h4>
            <div class="related-topics topic-suggestions">
    <a href="https://jamanetwork.com/collections/6262/diabetes" id="item_Link" class="related-topic topic-suggestion no-wrap sb-anchor-light">Diabetes</a>    <a href="https://jamanetwork.com/collections/44011/diabetes-and-endocrinology" id="item_Link_1" class="related-topic topic-suggestion no-wrap sb-anchor-light">Diabetes and Endocrinology</a>    <a href="https://jamanetwork.com/collections/5791/obesity" id="item_Link_2" class="related-topic topic-suggestion no-wrap sb-anchor-light">Obesity</a>    <a href="https://jamanetwork.com/collections/5672/guidelines" id="item_Link_3" class="related-topic topic-suggestion no-wrap sb-anchor-light">Guidelines</a>    <a href="https://jamanetwork.com/collections/44068/united-states-preventive-services-task-force" id="item_Link_4" class="related-topic topic-suggestion no-wrap sb-anchor-light">United States Preventive Services Task Force</a>            </div>
        </div>
 
    </div>
                <div class="ymal--footer">
    <div class="widget-WidgetLoader widget-instance-AMA_PersonalizedContent_SplitScreenView_Footer">
        <div class="SCM-SharedWidgets-AsyncWidgetLoader" data-url="/Personalization/PersonalizedContent/AMA_PersonalizedContent_SplitScreenView_Footer" data-params="{&quot;parameters&quot;:{&quot;resourceIdToExclude&quot;:2783414,&quot;resourceTypeToExclude&quot;:3},&quot;dynamicParameters&quot;:{&quot;localParams&quot;:&quot;[REPLACE_WITH_LOCAL]&quot;}}"></div>
 
    </div>

                </div>
                <hr />
                <div class="manage-interest">
                    <h4><a href="#" class="manage-interests-link-no-access thm-col-sec">Select Your Interests</a></h4>
    <div class="widget-ManageCollectionInterests widget-instance-ManageCollectionInterests_SplitScreen">
        <div class="manage-interests-modal reveal-modal small modal" data-reveal>
<div class="manage-interests--header">
    <div class="widget-SelfServeContent widget-instance-AMA_ManageInterests_Header">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="AllSitesManageInterestsHeader" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<style>
    h4 {
    font-size: 20px !important;
    }
</style>
<h4>Select Your Interests</h4>
<p>Customize your JAMA Network experience by selecting one or more topics from the list below.</p>


</div>

 
    </div>

</div><div class="manage-interests--categories">
    <ul class="category-list">
            <li><span class="category-list-item " data-categoryid="46425">Academic Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5489">Acid Base, Electrolytes, Fluids</span></li>
            <li><span class="category-list-item " data-categoryid="5504">Allergy and Clinical Immunology</span></li>
            <li><span class="category-list-item " data-categoryid="46447">American Indian or Alaska Natives</span></li>
            <li><span class="category-list-item " data-categoryid="5510">Anesthesiology</span></li>
            <li><span class="category-list-item " data-categoryid="42143">Anticoagulation</span></li>
            <li><span class="category-list-item " data-categoryid="6261">Art and Images in Psychiatry</span></li>
            <li><span class="category-list-item " data-categoryid="44024">Artificial Intelligence</span></li>
            <li><span class="category-list-item " data-categoryid="42097">Assisted Reproduction</span></li>
            <li><span class="category-list-item " data-categoryid="42099">Bleeding and Transfusion</span></li>
            <li><span class="category-list-item " data-categoryid="5548">Cardiology</span></li>
            <li><span class="category-list-item " data-categoryid="44036">Caring for the Critically Ill Patient</span></li>
            <li><span class="category-list-item " data-categoryid="6255">Challenges in Clinical Electrocardiography</span></li>
            <li><span class="category-list-item " data-categoryid="46435">Climate and Health</span></li>
            <li><span class="category-list-item " data-categoryid="46448">Climate Change</span></li>
            <li><span class="category-list-item " data-categoryid="44038">Clinical Challenge</span></li>
            <li><span class="category-list-item " data-categoryid="5589">Clinical Decision Support</span></li>
            <li><span class="category-list-item " data-categoryid="44039">Clinical Implications of Basic Neuroscience</span></li>
            <li><span class="category-list-item " data-categoryid="5614">Clinical Pharmacy and Pharmacology</span></li>
            <li><span class="category-list-item " data-categoryid="5575">Complementary and Alternative Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="44040">Consensus Statements</span></li>
            <li><span class="category-list-item " data-categoryid="46099">Coronavirus (COVID-19)</span></li>
            <li><span class="category-list-item " data-categoryid="5584">Critical Care Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="46325">Cultural Competency</span></li>
            <li><span class="category-list-item " data-categoryid="44019">Dental Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5598">Dermatology</span></li>
            <li><span class="category-list-item " data-categoryid="44011">Diabetes and Endocrinology</span></li>
            <li><span class="category-list-item " data-categoryid="46320">Diagnostic Test Interpretation</span></li>
            <li><span class="category-list-item " data-categoryid="42054">Drug Development</span></li>
            <li><span class="category-list-item " data-categoryid="5620">Electronic Health Records</span></li>
            <li><span class="category-list-item " data-categoryid="5621">Emergency Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5819">End of Life, Hospice, Palliative Care</span></li>
            <li><span class="category-list-item " data-categoryid="42107">Environmental Health</span></li>
            <li><span class="category-list-item " data-categoryid="46387">Equity, Diversity, and Inclusion</span></li>
            <li><span class="category-list-item " data-categoryid="42108">Ethics</span></li>
            <li><span class="category-list-item " data-categoryid="5644">Facial Plastic Surgery</span></li>
            <li><span class="category-list-item " data-categoryid="44012">Gastroenterology and Hepatology</span></li>
            <li><span class="category-list-item " data-categoryid="5664">Genetics and Genomics</span></li>
            <li><span class="category-list-item " data-categoryid="44041">Genomics and Precision Health</span></li>
            <li><span class="category-list-item " data-categoryid="5668">Geriatrics</span></li>
            <li><span class="category-list-item " data-categoryid="5670">Global Health</span></li>
            <li><span class="category-list-item " data-categoryid="46427">Guide to Statistics and Methods</span></li>
            <li><span class="category-list-item " data-categoryid="5672">Guidelines</span></li>
            <li><span class="category-list-item " data-categoryid="5674">Hair Disorders</span></li>
            <li><span class="category-list-item " data-categoryid="42113">Health Care Delivery Models</span></li>
            <li><span class="category-list-item " data-categoryid="42114">Health Care Economics, Insurance, Payment</span></li>
            <li><span class="category-list-item " data-categoryid="42116">Health Care Quality</span></li>
            <li><span class="category-list-item " data-categoryid="5680">Health Care Reform</span></li>
            <li><span class="category-list-item " data-categoryid="5830">Health Care Safety</span></li>
            <li><span class="category-list-item " data-categoryid="5682">Health Care Workforce</span></li>
            <li><span class="category-list-item " data-categoryid="5679">Health Disparities</span></li>
            <li><span class="category-list-item " data-categoryid="46328">Health Inequities</span></li>
            <li><span class="category-list-item " data-categoryid="44020">Health Policy</span></li>
            <li><span class="category-list-item " data-categoryid="46451">Health Systems Science</span></li>
            <li><span class="category-list-item " data-categoryid="5688">Hematology</span></li>
            <li><span class="category-list-item " data-categoryid="5692">History of Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5514">Humanities</span></li>
            <li><span class="category-list-item " data-categoryid="5697">Hypertension</span></li>
            <li><span class="category-list-item " data-categoryid="44043">Images in Neurology</span></li>
            <li><span class="category-list-item " data-categoryid="45887">Implementation Science</span></li>
            <li><span class="category-list-item " data-categoryid="5702">Infectious Diseases</span></li>
            <li><span class="category-list-item " data-categoryid="44044">Innovations in Health Care Delivery</span></li>
            <li><span class="category-list-item " data-categoryid="44070">JAMA Infographic</span></li>
            <li><span class="category-list-item " data-categoryid="5716">Law and Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="45308">Leading Change</span></li>
            <li><span class="category-list-item " data-categoryid="44045">Less is More</span></li>
            <li><span class="category-list-item " data-categoryid="46327">LGBTQIA Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5720">Lifestyle Behaviors</span></li>
            <li><span class="category-list-item " data-categoryid="45311">Medical Coding</span></li>
            <li><span class="category-list-item " data-categoryid="5738">Medical Devices and Equipment</span></li>
            <li><span class="category-list-item " data-categoryid="44023">Medical Education</span></li>
            <li><span class="category-list-item " data-categoryid="5739">Medical Education and Training</span></li>
            <li><span class="category-list-item " data-categoryid="5713">Medical Journals and Publishing</span></li>
            <li><span class="category-list-item " data-categoryid="5746">Melanoma</span></li>
            <li><span class="category-list-item " data-categoryid="44025">Mobile Health and Telemedicine</span></li>
            <li><span class="category-list-item " data-categoryid="5766">Narrative Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5769">Nephrology</span></li>
            <li><span class="category-list-item " data-categoryid="5777">Neurology</span></li>
            <li><span class="category-list-item " data-categoryid="44052">Neuroscience and Psychiatry</span></li>
            <li><span class="category-list-item " data-categoryid="44053">Notable Notes</span></li>
            <li><span class="category-list-item " data-categoryid="5787">Nursing</span></li>
            <li><span class="category-list-item " data-categoryid="5788">Nutrition</span></li>
            <li><span class="category-list-item " data-categoryid="44027">Nutrition, Obesity, Exercise</span></li>
            <li><span class="category-list-item " data-categoryid="5791">Obesity</span></li>
            <li><span class="category-list-item " data-categoryid="44013">Obstetrics and Gynecology</span></li>
            <li><span class="category-list-item " data-categoryid="5796">Occupational Health</span></li>
            <li><span class="category-list-item " data-categoryid="5801">Oncology</span></li>
            <li><span class="category-list-item " data-categoryid="5804">Ophthalmology</span></li>
            <li><span class="category-list-item " data-categoryid="5808">Orthopedics</span></li>
            <li><span class="category-list-item " data-categoryid="5811">Otolaryngology</span></li>
            <li><span class="category-list-item " data-categoryid="44028">Pain Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="46446">Palliative Care</span></li>
            <li><span class="category-list-item " data-categoryid="44029">Pathology and Laboratory Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="45306">Patient Care</span></li>
            <li><span class="category-list-item " data-categoryid="6258">Patient Information</span></li>
            <li><span class="category-list-item " data-categoryid="5843">Pediatrics</span></li>
            <li><span class="category-list-item " data-categoryid="44060">Performance Improvement</span></li>
            <li><span class="category-list-item " data-categoryid="45315">Performance Measures</span></li>
            <li><span class="category-list-item " data-categoryid="42050">Perioperative Care and Consultation</span></li>
            <li><span class="category-list-item " data-categoryid="42125">Pharmacoeconomics</span></li>
            <li><span class="category-list-item " data-categoryid="42126">Pharmacoepidemiology</span></li>
            <li><span class="category-list-item " data-categoryid="5851">Pharmacogenetics</span></li>
            <li><span class="category-list-item " data-categoryid="44030">Pharmacy and Clinical Pharmacology</span></li>
            <li><span class="category-list-item " data-categoryid="5856">Physical Medicine and Rehabilitation</span></li>
            <li><span class="category-list-item " data-categoryid="42059">Physical Therapy</span></li>
            <li><span class="category-list-item " data-categoryid="45313">Physician Leadership</span></li>
            <li><span class="category-list-item " data-categoryid="44061">Poetry</span></li>
            <li><span class="category-list-item " data-categoryid="45316">Population Health</span></li>
            <li><span class="category-list-item " data-categoryid="46445">Primary Care</span></li>
            <li><span class="category-list-item " data-categoryid="45309">Professional Well-being</span></li>
            <li><span class="category-list-item " data-categoryid="44064">Professionalism</span></li>
            <li><span class="category-list-item " data-categoryid="5871">Psychiatry and Behavioral Health</span></li>
            <li><span class="category-list-item " data-categoryid="42128">Public Health</span></li>
            <li><span class="category-list-item " data-categoryid="5877">Pulmonary Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="42129">Radiology</span></li>
            <li><span class="category-list-item " data-categoryid="42058">Regulatory Agencies</span></li>
            <li><span class="category-list-item " data-categoryid="46443">Reproductive Health</span></li>
            <li><span class="category-list-item " data-categoryid="5916">Research, Methods, Statistics</span></li>
            <li><span class="category-list-item " data-categoryid="42142">Resuscitation</span></li>
            <li><span class="category-list-item " data-categoryid="5896">Rheumatology</span></li>
            <li><span class="category-list-item " data-categoryid="46326">Risk Management</span></li>
            <li><span class="category-list-item " data-categoryid="38802">Scientific Discovery and the Future of Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5833">Shared Decision Making and Communication</span></li>
            <li><span class="category-list-item " data-categoryid="5912">Sleep Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5915">Sports Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5533">Stem Cell Transplantation</span></li>
            <li><span class="category-list-item " data-categoryid="5921">Substance Use and Addiction Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5923">Surgery</span></li>
            <li><span class="category-list-item " data-categoryid="44065">Surgical Innovation</span></li>
            <li><span class="category-list-item " data-categoryid="44066">Surgical Pearls</span></li>
            <li><span class="category-list-item " data-categoryid="44067">Teachable Moment</span></li>
            <li><span class="category-list-item " data-categoryid="45310">Technology and Finance</span></li>
            <li><span class="category-list-item " data-categoryid="44034">The Art of JAMA</span></li>
            <li><span class="category-list-item " data-categoryid="44037">The Arts and Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="6257">The Rational Clinical Examination</span></li>
            <li><span class="category-list-item " data-categoryid="5936">Tobacco and e-Cigarettes</span></li>
            <li><span class="category-list-item " data-categoryid="5938">Toxicology</span></li>
            <li><span class="category-list-item " data-categoryid="46433">Translational Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="42136">Trauma and Injury</span></li>
            <li><span class="category-list-item " data-categoryid="5942">Treatment Adherence</span></li>
            <li><span class="category-list-item " data-categoryid="46323">Ultrasonography</span></li>
            <li><span class="category-list-item " data-categoryid="5947">Urology</span></li>
            <li><span class="category-list-item " data-categoryid="44069">Users&#39; Guide to the Medical Literature</span></li>
            <li><span class="category-list-item " data-categoryid="5950">Vaccination</span></li>
            <li><span class="category-list-item " data-categoryid="5955">Venous Thromboembolism</span></li>
            <li><span class="category-list-item " data-categoryid="45312">Veterans Health</span></li>
            <li><span class="category-list-item " data-categoryid="5957">Violence</span></li>
            <li><span class="category-list-item " data-categoryid="42139">Women&#39;s Health</span></li>
            <li><span class="category-list-item " data-categoryid="45307">Workflow and Process</span></li>
            <li><span class="category-list-item " data-categoryid="42140">Wound Care, Infection, Healing</span></li>
    </ul>
</div>

    
<div class="manage-interests--save-preferences">
    <div class="save-preferences-btn thm-bg ">
        <span class="save-preferences-btn-text fw-b">Save Preferences</span>
    </div>
</div>
<div class="manage-interests--privacy-terms"> <a class="manage-interests--privacy-terms-color" href="/pages/privacy-policy">Privacy Policy</a> | <a class="manage-interests--privacy-terms-color" href="/pages/terms-of-use">Terms of Use</a></div>

    
    <a class="close-reveal-modal icon-close"></a>
</div> 
    </div>

                </div>
                <h4 class="thm-col-sec" align="center">
                    Others Also Liked
                </h4>
                <div id="trendmd-suggestions"></div>

        </div>


        
        <div id="comments-tab" class="resource-tab js-resource-tab comments-tab js-comments-tab single-comment-view">



        </div>
    </div>
</div>

<a id="skip-to-navigation" href="#" tabindex="-1"></a>
<div id="content-panel" class="content-panel">
    <a id="top"></a>

    <div id="full-text-tab" class="resource-tab js-resource-tab full-text-tab">
    <div class="widget-ArticleLinks widget-instance-AMA_ErrataArticleLinks_FullText">
         
    </div>
    <div class="widget-ArticleLinks widget-instance-AMA_ArticleLinks_ToErrata_FullText">
        
    <div class="errata-links ">
        
        

        

        
            <div class="errata-link">
                <a class="errata-link--btn thm-col-sec" href="https://jamanetwork.com/journals/jama/fullarticle/2785526">View Correction</a>
            </div>
    </div>
 
    </div>
    <div class="widget-ArticleNavLinks widget-instance-AMA_ArticleNavLinks">
                <a class="toc-link btn" href="https://jamanetwork.com/journals/jama/issue/326/8">This Issue</a>
 
    </div>



            <div class="article-metrics-wrapper" id="divArticleLevelMetrics">
    <div class="widget-ArticleLevelMetrics widget-instance-AMA_ArticleMetrics">
        

    <div class="artmet-condensed-wrap clearfix">
        <div class="artmet-condensed-stats clearfix">
                <div class="artmet-item artmet-views">
                    <span class="artmet-text sb-sc">Views</span>
                    <span class="artmet-number sb-sc">245,764</span>
                </div>
                                <div class="artmet-item artmet-citations">
                            <a class="artmet-citations-link" href="https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=silverchair&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000694028500014&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL" target="_blank">
                                <span class="artmet-text">Citations</span>
                                <span class="artmet-number">187</span>
                            </a>
                    </div>
                                <div class="artmet-item artmet-altmetric">
    <div class="widget-AltmetricLink widget-instance-AMAv2_ArticleLevelMetrics_AltmetricLinkSummary">
            <!-- Altmetrics -->
    <div id="altmetricEmbedId" class='altmetric-embed' data-link-target="_blank" data-badge-type="text" data-hide-no-mentions="false" data-doi="10.1001/jama.2021.12531"
     
        
        ></div>
 
    </div>

                    </div>

        </div>

        <div class="artmet-modal-trigger-wrap">
            <a rel="nofollow" class="artmet-modal-trigger" data-article-id="2783414"><i class="icon-metrics"></i><span>View Metrics</span></a>
        </div>
    </div>

 
    </div>

            </div>
        <ul class="toolbar">
            <li class="toolbar-pdf-wrap toolbar-tool-wrap">
            <a id="pdf-link" class="toolbar-tool toolbar-pdf al-link pdfaccess" data-article-id="2783414" data-article-url="/journals/jama/articlepdf/2783414/jama_davidson_2021_us_210018_1634939301.84191.pdf" data-ajax-url="/Content/CheckPdfAccess"><span class="toolbar-pdf-text"><span class="toolbar-link-text-extra">Download </span><span class="toolbar-link-text">PDF</span></span>
            </a>

            </li>
            <li class="toolbar-share-wrap toolbar-tool-wrap">
                <div class="toolbar-tool">
                    <a class="st-custom-button addthis_button_twitter is-b toolbar-twitter toolbar-share"
                       data-network="twitter"
                       data-title=""
                       data-url=""
                       data-email-subject=""
                       rel="nofollow"
                       href="javascript:;">
                        <span class="share-text">X</span>
                    </a>
                    <a class="st-custom-button addthis_button_facebook is-b toolbar-facebook toolbar-share"
                       data-network="facebook"
                       data-title=""
                       data-url=""
                       data-email-subject=""
                       rel="nofollow"
                       href="javascript:;">
                        <span class="share-text">Facebook</span>
                    </a>
                    <a class="toolbar-share-more-link is-a" rel="nofollow"><span class="icon icon-carrot_down social-arrow"></span><span class="more-text-wrap">More</span></a>
                    <div class="toolbar-share-more">
                        <a class="st-custom-button addthis_button_linkedin is-b toolbar-linkedin toolbar-share"
                           data-network="linkedin"
                           data-title=""
                           data-url=""
                           data-email-subject=""
                           rel="nofollow"
                           href="javascript:;">
                            <span class="share-text">LinkedIn</span>
                        </a>
                    </div>
                </div>
            </li>
    <li class="toolbar-cme-wrap toolbar-tool-wrap">
                <a class="toolbar-tool toolbar-cme is-b jama-active-cme-button" rel="nofollow" href="https://edhub.ama-assn.org/jn-learning/module/2783414">CME &amp; MOC</a>

    </li>







            <li class="toolbar-citation-wrap toolbar-tool-wrap">
    <div class="widget-ToolboxGetCitation widget-instance-AMA_Get_Citation">
        
        <a class="toolbar-tool toolbar-citation is-b stats-citation" rel="nofollow" data-reveal-id="get-citation" data-reveal>
            <span class="toolbar-link-text">Cite</span>
            <span class="toolbar-link-text-extra">This</span>
        </a>
    <div id="get-citation" class="reveal-modal get-citation" data-reveal>
        <h3 class="get-citation-title">Citation</h3>
        <p class="get-citation-citation">US Preventive Services Task Force. Screening for Prediabetes and Type 2 Diabetes<span class="subtitle"><span class="colon-for-citation-subtitle">: </span>US Preventive Services Task Force Recommendation Statement</span>. <em>JAMA.</em> 2021;326(8):736–743. doi:10.1001/jama.2021.12531</p>
        <h4 class="get-citation-download-heading">Manage citations:</h4>
        <div class="get-citation-types">
            <a class="get-citation-format" rel="nofollow" href="/Citation/Download?resourceId=2783414&amp;resourceType=3&amp;citationFormat=0">Ris (Zotero)</a>
            <a class="get-citation-format" rel="nofollow" href="/Citation/Download?resourceId=2783414&amp;resourceType=3&amp;citationFormat=1">EndNote</a>
            <a class="get-citation-format" rel="nofollow" href="/Citation/Download?resourceId=2783414&amp;resourceType=3&amp;citationFormat=2">BibTex</a>
            <a class="get-citation-format" rel="nofollow" href="/Citation/Download?resourceId=2783414&amp;resourceType=3&amp;citationFormat=3">Medlars</a>
            <a class="get-citation-format" rel="nofollow" href="/Citation/Download?resourceId=2783414&amp;resourceType=3&amp;citationFormat=0">ProCite</a>
            <a class="get-citation-format" rel="nofollow" href="/Citation/Download?resourceId=2783414&amp;resourceType=3&amp;citationFormat=3">RefWorks</a>
            <a class="get-citation-format" rel="nofollow" href="/Citation/Download?resourceId=2783414&amp;resourceType=3&amp;citationFormat=0">Reference Manager</a>
            <a class="get-citation-format" rel="nofollow" href="/Citation/Download?resourceId=2783414&amp;resourceType=3&amp;citationFormat=0">Mendeley</a>
        </div>

        <p class="get-citation-copyright">&#169; 2024 </p>
        <a class="close-reveal-modal icon-close" rel="nofollow"></a>
    </div>


 
    </div>

            </li>
            <li class="toolbar-permissions-wrap toolbar-tool-wrap">
    <div class="widget-ToolboxPermissions widget-instance-AMA_Get_Permissions">
            <a href="http://s100.copyright.com/AppDispatchServlet?publisherName=AMA&amp;publication=0098-7484&amp;title=Screening+for+Prediabetes+and+Type+2+Diabetes%3a+US+Preventive+Services+Task+Force+Recommendation+Statement&amp;publicationDate=2021-08-24&amp;volumeNum=326&amp;issueNum=8&amp;author=US+Preventive+Services+Task+Force%3b+Davidson%2c+Karina+W.&amp;startPage=736&amp;endPage=743&amp;contentId=10.1001%2fjama.2021.12531&amp;oa=&amp;orderBeanReset=True" rel="nofollow" id="PermissionsLink" class="toolbar-tool toolbar-permissions is-b" target="_blank"><span class="toolbar-link-text">Permissions</span></a>
 
    </div>

            </li>
        </ul>

    <div class="widget-ArticleTopInfo widget-instance-AMA_ArticleTop_Info_Widget">
        

    <div class="meta-access-type free-access is-b"></div>


            <span class="hide tagmanagervalue" data-attribute="articleId" data-value="2783414" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="arrArticleAuthor" data-value="US%20Preventive%20Services%20Task%20Force" data-type="array"></span>
            <span class="hide tagmanagervalue" data-attribute="articleDOI" data-value="10.1001/jama.2021.12531" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="articleTitle" data-value="Screening for Prediabetes and Type 2 Diabetes&lt;span class=&quot;subtitle&quot;&gt;&lt;span class=&quot;colon-for-citation-subtitle&quot;&gt;: &lt;/span&gt;US Preventive Services Task Force Recommendation Statement&lt;/span&gt;" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="type" data-value="US Preventive Services Task Force" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="thematicLabel" data-value="Recommendation Statement" data-type="array"></span>
            <span class="hide tagmanagervalue" data-attribute="issueVolume" data-value="326" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="issueNo" data-value="8" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="publishDate" data-value="August 24, 2021" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="topics" data-value="Diabetes, Diabetes and Endocrinology, Obesity, Guidelines, United States Preventive Services Task Force" data-type="array"></span>
            <span class="hide tagmanagervalue" data-attribute="topicCode" data-value="6262, 44011, 5791, 5672, 44068" data-type="array"></span>
            <span class="hide tagmanagervalue" data-attribute="category" data-value="Research" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="journalClub" data-value="No" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="contentStatus" data-value="Free" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="articlePubState" data-value="Final" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="contentMedium" data-value="Article" data-type="string"></span>


        <div class="meta-article-type-wrap">
            <div class="meta-article-type thm-col">US Preventive Services Task Force </div>
                <div class="meta-super-class">Recommendation Statement</div>
        </div>
        <div class="meta-date"><span class="ppub"><span class="month">August </span><span class="day">24/31, </span><span class="year">2021</span></span></div>
        <div class="meta-article-title-wrap">
            
            <h1 class="meta-article-title ">Screening for Prediabetes and Type 2 Diabetes<span class="subtitle"><span class="colon-for-citation-subtitle">: </span>US Preventive Services Task Force Recommendation Statement</span></h1>

            
        </div>
            <div class="meta-authors">
                US Preventive Services Task Force<sup></sup>
            </div>
            <div class="meta-author">
                <a class="meta-articleinfo-jumplink no-affiliations section-jump-link scroll-to" data-tab-toggle=".tab-nav-full-text" href="#248067174">Article Information</a>
            </div>
        <div class="meta-citation-wrap">
            <span class="meta-citation-journal-name">JAMA. </span><span class="meta-citation"> 2021;326(8):736-743. doi:10.1001/jama.2021.12531</span>
        </div>

 
    </div>
    <div class="widget-EditorsChoice widget-instance-AMA_EditorsChoice_Links">
        
 
    </div>
    <div class="widget-LinkedContentToolbar widget-instance-AMA_LinkedContentToolbar">
        
<div class="linked-content-toolbar">
    
    <div class="hidden js-search-open-multimedia-by-default" showContentByDefault="False"></div>
    <div class="linked-content-controls">
        <a class="linked-content-trigger td-n stats-graphical-abstract" href="#graphical-abstract-tab">
            <i class="icon-visual-abstract"><span class="sr-t">visual abstract icon</span></i>
            <div class="trigger-text d-ib va-m ta-l fw-5">Visual <div>Abstract</div></div>
        </a>
        <a class="linked-content-trigger td-n stats-editorial-comment" href="#editorial-comment-tab">
            <i class="icon-document"><span class="sr-t">editorial comment icon</span></i>
            <div class="trigger-text d-ib va-m ta-l fw-5">Editorial <div>Comment</div></div>
        </a>
        <a class="linked-content-trigger td-n stats-related-articles" href="#related-articles-tab">
            <i class="icon-related"><span class="sr-t">related articles icon</span></i>
            <div class="trigger-text d-ib va-m ta-l fw-5">Related <div>Articles</div></div>
        </a>
        <a class="linked-content-trigger td-n stats-author-interviews" href="#author-interviews-tab">
            <i class="icon-author_interview"><span class="sr-t">author interview icon</span></i>
            <div class="trigger-text d-ib va-m ta-l fw-5">Interviews</div>
        </a>
        <a class="linked-content-trigger td-n stats-more-multimedia" href="#more-multimedia-tab">
            <i class="icon-multimedia"><span class="sr-t">multimedia icon</span></i>
            <div class="trigger-text d-ib va-m ta-l fw-5">Multimedia</div>
        </a>
        <a class="linked-content-trigger td-n stats-listen-to-this-article" href="#listen-to-this-article-tab">
            <i class="icon-audio"><span class="sr-t">audio icon</span></i>
            <div class="trigger-text d-ib va-m ta-l fw-5">Listen to <div>this article</div></div>
        </a>
    </div>

    
<div class="linked-content-tabs">
    <div id="graphical-abstract-tab" class="linked-content-tab graphical-abstract-tab">
    <div class="widget-SectionDisplay widget-instance-AMA_GraphicalAbstract_Tab">
        
 
    </div>

    </div>

    
    <div id="editorial-comment-tab" class="linked-content-tab editorial-comment-tab">
    <div class="widget-ArticleLinks widget-instance-AMA_LinkedContentToolbar_EditorialComments">
        
    <ul class="article-abstract-links related-abstract-content">
            <li class="article-link related-abstract-article">

                    <a class="related-article-title" href="https://jamanetwork.com/journals/jama/fullarticle/2783444">
                            <div class="related-article-type">Editorial</div>
                        <div class="related-article-title sb-tc">New USPSTF Recommendations for Screening for Prediabetes and Type 2 Diabetes</div>
                    </a>
                    <div class="related-article-authors">Edward W. Gregg, PhD; Tannaz Moin, MD, MBA, MSHS</div>
                                    <div class="related-article-journal-name">JAMA</div>
            </li>
            <li class="article-link related-abstract-article">

                    <a class="related-article-title" href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2783521">
                            <div class="related-article-type">Editorial</div>
                        <div class="related-article-title sb-tc">Updated USPSTF Screening Recommendations for Diabetes</div>
                    </a>
                    <div class="related-article-authors">Richard W. Grant, MD, MPH; Anjali Gopalan, MD, MS; Marc G. Jaffe, MD</div>
                                    <div class="related-article-journal-name">JAMA Internal Medicine</div>
            </li>
    </ul>
 
    </div>

    </div>

    
    <div id="related-articles-tab" class="linked-content-tab related-article-tab">
    <div class="widget-ArticleLinks widget-instance-AMA_LinkedContentToolbar_RelatedArticle">
        
    <ul class="article-abstract-links related-abstract-content">
            <li class="article-link related-abstract-article">

                    <a class="related-article-title" href="https://jamanetwork.com/journals/jama/fullarticle/2783415">
                            <div class="related-article-type">US Preventive Services Task Force</div>
                        <div class="related-article-title sb-tc">USPSTF Report: Screening for Prediabetes and Type 2 Diabetes</div>
                    </a>
                    <div class="related-article-authors">Daniel E. Jonas, MD, MPH; Karen Crotty, PhD, MPH; Jonathan D. Y. Yun, MD, MPH; Jennifer Cook Middleton, PhD; Cynthia Feltner, MD, MPH; Sian Taylor-Phillips, PhD, MPhys, MSc; Colleen Barclay, MPH; Andrea Dotson, MD, MSPH; Claire Baker; Casey P. Balio, PhD; Christiane E. Voisin, MSLS; Russell P. Harris, MD, MPH</div>
                                    <div class="related-article-journal-name">JAMA</div>
            </li>
            <li class="article-link related-abstract-article">

                    <a class="related-article-title" href="https://jamanetwork.com/journals/jama/fullarticle/2783419">
                            <div class="related-article-type">JAMA Patient Page</div>
                        <div class="related-article-title sb-tc">Patient Information: Screening for Prediabetes and Type 2 Diabetes</div>
                    </a>
                    <div class="related-article-authors">Jill Jin, MD, MPH</div>
                                    <div class="related-article-journal-name">JAMA</div>
            </li>
            <li class="article-link related-abstract-article">

                    <a class="related-article-title" href="https://jamanetwork.com/journals/jama/fullarticle/2785526">
                            <div class="related-article-type">Correction</div>
                        <div class="related-article-title sb-tc">Unclear Diagnostic Testing Standard</div>
                    </a>
                    <div class="related-article-authors"></div>
                                    <div class="related-article-journal-name">JAMA</div>
            </li>
    </ul>
 
    </div>
    <div class="widget-ArticleLinks widget-instance-AMA_LinkedContentToolbar_RelatedEditorsChoices">
        
 
    </div>

    </div>

    
    <div id="author-interviews-tab" class="linked-content-tab linked-author-interviews-tab">
    <div class="widget-AudioPlayer widget-instance-AMA_LinkedContentToolbar_PlatformAudioPlayer_AuthorInterviews">
                <div class="audio-border-top  thm-bg-col sb-background-pc"></div>
    <div class="audio-element-wrapper js-audio-element-wrapper">
            <div class="audio-group-duration">
                Audio Clinical Review  (16:25)
            </div>
                    <div><a class="audio-title" href="https://jamanetwork.com/learning/audio-player/18635651" target="_blank" aria-label="Linked Multimedia Button">USPSTF Recommendation: Screening for Prediabetes and Type 2 Diabetes</a></div>
                <div id="audio-player-wrapper" class="js-audio-player-wrapper audio-player-wrapper">
            <audio class="js-audio-player" id="audio-player" type="audio/mp3" preload="none" src=https://traffic.libsyn.com/jamaclinicalreviews/uspstf_recommendation__screening_for_prediabetes_and_type_2_diabetes.mp3></audio>
            <div class="display-elements">
                <div class="audio-controls">
                    <a id="backward" class="js-btn-backward audio-back" href="javascript:;" aria-label="Back Button">
                        <img src="//cdn.jamanetwork.com/UI/app/svg/multimedia/Backward_15.svg" alt="Backward 15" />
                    </a>
                    <a id="play-pause" class="js-play-pause audio-play" href="javascript:;" aria-label="Play Button">
                        <img src="//cdn.jamanetwork.com/UI/app/svg/multimedia/Play.svg" alt="Play" />
                    </a>
                    <a id="play-pause" class="js-play-pause audio-pause" href="javascript:;" aria-label="Pause Button">
                        <img src="//cdn.jamanetwork.com/UI/app/svg/multimedia/Pause.svg" alt="Pause" />
                    </a>
                    <a id="forward" class="js-btn-forward audio-forward" href="javascript:;" aria-label="Fast Forward Button">
                        <img src="//cdn.jamanetwork.com/UI/app/svg/multimedia/Forward_15.svg" alt="Forward 15" />
                    </a>
                </div>
                <div class="js-progressBar-clickable progressBar-clickable">
                    <div class="js-progressBar progressBar">
                        <div class="js-loading-animation">
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                            <div class="loading-blade thm-bg-col sb-pc"></div>
                        </div>
                        <div class="js-timeBar timeBar thm-bg-col sb-background-pc" tabindex="0" aria-label="Progress Bar"></div>
                    </div>
                </div>
                <div class="audio-speed">
                    <a id="speed-1x" class="js-btn-speed" play-speed=1 href="javascript:;" aria-label="Speed Control Button">1x</a>
                </div>
                <div class="audio-time">
                    <span id="time" class="js-time js-timeAudioCurrent">0:00</span>
                    <span> / </span>
                    <span class="js-initialTime">0:00</span>
                    <span class="js-duration hide"></span>
                </div>
            </div>
        </div>
            <div class="linked-content-urls-wrapper">
                            <span><a class="thm-col sb-pc linked-content" target="_blank" href="https://jamanetwork.com/journals/jama/pages/jama-clinical-reviews" aria-label="Subscribe To Podcast Button">Subscribe to Podcast</a></span>

            </div>
        
    </div>
 
    </div>
    <div class="widget-MultimediaInfo widget-instance-AMA_LinkedContentToolbar_AuthorInterviews">
        





 
    </div>

    </div>

    
    <div id="listen-to-this-article-tab" class="linked-content-tab linked-listen-to-this-article-tab">
    <div class="widget-AudioPlayer widget-instance-AMA_LinkedContentToolbar_PlatformAudioPlayer_ListenToThisArticle">
         
    </div>

    </div>

    
    <div id="more-multimedia-tab" class="linked-content-tab more-multimedia-tab">
    <div class="widget-MultimediaInfo widget-instance-AMA_LinkedContentToolbar_MoreMultimedia">
        

<div class="multimedia-item brightcove extrinsic-video">
        <a class="multimedia-link  sb-anchor-light" target="_blank" href="https://jamanetwork.com/learning/video-player/18668918">
                    <span class="multimedia-group-type">Video</span>
                    <span class="multimedia-duration">(7:14)</span>
                            <div class="multimedia-title sb-tc">
                    <div class="multimedia-title">Screening for Prediabetes</div>
                </div>
        </a>
    </div>


            <span class="hide tagmanagervalue" data-attribute="arrRelatedVideo" data-value="10.1001/jama.2021.24012" data-type="array"></span>


 
    </div>

    </div>
</div>
</div> 
    </div>

            <div class="widget-ArticleFulltext widget-instance-AMA_Article_FullText_Widget">
        <div class="article-full-text" data-userHasAccess="True">
    

            <a class="article-section-id-anchor" id="248067107"></a>
                        <div class="h3 cb section-type-abstract decorated-hed ">

                            <div class="heading-text thm-col sb-sc">
                                Abstract
                            </div>
                        </div>
<p><strong>Importance</strong> 
    <span>An estimated 13% of all US adults (18 years or older) have diabetes, and 34.5% meet criteria for prediabetes. The prevalences of prediabetes and diabetes are higher in older adults. Estimates of the risk of progression from prediabetes to diabetes vary widely, perhaps because of differences in the definition of prediabetes or the heterogeneity of prediabetes. Diabetes is the leading cause of kidney failure and new cases of blindness among adults in the US. It is also associated with increased risks of cardiovascular disease, nonalcoholic fatty liver disease, and nonalcoholic steatohepatitis and was estimated to be the seventh leading cause of death in the US in 2017. Screening asymptomatic adults for prediabetes and type 2 diabetes may allow earlier detection, diagnosis, and treatment, with the ultimate goal of improving health outcomes.</span></p><p><strong>Objective</strong> 
    <span>To update its 2015 recommendation, the USPSTF commissioned a systematic review to evaluate screening for prediabetes and type 2 diabetes in asymptomatic, nonpregnant adults and preventive interventions for those with prediabetes.</span></p><p><strong>Population</strong> 
    <span>Nonpregnant adults aged 35 to 70 years seen in primary care settings who have overweight or obesity (defined as a body mass index ≥25 and ≥30, respectively) and no symptoms of diabetes.</span></p><p><strong>Evidence Assessment</strong> 
    <span>The USPSTF concludes with moderate certainty that screening for prediabetes and type 2 diabetes and offering or referring patients with prediabetes to effective preventive interventions has a moderate net benefit.</span></p><p><strong>Conclusions and Recommendation</strong> 
    <span>The USPSTF recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 years who have overweight or obesity. Clinicians should offer or refer patients with prediabetes to effective preventive interventions. (B recommendation)</span></p>            <div class="movable-ad-target bta"> </div>
            <a class="article-section-id-anchor" id="248067113"></a>
                        <div class="h3 cb section-type-section  ">

                            <div class="heading-text thm-col sb-sc">
                                Summary of Recommendation
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248067115"></a>
<p class="para">See the Summary of Recommendation figure.</p>            <a class="article-section-id-anchor" id="248067116"></a>
                        <div class="h3 cb section-type-section  ">

                            <div class="heading-text thm-col sb-sc">
                                Importance
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248067117"></a>
<p class="para">According to the Centers for Disease Control and Prevention 2020 National Diabetes Statistics Report, an estimated 13% of all US adults (18 years or older) have diabetes, and 34.5% meet criteria for prediabetes.<sup><a href="#jus210018r1" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">1</a></sup> The prevalence of prediabetes and diabetes are higher in older adults. Of persons with diabetes, 21.4% were not aware of or did not report having diabetes, and only 15.3% of persons with prediabetes reported being told by a health professional that they had this condition.<sup><a href="#jus210018r1" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">1</a></sup> Estimates of the risk of progression from prediabetes to diabetes vary widely, perhaps because of differences in the definition of prediabetes or the heterogeneity of prediabetes.<sup><a href="#jus210018r2" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">2</a></sup> A large cohort study of 77 107 persons with prediabetes reported that the risk of developing diabetes increased with increasing hemoglobin A<sub>1c</sub> (HbA<sub>1c</sub>) level and with increasing body mass index (BMI).<sup><a href="#jus210018r3" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">3</a></sup></p>            <a class="article-section-id-anchor" id="248067118"></a>
<p class="para"><a name="q1"><span style="display:none;">Quiz Ref ID</span></a><span class="quizSection">Diabetes is the leading cause of kidney failure and new cases of blindness among adults in the US. It is also associated with increased risks of cardiovascular disease (CVD), nonalcoholic fatty liver disease, and nonalcoholic steatohepatitis<sup><a href="#jus210018r4" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">4</a></sup><sup>-<a href="#jus210018r4" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">6</a></sup> and was estimated to be the seventh leading cause of death in the US in 2017.<sup><a href="#jus210018r1" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">1</a></sup> Screening asymptomatic adults for prediabetes and type 2 diabetes may allow earlier detection, diagnosis, and treatment, with the ultimate goal of improving health outcomes.</span></p>            <a class="article-section-id-anchor" id="248067119"></a>
                        <div class="h3 cb section-type-section  ">

                            <div class="heading-text thm-col sb-sc">
                                USPSTF Assessment of Magnitude of Net Benefit
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248067120"></a>
<p class="para">The US Preventive Services Task Force (USPSTF) concludes with moderate certainty that screening for prediabetes and type 2 diabetes and offering or referring patients with prediabetes to effective preventive interventions has a <strong>moderate net benefit</strong> (<a href="#jus210018t1" class="table-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Table</a>).</p>            <a class="article-section-id-anchor" id="248067122"></a>
<p class="para">See the <a href="#jus210018t1" class="table-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Table</a> for more information on the USPSTF recommendation rationale and assessment and the eFigure in the <a class="supplement-link section-jump-link" data-tab-toggle=".tab-nav-supplemental" href="#note-JUS210018-1">Supplement</a> for information on the recommendation grade. See the <a href="#jus210018f1" class="figure-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Figure</a> for a summary of the recommendation for clinicians. For more details on the methods the USPSTF uses to determine the net benefit, see the USPSTF Procedure Manual.<sup><a href="#jus210018r7" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">7</a></sup></p>            <a class="article-section-id-anchor" id="248067124"></a>
                        <div class="h3 cb section-type-section  ">

                            <div class="heading-text thm-col sb-sc">
                                Practice Considerations
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248067125"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Patient Population Under Consideration
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248067126"></a>
<p class="para"><a name="q2"><span style="display:none;">Quiz Ref ID</span></a><span class="quizSection">This recommendation applies to nonpregnant adults aged 35 to 70 years seen in primary care settings who have overweight or obesity (defined as a BMI ≥25 [calculated as weight in kilograms divided by height in meters squared] and ≥30, respectively) and no symptoms of diabetes.</span></p>            <a class="article-section-id-anchor" id="248067127"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Assessment of Risk
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248067128"></a>
<p class="para">Overweight and obesity are the strongest risk factors for developing prediabetes and type 2 diabetes in adults.<sup><a href="#jus210018r8" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">8</a></sup> Other risk factors include older age, family history, history of gestational diabetes, history of polycystic ovarian syndrome, and dietary and lifestyle factors.<sup><a href="#jus210018r8" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">8</a></sup><sup>,<a href="#jus210018r9" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">9</a></sup> The prevalence of diabetes is higher among American Indian/Alaska Native (14.7%), Asian (9.2%), Hispanic/Latino (12.5%), and non-Hispanic Black (11.7%) persons than among non-Hispanic White (7.5%) persons.<sup><a href="#jus210018r1" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">1</a></sup> Disparities in diabetes prevalence are the result of a variety of factors. A large body of evidence demonstrates strong associations between prevalence of diabetes and social factors such as socioeconomic status, food environment, and physical environment.<sup><a href="#jus210018r10" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">10</a></sup> The higher prevalence of diabetes in Asian persons may be related to differences in body composition. A difference in body fat composition in Asian persons results in underestimation of risk based on BMI thresholds used to define overweight in the US.<sup><a href="#jus210018r11" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">11</a></sup></p>            <a class="article-section-id-anchor" id="248067129"></a>
<p class="para"><a name="q3"><span style="display:none;">Quiz Ref ID</span></a><span class="quizSection">Clinicians should consider screening at an earlier age in persons from groups with disproportionately high incidence and prevalence (American Indian/Alaska Native, Asian American, Black, Hispanic/Latino, or Native Hawaiian/Pacific Islander persons) or in persons who have a family history of diabetes, a history of gestational diabetes, or a history of polycystic ovarian syndrome, and at a lower BMI in Asian American persons.<sup><a href="#jus210018r11" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">11</a></sup><sup>,<a href="#jus210018r12" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">12</a></sup> Data suggest that a BMI of 23 or greater may be an appropriate cut point in Asian American persons.<sup><a href="#jus210018r13" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">13</a></sup></span></p>            <a class="article-section-id-anchor" id="248067130"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Screening Tests
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248067131"></a>
<p class="para">Prediabetes and type 2 diabetes can be detected by measuring fasting plasma glucose or HbA<sub>1c</sub> level, or with an oral glucose tolerance test. A fasting plasma glucose level of 126 mg/dL (6.99 mmol/L) or greater, an HbA<sub>1c</sub> level of 6.5% or greater, or a 2-hour postload glucose level of 200 mg/dL (11.1 mmol/L) or greater are consistent with the diagnosis of type 2 diabetes. A fasting plasma glucose level of 100 to 125 mg/dL (5.55-6.94 mmol/L), an HbA<sub>1c</sub> level of 5.7% to 6.4%, or a 2-hour postload glucose level of 140 to 199 mg/dL (7.77-11.04 mmol/L) are consistent with prediabetes.<sup><a href="#jus210018r14" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">14</a></sup></p>            <a class="article-section-id-anchor" id="248067132"></a>
<p class="para">HbA<sub>1c</sub> is a measure of long-term blood glucose concentration and is not affected by acute changes in glucose levels caused by stress or illness. Because HbA<sub>1c</sub> measurements do not require fasting, they are more convenient than using a fasting plasma glucose level or an oral glucose tolerance test. Both fasting plasma glucose and HbA<sub>1c</sub> levels are simpler to measure than performing an oral glucose tolerance test. The oral glucose tolerance test is done in the morning in a fasting state; blood glucose concentration is measured 2 hours after ingestion of a 75-g oral glucose load. The diagnosis of type 2 diabetes should be confirmed with repeat testing.<sup><a href="#jus210018r14" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">14</a></sup></p>            <a class="article-section-id-anchor" id="248067133"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Screening Intervals
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248067134"></a>
<p class="para">Evidence on the optimal screening interval for adults with an initial normal glucose test result is limited. Cohort and modeling studies suggest that screening every 3 years may be a reasonable approach for adults with normal blood glucose levels.<sup><a href="#jus210018r15" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">15</a></sup><sup>-<a href="#jus210018r15" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">17</a></sup></p>            <a class="article-section-id-anchor" id="248067135"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Preventive Interventions
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248067136"></a>
<p class="para">Both lifestyle interventions that focus on diet, physical activity, or both and metformin have demonstrated efficacy in preventing or delaying progression to diabetes in persons with prediabetes.<sup><a href="#jus210018r2" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">2</a></sup> However, metformin has not been approved for this specific indication by the US Food and Drug Administration.</p>            <a class="article-section-id-anchor" id="248067137"></a>
<p class="para">Clinicians and patients may want to consider several other factors as they discuss preventive interventions for prediabetes. In the Diabetes Prevention Program (DPP) study (which serves as a model for many lifestyle intervention programs in the US), lifestyle intervention was more effective than metformin in preventing or delaying diabetes. In addition to preventing progression to diabetes, lifestyle interventions have a beneficial effect on weight, blood pressure, and lipid levels (increasing high-density lipoprotein cholesterol levels and lowering triglyceride levels). Metformin has a beneficial effect on weight, but it does not appear to affect blood pressure, or to consistently improve lipid levels.<sup><a href="#jus210018r2" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">2</a></sup> In post hoc analyses of the DPP, lifestyle intervention was effective in all subgroups, while similar analyses of the DPP and the DPP Outcomes Study (DPPOS) suggest that metformin was effective in persons younger than 60 years, in persons with a BMI of 35 or greater, in persons with a fasting plasma glucose level of 110 mg/dL (6.11 mmol/L) or greater, or in persons with a history of gestational diabetes.<sup><a href="#jus210018r18" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">18</a></sup><sup>,<a href="#jus210018r19" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">19</a></sup></p>            <a class="article-section-id-anchor" id="248067138"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Additional Tools and Resources
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248067139"></a>
<p class="para">The Centers for Disease Control and Prevention has several resources related to the diagnosis, prevention, and treatment of prediabetes and type 2 diabetes available at <a href="https://www.cdc.gov/diabetes/index.html">https://www.cdc.gov/diabetes/index.html</a> and <a href="https://www.cdc.gov/diabetes/prevent-type-2/index.html">https://www.cdc.gov/diabetes/prevent-type-2/index.html</a>, as well as information on the National Diabetes Prevention Program at <a href="https://www.cdc.gov/diabetes/prevention/index.html">https://www.cdc.gov/diabetes/prevention/index.html</a>.</p>            <a class="article-section-id-anchor" id="248067140"></a>
<p class="para">The National Institutes of Health has several resources related to screening, diagnosis, prevention, and management of prediabetes and type 2 diabetes available at <a href="https://www.niddk.nih.gov/health-information/professionals/clinical-tools-patient-management/diabetes">https://www.niddk.nih.gov/health-information/professionals/clinical-tools-patient-management/diabetes</a>.</p>            <a class="article-section-id-anchor" id="248067141"></a>
<p class="para">The Community Preventive Services Task Force recommends diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk (<a href="https://www.thecommunityguide.org/findings/diabetes-combined-diet-and-physical-activity-promotion-programs-prevent-type-2-diabetes">https://www.thecommunityguide.org/findings/diabetes-combined-diet-and-physical-activity-promotion-programs-prevent-type-2-diabetes</a>).</p>            <a class="article-section-id-anchor" id="248067142"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Other Related USPSTF Recommendations
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248067143"></a>
<p class="para">The USPSTF recommends offering or referring adults with a BMI of 30 or greater to intensive, multicomponent behavioral interventions.<sup><a href="#jus210018r20" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">20</a></sup></p>            <a class="article-section-id-anchor" id="248067144"></a>
                        <div class="h3 cb section-type-section  ">

                            <div class="heading-text thm-col sb-sc">
                                Update of Previous USPSTF Recommendation
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248067145"></a>
<p class="para">This recommendation replaces the 2015 USPSTF recommendation statement on screening for abnormal blood glucose levels and type 2 diabetes in asymptomatic adults. In 2015, the USPSTF recommended screening for abnormal blood glucose levels as part of cardiovascular risk assessment in adults aged 40 to 70 years who have overweight or obesity. The USPSTF also recommended that clinicians should offer or refer patients with abnormal blood glucose levels to intensive behavioral counseling interventions to promote a healthful diet and physical activity.<sup><a href="#jus210018r21" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">21</a></sup> For the current recommendation statement, the USPSTF recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 years who have overweight or obesity, and that clinicians should offer or refer patients with prediabetes to effective preventive interventions. Based on data suggesting that the incidence of diabetes increases at age 35 years compared with younger ages<sup><a href="#jus210018r22" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">22</a></sup> and on the evidence for the benefits of interventions for newly diagnosed diabetes (discussed below), the USPSTF has decreased the age at which to begin screening to 35 years.</p>            <a class="article-section-id-anchor" id="248067146"></a>
                        <div class="h3 cb section-type-section  ">

                            <div class="heading-text thm-col sb-sc">
                                Supporting Evidence
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248067147"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Scope of Review
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248067148"></a>
<p class="para">To update its 2015 recommendation statement, the USPSTF commissioned a systematic review<sup><a href="#jus210018r2" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">2</a></sup><sup>,<a href="#jus210018r23" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">23</a></sup> of the evidence on screening for prediabetes and type 2 diabetes in asymptomatic, nonpregnant adults and preventive interventions for those with prediabetes. This review focused on direct evidence on the benefits and harms of screening for prediabetes and type 2 diabetes and the benefits and harms of interventions (such as behavioral counseling focused on diet, physical activity, or both, or pharmacotherapy for glycemic, blood pressure, or lipid control, compared with no treatment or usual care) for screen-detected prediabetes and type 2 diabetes or recently diagnosed type 2 diabetes. The review also looked at the evidence on the effectiveness of interventions for prediabetes to delay or prevent progression to type 2 diabetes.</p>            <a class="article-section-id-anchor" id="248067149"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Benefits of Early Detection and Treatment
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248067150"></a>
                        <div class="h5 cb section-type-section  ">

                            <div class="heading-text ">
                                Screening for Diabetes
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248067151"></a>
<p class="para">The USPSTF found 2 randomized clinical trials, the Anglo-Danish-Dutch Study of Intensive Treatment In People with Screen Detected Diabetes in Primary Care (ADDITION)–Cambridge (n = 20 184 participants)<sup><a href="#jus210018r24" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">24</a></sup><sup>-<a href="#jus210018r24" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">26</a></sup> and the Ely study (n = 4936 participants),<sup><a href="#jus210018r27" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">27</a></sup><sup>-<a href="#jus210018r27" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">29</a></sup> that evaluated the effect of screening for diabetes on health outcomes. ADDITION-Cambridge was a cluster randomized trial that randomly assigned practices to no screening, screening followed by intensive treatment of screen-detected diabetes (HbA<sub>1c</sub> target &lt;7.0%, blood pressure target ≤135/85 mm Hg, and cholesterol targets, and low-dose aspirin use unless contraindicated), or screening followed by routine care of screen-detected diabetes. In the Ely study, the treatment of persons with screen-detected diabetes was managed by primary care clinicians as they deemed appropriate. Neither trial found a reduction in all-cause or type-specific mortality with screening compared with no screening over approximately 10 years of follow-up, which notably may have been too short to detect an effect on health outcomes. Neither trial found statistically significant differences in cardiovascular events, quality of life, nephropathy, or neuropathy between screening and control groups, but data collection for these outcomes was limited to a minority of trial participants.</p>            <a class="article-section-id-anchor" id="248067152"></a>
                        <div class="h5 cb section-type-section  ">

                            <div class="heading-text ">
                                Effect of Interventions for Screen-Detected Type 2 Diabetes or Prediabetes on Health Outcomes
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248067153"></a>
<p class="para">One randomized clinical trial (ADDITION-Europe)<sup><a href="#jus210018r30" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">30</a></sup><sup>-<a href="#jus210018r30" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">33</a></sup> evaluated interventions for persons with screen-detected type 2 diabetes. It found no difference over 5 to 10 years of follow-up between an intensive multifactorial intervention aimed at controlling glucose, blood pressure, and cholesterol levels and routine care in the risk of all-cause mortality, cardiovascular-related mortality, occurrence of a first cardiovascular event, chronic kidney disease, visual impairment, or neuropathy. Follow-up may have been too short in this trial to detect an effect on the health outcomes of interest.</p>            <a class="article-section-id-anchor" id="248067154"></a>
<p class="para">Thirty-eight trials that assessed behavioral or pharmacologic interventions for prediabetes reported on health outcomes.<sup><a href="#jus210018r2" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">2</a></sup><sup>,<a href="#jus210018r23" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">23</a></sup> Overall, trials found no statistically significant differences in all-cause mortality or CVD events, and no difference or only small improvements in quality of life scores that are not likely clinically significant. Follow-up duration in most of these trials may have been too short to detect an effect on health outcomes. One trial, the Da Qing Diabetes Prevention Study comparing a 6-year lifestyle intervention (diet, exercise, or both) with control, found lower all-cause mortality and CVD-related mortality in the combined intervention groups vs control group at 23 and 30 years of follow-up, though not at 20 years of follow-up (all-cause mortality: 28.1% vs 38.4%; hazard ratio [HR], 0.71 [95% CI, 0.51 to 0.99] at 23 years and 45.7% vs 56.3%; HR, 0.74 [95% CI, 0.61 to 0.89] at 30 years; CVD-related mortality: 11.9% vs 19.6%; HR, 0.59 [95% CI, 0.36 to 0.96] at 23 years and 29.6% vs 22.0%; HR, 0.67 [95% CI, 0.48 to 0.94] at 30 years).<sup><a href="#jus210018r34" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">34</a></sup><sup>,<a href="#jus210018r35" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">35</a></sup> However, this trial was limited by baseline differences between intervention and control groups that were likely to bias results in favor of the intervention.</p>            <a class="article-section-id-anchor" id="248067155"></a>
                        <div class="h5 cb section-type-section  ">

                            <div class="heading-text ">
                                Effect of Interventions for Newly or Recently Diagnosed Type 2 Diabetes on Health Outcomes
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248067156"></a>
<p class="para">The UK Prospective Diabetes Study (UKPDS) and 2 other studies reported the effect of interventions for newly diagnosed diabetes on health outcomes. The UKPDS found that all-cause mortality, diabetes-related mortality, and myocardial infarction were improved with intensive glucose control with sulfonylureas or insulin over 20 years (10-year posttrial assessment) but not at shorter follow-up. Intensive glucose control was associated with a decreased risk for all-cause mortality (relative risk [RR], 0.87 [95% CI, 0.79 to 0.96]), diabetes-related mortality (RR, 0.83 [95% CI, 0.73 to 0.96]), and myocardial infarction (RR, 0.85 [95% CI, 0.74 to 0.97]) over 20 years.<sup><a href="#jus210018r36" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">36</a></sup><sup>,<a href="#jus210018r37" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">37</a></sup> For persons who had overweight, intensive glucose control with metformin decreased all-cause mortality (RR, 0.64 [95% CI, 0.45 to 0.91]), diabetes-related mortality (RR, 0.58 [95% CI, 0.37 to 0.91]), and myocardial infarction (RR, 0.61 [95% CI, 0.41 to 0.89]) at the 10-year follow-up, and benefits were maintained during the subsequent 10 years of posttrial follow-up.<sup><a href="#jus210018r37" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">37</a></sup><sup>,<a href="#jus210018r38" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">38</a></sup></p>            <a class="article-section-id-anchor" id="248067157"></a>
<p class="para">The other 2 studies found no statistically significant difference between intervention and control groups in all-cause mortality and risk of myocardial infarction; however, these studies were limited by short duration of follow-up, small study size, or both. The Diabetes Education and Self Management for Ongoing and Newly Diagnosed (DESMOND) trial<sup><a href="#jus210018r39" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">39</a></sup><sup>,<a href="#jus210018r40" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">40</a></sup> found no statistically significant difference in all-cause mortality between persons randomly assigned to group education and those randomly assigned to the control group over 1 and 3 years of follow-up. Another trial (n = 150)<sup><a href="#jus210018r41" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">41</a></sup> found no statistically significant difference in myocardial infarction over 7 years of follow-up.</p>            <a class="article-section-id-anchor" id="248067158"></a>
                        <div class="h5 cb section-type-section  ">

                            <div class="heading-text ">
                                Effect of Interventions for Prediabetes on Progression to Diabetes
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248067159"></a>
<p class="para"><a name="q4"><span style="display:none;">Quiz Ref ID</span></a><span class="quizSection">Twenty-three trials compared lifestyle interventions with a control group for delaying or preventing the onset of type 2 diabetes.<sup><a href="#jus210018r2" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">2</a></sup><sup>,<a href="#jus210018r23" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">23</a></sup> In most trials (18 trials), the lifestyle interventions focused on both diet/nutrition and physical activity, and most (18 trials) delivered high-contact lifestyle interventions, defined as intervention contact time of more than 360 minutes. Most of the trials focused on persons with impaired glucose tolerance. Meta-analysis of the 23 trials found that lifestyle interventions were associated with a reduction in progression to diabetes (pooled RR, 0.78 [95% CI, 0.69 to 0.88]; n = 12 915 participants). In post hoc analyses, the DPP reported that lifestyle intervention was effective in all subgroups and treatment effects did not differ by age, sex, race and ethnicity, or BMI after 3 years of follow-up.<sup><a href="#jus210018r18" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">18</a></sup></span></p>            <a class="article-section-id-anchor" id="248067160"></a>
<p class="para">Several trials also reported the effects of lifestyle interventions on intermediate outcomes. In pooled analyses, lifestyle interventions were associated with a reduction in weight (pooled weighted mean difference [WMD], −1.2 kg [95% CI, −1.6 to −0.7 kg]) and BMI (pooled WMD, −0.54 [95% CI, −0.76 to −0.33]). In addition, lifestyle interventions were associated with a reduction in both systolic and diastolic blood pressure (pooled WMD, −1.7 mm Hg [95% CI, −2.6 to −0.8 mm Hg] and pooled WMD, −1.2 mm Hg [95% CI, −2.0 to −0.4 mm Hg], respectively), and high-contact lifestyle interventions were associated with reduced triglyceride levels and increased high-density lipoprotein cholesterol levels.<sup><a href="#jus210018r2" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">2</a></sup><sup>,<a href="#jus210018r23" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">23</a></sup></p>            <a class="article-section-id-anchor" id="248067161"></a>
<p class="para"><a name="q5"><span style="display:none;">Quiz Ref ID</span></a><span class="quizSection">Fifteen trials evaluated pharmacologic interventions to delay or prevent diabetes.<sup><a href="#jus210018r2" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">2</a></sup><sup>,<a href="#jus210018r23" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">23</a></sup> For metformin, meta-analysis of 3 trials found that it was associated with a reduction in the incidence of diabetes (pooled RR, 0.73 [95% CI, 0.64 to 0.83]).<sup><a href="#jus210018r2" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">2</a></sup><sup>,<a href="#jus210018r23" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">23</a></sup> In post hoc analyses, the DPP reported that the effect associated with use of metformin compared with placebo was not statistically significantly different after 3 years of follow-up for subgroups defined by age, sex, or race and ethnicity. The analysis reported a statistically significant effect modification by BMI, with greater effect on diabetes incidence for persons with a higher BMI (eg, reduction in diabetes incidence, 53% [95% CI, 36% to 65%] for BMI ≥35 vs 3% [95% CI, −36% to 30%] for BMI of 22 to &lt;30).<sup><a href="#jus210018r18" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">18</a></sup> For both thiazolidinediones and α-glucosidase inhibitors, meta-analysis of 3 trials each found associations with a reduction in the incidence of diabetes, but the results were limited by imprecision and inconsistency across trials.<sup><a href="#jus210018r2" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">2</a></sup><sup>,<a href="#jus210018r23" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">23</a></sup> Other pharmacologic interventions seeking to delay or prevent diabetes have been studied, but only in 1 study each.<sup><a href="#jus210018r2" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">2</a></sup></span></p>            <a class="article-section-id-anchor" id="248067162"></a>
<p class="para">Two trials reported the effects of metformin on intermediate outcomes. The DPP (n = 2155) reported greater decreases in weight for persons receiving metformin compared with those receiving placebo (−2.0 kg [95% CI, −3.2 to −0.8 kg]).<sup><a href="#jus210018r18" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">18</a></sup> The Promotora Effectiveness Versus Metformin Trial (PREVENT-DM) of metformin also found that participants in the intervention group had greater decreases in weight and BMI, but the differences were not statistically significant.<sup><a href="#jus210018r42" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">42</a></sup> Both trials reported no significant difference in blood pressure among persons receiving metformin compared with placebo.<sup><a href="#jus210018r42" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">42</a></sup><sup>,<a href="#jus210018r43" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">43</a></sup> The DPP reported a greater increase in high-density lipoprotein levels for persons receiving metformin compared with those receiving placebo after 3 years (difference between groups, 0.40 [95% CI, 0.15 to 0.65]) but no difference between groups for other lipid levels,<sup><a href="#jus210018r43" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">43</a></sup> whereas the PREVENT-DM study (n = 92) found no statistically significant difference in lipid levels between metformin and control groups at 1 year.<sup><a href="#jus210018r42" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">42</a></sup></p>            <a class="article-section-id-anchor" id="248067163"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Harms of Screening and Treatment
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248067164"></a>
<p class="para">Some of the trials reporting on the benefits of screening and interventions for prediabetes and type 2 diabetes also reported harms. Overall, the ADDITION-Cambridge and Ely trials, and a pilot study of ADDITION-Cambridge,<sup><a href="#jus210018r28" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">28</a></sup><sup>,<a href="#jus210018r29" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">29</a>,<a href="#jus210018r44" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">44</a></sup><sup>-<a href="#jus210018r44" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">46</a></sup> did not find clinically significant differences between screening and control groups in measures of anxiety, depression, worry, or self-reported health. However, the results suggest possible short-term increases in anxiety (at 6 weeks) among persons screened and diagnosed with diabetes compared with those screened and not diagnosed with diabetes.</p>            <a class="article-section-id-anchor" id="248067165"></a>
<p class="para">Harms of interventions for screen-detected or recently diagnosed type 2 diabetes were sparsely reported and, when reported, were rare and not significantly different between intervention and control groups across trials.<sup><a href="#jus210018r2" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">2</a></sup><sup>,<a href="#jus210018r23" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">23</a></sup> The UKPDS trial reported 1 patient of 911 in the intervention group receiving insulin who died from hypoglycemia, and serious hypoglycemic events requiring medical attention in 6 of 619 participants (1%) receiving chlorpropamide, 9 of 615 (1.5%) receiving glibenclamide, 16 of 911 (1.8%) receiving insulin, and 6 of 896 (0.7%) in the conventional care group.<sup><a href="#jus210018r36" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">36</a></sup></p>            <a class="article-section-id-anchor" id="248067166"></a>
<p class="para">Several trials reported on harms associated with interventions for prediabetes. Four studies of pharmacotherapy interventions reported on any hypoglycemia and found no difference between interventions and placebo over 8 weeks to 5 years. Three trials found higher rates of gastrointestinal adverse events associated with metformin. Although not reported in studies, lactic acidosis is a rare but potentially serious adverse effect of metformin, primarily in persons with significant renal impairment.<sup><a href="#jus210018r47" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">47</a></sup> In studies of lifestyle interventions that reported on musculoskeletal events, 1 study found no significant difference between groups for rates of joint sprains/strains or muscle or joint aches over 1 year, 1 study found few cases of musculoskeletal problems (&lt;1% per group), and 1 study (the DPP) found higher rates of musculoskeletal symptoms per 100 person-years in the intensive lifestyle intervention group than in the control group (24.1 vs 21.1 events per 100 person-years; <i>P</i> &lt; .017).<sup><a href="#jus210018r2" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">2</a></sup><sup>,<a href="#jus210018r23" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">23</a></sup></p>            <a class="article-section-id-anchor" id="248067167"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Response to Public Comment
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248067168"></a>
<p class="para">A draft version of this recommendation statement was posted for public comment on the USPSTF website from March 16 to April 12, 2021. Many comments agreed with the USPSTF recommendation. In response to public comment, the USPSTF clarified that disparities in the prevalence of prediabetes and type 2 diabetes are due to social factors and not biological ones, and incorporated person-first language when referring to persons who have overweight or obesity. Some comments requested broadening the eligibility criteria for screening to all adults, or to persons with any risk factor for diabetes, and not confined to persons who have overweight or obesity. The USPSTF appreciates these perspectives; however, the available evidence best supports screening starting at age 35 years. The USPSTF also added language clarifying that overweight and obesity are the strongest risk factors for developing prediabetes and type 2 diabetes. In response to comments, the USPSTF also noted that metformin appears to be effective in reducing the risk of progression from prediabetes to diabetes in persons with a history of gestational diabetes, based on post hoc analyses of the DPP and DPPOS.</p>            <a class="article-section-id-anchor" id="248067169"></a>
                        <div class="h3 cb section-type-section  ">

                            <div class="heading-text thm-col sb-sc">
                                Research Needs and Gaps
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248067170"></a>
<p class="para">More research is needed to evaluate the following.</p>            <a class="article-section-id-anchor" id="248067171"></a>
<p class="para"><ul class="bullet"><li><p class="para">More studies are needed on the effects of screening on health outcomes that enroll populations reflective of the prevalence of diabetes in the US, particularly racial and ethnic groups that have a higher prevalence of diabetes than White persons.</p></li><li><p class="para">More US data are needed on the effects of lifestyle interventions and medical treatments for screen-detected prediabetes and diabetes on health outcomes over a longer follow-up period, particularly in populations reflective of the prevalence of diabetes.</p></li><li><p class="para">More research is needed on how best to increase uptake of lifestyle interventions, especially among populations at highest risk for progression to diabetes and adverse health outcomes.</p></li><li><p class="para">Clinical trials and additional modeling studies are needed to better elucidate the optimal frequency of screening and the age at which to start and stop screening.</p></li><li><p class="para">More research is needed on the natural history of prediabetes, including the identification of factors associated with risk of progression to diabetes or reversion to normoglycemia.</p></li></ul></p>            <a class="article-section-id-anchor" id="248067172"></a>
                        <div class="h3 cb section-type-section  ">

                            <div class="heading-text thm-col sb-sc">
                                Recommendations of Others
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="248067173"></a>
<p class="para">The American Diabetes Association<sup><a href="#jus210018r48" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">48</a></sup> recommends universal screening for prediabetes and diabetes, using a fasting plasma glucose level, 2-hour plasma glucose level during a 75-g oral glucose tolerance test, or HbA<sub>1c</sub> level, for all adults 45 years or older, regardless of risk factors, and screening adults who have overweight or obesity (BMI ≥25 or ≥23 in Asian American persons) with 1 or more risk factors, regardless of age. If the results are normal, it recommends repeat screening at a minimum of 3-year intervals. The American Association of Clinical Endocrinology<sup><a href="#jus210018r49" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">49</a></sup> recommends universal screening for prediabetes and diabetes for all adults 45 years or older, regardless of risk factors, and screening persons with risk factors for diabetes (regardless of age). Testing for prediabetes and diabetes can be done using a fasting plasma glucose level, 2-hour plasma glucose level during a 75-g oral glucose tolerance test, or HbA<sub>1c</sub> level. It recommends repeat screening every 3 years.</p>            <a class="article-section-id-anchor" id="248067174"></a>
                        <div class="h3 cb section-type-acknowledgements  has-back-to-top">
                                <a href="#top" class="section-jump-link back-to-top" data-tab-toggle=".tab-nav-full-text">Back to top</a>

                            <div class="heading-text thm-col sb-sc">
                                Article Information
                            </div>
                        </div>
<p class="authorInfoSection"><strong>Corresponding Author:</strong> Karina W. Davidson, PhD, MASc, Feinstein Institutes for Medical Research, 130 E 59th St, Ste 14C, New York, NY 10032(<a href="mailto:chair@uspstf.net" target="_blank">chair@uspstf.net</a>)</p><p class="para"><strong>Accepted for Publication:</strong> July 20, 2021.</p><p class="paracorrection-note"><strong>Correction: </strong>This article was corrected on October 26, 2021, to fix an unclear diagnostic testing standard in the Practice Considerations section.</p><p class="paranonbyline-authors-end"><strong>The US Preventive Services Task Force (USPSTF) members:</strong> Karina W. Davidson, PhD, MASc; Michael J. Barry, MD; Carol M. Mangione, MD, MSPH; Michael Cabana, MD, MA, MPH; Aaron B. Caughey, MD, PhD; Esa M. Davis, MD, MPH; Katrina E. Donahue, MD, MPH; Chyke A. Doubeni, MD, MPH; Alex H. Krist, MD, MPH; Martha Kubik, PhD, RN; Li Li, MD, PhD, MPH; Gbenga Ogedegbe, MD, MPH; Douglas K. Owens, MD, MS; Lori Pbert, PhD; Michael Silverstein, MD, MPH; James Stevermer, MD, MSPH; Chien-Wen Tseng, MD, MPH, MSEE; John B. Wong, MD.</p><p class="paranonbyline-affils-end"><strong>Affiliations of The US Preventive Services Task Force (USPSTF) members: </strong>Feinstein Institutes for Medical Research at Northwell Health, Manhasset, New York (Davidson); Harvard Medical School, Boston, Massachusetts (Barry); University of California, Los Angeles (Mangione); Albert Einstein College of Medicine, New York, New York (Cabana); Oregon Health &amp; Science University, Portland (Caughey); University of Pittsburgh, Pittsburgh, Pennsylvania (Davis); University of North Carolina at Chapel Hill (Donahue); Mayo Clinic, Rochester, Minnesota (Doubeni); Fairfax Family Practice Residency, Fairfax, Virginia (Krist); Virginia Commonwealth University, Richmond (Krist); George Mason University, Fairfax, Virginia (Kubik); University of Virginia, Charlottesville (Li); New York University, New York, New York (Ogedegbe); Stanford University, Stanford, California (Owens); University of Massachusetts Medical School, Worcester (Pbert); Boston University, Boston, Massachusetts (Silverstein); University of Missouri, Columbia (Stevermer); University of Hawaii, Honolulu (Tseng); Pacific Health Research and Education Institute, Honolulu, Hawaii (Tseng); Tufts University School of Medicine, Boston, Massachusetts (Wong).</p><p class="paraauthor-contributions"><strong>Author Contributions:</strong> Dr Davidson had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The USPSTF members contributed equally to the recommendation statement.</p><p class="parafinancial-disclosure"><strong>Conflict of Interest Disclosures:</strong>  Authors followed the policy regarding conflicts of interest described at <a href="https://www.uspreventiveservicestaskforce.org/Page/Name/conflict-of-interest-disclosures">https://www.uspreventiveservicestaskforce.org/Page/Name/conflict-of-interest-disclosures</a>. All members of the USPSTF receive travel reimbursement and an honorarium for participating in USPSTF meetings.</p><p class="parafunding-statement"><strong>Funding/Support:</strong> The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.</p><p class="para"><strong>Role of the Funder/Sponsor:</strong> AHRQ staff assisted in the following: development and review of the research plan, commission of the systematic evidence review from an Evidence-based Practice Center, coordination of expert review and public comment of the draft evidence report and draft recommendation statement, and the writing and preparation of the final recommendation statement and its submission for publication. AHRQ staff had no role in the approval of the final recommendation statement or the decision to submit for publication.</p><p class="para"><strong>Disclaimer:</strong> Recommendations made by the USPSTF are independent of the US government. They should not be construed as an official position of AHRQ or the US Department of Health and Human Services.</p><p class="para"><strong>Additional Contributions:</strong> We thank Howard Tracer, MD (AHRQ), who contributed to the writing of the manuscript, and Lisa Nicolella, MA (AHRQ), who assisted with coordination and editing.</p><p class="para"><strong>Additional Information:</strong> The US Preventive Services Task Force (USPSTF) makes recommendations about the effectiveness of specific preventive care services for patients without obvious related signs or symptoms. It bases its recommendations on the evidence of both the benefits and harms of the service and an assessment of the balance. The USPSTF does not consider the costs of providing a service in this assessment. The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision-making to the specific patient or situation. Similarly, the USPSTF notes that policy and coverage decisions involve considerations in addition to the evidence of clinical benefits and harms.</p>            <a class="article-section-id-anchor" id="248067175"></a>
                        <div class="h3 cb section-type-references  ">

                            <div class="heading-text thm-col sb-sc">
                                References
                            </div>
                        </div>
<div class="references"><div class="reference"><a class="reference-number" id="jus210018r1">1.</a><div class="reference-content">Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020. Accessed June 29, 2021. <a href="https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf">https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf</a></div></div><div class="reference"><a class="reference-number" id="jus210018r2">2.</a><div class="reference-content">Jonas
         D﻿, Crotty
         K﻿, Yun
         JD﻿, 
     et al. <i xmlns:helper="urn:XsltStringHelper"> Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: An Evidence Review for the U.S. Preventive Services Task Force. Evidence Synthesis No. 207</i>.  Agency for Healthcare Research and Quality; 2021. AHRQ publication 21-05276-EF-1.</div></div><div class="reference"><a class="reference-number" id="jus210018r3">3.</a><div class="reference-content">Glauber
         H﻿, Vollmer
         WM﻿, Nichols
         GA﻿.  A simple model for predicting two-year risk of diabetes development in individuals with prediabetes. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Perm J</i>. 2018;22:17-050.<a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/29309270" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=A%20simple%20model%20for%20predicting%20two-year%20risk%20of%20diabetes%20development%20in%20individuals%20with%20prediabetes.&amp;author=H%20Glauber&amp;author=WM%20Vollmer&amp;author=GA%20Nichols&amp;publication_year=2018&amp;journal=Perm%20J&amp;volume=22&amp;pages=17-050" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jus210018r4">4.</a><div class="reference-content">Leon
         BM﻿, Maddox
         TM﻿.  Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. ﻿ <i xmlns:helper="urn:XsltStringHelper"> World J Diabetes</i>. 2015;6(13):1246-1258. doi:<a href="http://dx.doi.org/10.4239/wjd.v6.i13.1246">10.4239/wjd.v6.i13.1246</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/26468341" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Diabetes%20and%20cardiovascular%20disease%3A%20epidemiology%2C%20biological%20mechanisms%2C%20treatment%20recommendations%20and%20future%20research.&amp;author=BM%20Leon&amp;author=TM%20Maddox&amp;publication_year=2015&amp;journal=World%20J%20Diabetes&amp;volume=6&amp;pages=1246-1258" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.4239/wjd.v6.i13.1246" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.4239/wjd.v6.i13.1246" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r5">5.</a><div class="reference-content">Portillo-Sanchez
         P﻿, Bril
         F﻿, Maximos
         M﻿, 
     et al.  High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels. ﻿ <i xmlns:helper="urn:XsltStringHelper"> J Clin Endocrinol Metab</i>. 2015;100(6):2231-2238. doi:<a href="http://dx.doi.org/10.1210/jc.2015-1966">10.1210/jc.2015-1966</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/25885947" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=High%20prevalence%20of%20nonalcoholic%20fatty%20liver%20disease%20in%20patients%20with%20type%202%20diabetes%20mellitus%20and%20normal%20plasma%20aminotransferase%20levels.&amp;author=P%20Portillo-Sanchez&amp;author=F%20Bril&amp;author=M%20Maximos&amp;publication_year=2015&amp;journal=J%20Clin%20Endocrinol%20Metab&amp;volume=100&amp;pages=2231-2238" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1210/jc.2015-1966" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1210/jc.2015-1966" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r6">6.</a><div class="reference-content">Younossi
         ZM﻿, Golabi
         P﻿, de Avila
         L﻿, 
     et al.  The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. ﻿ <i xmlns:helper="urn:XsltStringHelper"> J Hepatol</i>. 2019;71(4):793-801. doi:<a href="http://dx.doi.org/10.1016/j.jhep.2019.06.021">10.1016/j.jhep.2019.06.021</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/31279902" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=The%20global%20epidemiology%20of%20NAFLD%20and%20NASH%20in%20patients%20with%20type%202%20diabetes%3A%20a%20systematic%20review%20and%20meta-analysis.&amp;author=ZM%20Younossi&amp;author=P%20Golabi&amp;author=L%20de Avila&amp;publication_year=2019&amp;journal=J%20Hepatol&amp;volume=71&amp;pages=793-801" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/j.jhep.2019.06.021" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/j.jhep.2019.06.021" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r7">7.</a><div class="reference-content">Procedure Manual. US Preventive Services Task Force. Published May 2021. Accessed June 29, 2021. <a href="https://uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual">https://uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual</a></div></div><div class="reference"><a class="reference-number" id="jus210018r8">8.</a><div class="reference-content">Zheng
         Y﻿, Ley
         SH﻿, Hu
         FB﻿.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Nat Rev Endocrinol</i>. 2018;14(2):88-98. doi:<a href="http://dx.doi.org/10.1038/nrendo.2017.151">10.1038/nrendo.2017.151</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/29219149" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Global%20aetiology%20and%20epidemiology%20of%20type%202%20diabetes%20mellitus%20and%20its%20complications.&amp;author=Y%20Zheng&amp;author=SH%20Ley&amp;author=FB%20Hu&amp;publication_year=2018&amp;journal=Nat%20Rev%20Endocrinol&amp;volume=14&amp;pages=88-98" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1038/nrendo.2017.151" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1038/nrendo.2017.151" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r9">9.</a><div class="reference-content">Rubin
         KH﻿, Glintborg
         D﻿, Nybo
         M﻿, Abrahamsen
         B﻿, Andersen
         M﻿.  Development and risk factors of type 2 diabetes in a nationwide population of women with polycystic ovary syndrome. ﻿ <i xmlns:helper="urn:XsltStringHelper"> J Clin Endocrinol Metab</i>. 2017;102(10):3848-3857. doi:<a href="http://dx.doi.org/10.1210/jc.2017-01354">10.1210/jc.2017-01354</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/28938447" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Development%20and%20risk%20factors%20of%20type%202%20diabetes%20in%20a%20nationwide%20population%20of%20women%20with%20polycystic%20ovary%20syndrome.&amp;author=KH%20Rubin&amp;author=D%20Glintborg&amp;author=M%20Nybo&amp;author=B%20Abrahamsen&amp;author=M%20Andersen&amp;publication_year=2017&amp;journal=J%20Clin%20Endocrinol%20Metab&amp;volume=102&amp;pages=3848-3857" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1210/jc.2017-01354" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1210/jc.2017-01354" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r10">10.</a><div class="reference-content">Hill-Briggs
         F﻿, Adler
         NE﻿, Berkowitz
         SA﻿, 
     et al.  Social determinants of health and diabetes: a scientific review. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetes Care</i>. 2020;44(1):258-279. doi:<a href="http://dx.doi.org/10.2337/dci20-0053">10.2337/dci20-0053</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/33139407" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Social%20determinants%20of%20health%20and%20diabetes%3A%20a%20scientific%20review.&amp;author=F%20Hill-Briggs&amp;author=NE%20Adler&amp;author=SA%20Berkowitz&amp;publication_year=2020&amp;journal=Diabetes%20Care&amp;volume=44&amp;pages=258-279" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.2337/dci20-0053" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.2337/dci20-0053" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r11">11.</a><div class="reference-content">Diabetes and Asian Americans. Centers for Disease Control and Prevention. Accessed June 29, 2021. <a href="https://www.cdc.gov/diabetes/library/spotlights/diabetes-asian-americans.html">https://www.cdc.gov/diabetes/library/spotlights/diabetes-asian-americans.html</a></div></div><div class="reference"><a class="reference-number" id="jus210018r12">12.</a><div class="reference-content">Lee
         JW﻿, Brancati
         FL﻿, Yeh
         HC﻿.  Trends in the prevalence of type 2 diabetes in Asians versus Whites: results from the United States National Health Interview Survey, 1997-2008. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetes Care</i>. 2011;34(2):353-357. doi:<a href="http://dx.doi.org/10.2337/dc10-0746">10.2337/dc10-0746</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/21216863" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Trends%20in%20the%20prevalence%20of%20type%202%20diabetes%20in%20Asians%20versus%20Whites%3A%20results%20from%20the%20United%20States%20National%20Health%20Interview%20Survey%2C%201997-2008.&amp;author=JW%20Lee&amp;author=FL%20Brancati&amp;author=HC%20Yeh&amp;publication_year=2011&amp;journal=Diabetes%20Care&amp;volume=34&amp;pages=353-357" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.2337/dc10-0746" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.2337/dc10-0746" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r13">13.</a><div class="reference-content">Araneta
         MR﻿, Kanaya
         AM﻿, Hsu
         WC﻿, 
     et al.  Optimum BMI cut points to screen Asian Americans for type 2 diabetes. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetes Care</i>. 2015;38(5):814-820. doi:<a href="http://dx.doi.org/10.2337/dc14-2071">10.2337/dc14-2071</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/25665815" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Optimum%20BMI%20cut%20points%20to%20screen%20Asian%20Americans%20for%20type%202%20diabetes.&amp;author=MR%20Araneta&amp;author=AM%20Kanaya&amp;author=WC%20Hsu&amp;publication_year=2015&amp;journal=Diabetes%20Care&amp;volume=38&amp;pages=814-820" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.2337/dc14-2071" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.2337/dc14-2071" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r14">14.</a><div class="reference-content">American Diabetes Association.  Classification and diagnosis of diabetes: standards of medical care in diabetes—2020. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetes Care</i>. 2020;43(suppl 1):S14-S31. doi:<a href="http://dx.doi.org/10.2337/dc20-S002">10.2337/dc20-S002</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/31862745" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Classification%20and%20diagnosis%20of%20diabetes%3A%20standards%20of%20medical%20care%20in%20diabetes%E2%80%942020.&amp;publication_year=2020&amp;journal=Diabetes%20Care&amp;volume=43&amp;pages=S14-S31" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.2337/dc20-S002" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.2337/dc20-S002" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r15">15.</a><div class="reference-content">Takahashi
         O﻿, Farmer
         AJ﻿, Shimbo
         T﻿, Fukui
         T﻿, Glasziou
         PP﻿.  A1C to detect diabetes in healthy adults: when should we recheck? ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetes Care</i>. 2010;33(9):2016-2017. doi:<a href="http://dx.doi.org/10.2337/dc10-0588">10.2337/dc10-0588</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/20566678" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=A1C%20to%20detect%20diabetes%20in%20healthy%20adults%3A%20when%20should%20we%20recheck%3F&amp;author=O%20Takahashi&amp;author=AJ%20Farmer&amp;author=T%20Shimbo&amp;author=T%20Fukui&amp;author=PP%20Glasziou&amp;publication_year=2010&amp;journal=Diabetes%20Care&amp;volume=33&amp;pages=2016-2017" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.2337/dc10-0588" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.2337/dc10-0588" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r16">16.</a><div class="reference-content">Kahn
         R﻿, Alperin
         P﻿, Eddy
         D﻿, 
     et al.  Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet</i>. 2010;375(9723):1365-1374. doi:<a href="http://dx.doi.org/10.1016/S0140-6736(09)62162-0">10.1016/S0140-6736(09)62162-0</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/20356621" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Age%20at%20initiation%20and%20frequency%20of%20screening%20to%20detect%20type%202%20diabetes%3A%20a%20cost-effectiveness%20analysis.&amp;author=R%20Kahn&amp;author=P%20Alperin&amp;author=D%20Eddy&amp;publication_year=2010&amp;journal=Lancet&amp;volume=375&amp;pages=1365-1374" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S0140-6736(09)62162-0" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S0140-6736(09)62162-0" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r17">17.</a><div class="reference-content">Herman
         WH﻿, Ye
         W﻿, Griffin
         SJ﻿, 
     et al.  Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe). ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetes Care</i>. 2015;38(8):1449-1455. doi:<a href="http://dx.doi.org/10.2337/dc14-2459">10.2337/dc14-2459</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/25986661" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Early%20detection%20and%20treatment%20of%20type%202%20diabetes%20reduce%20cardiovascular%20morbidity%20and%20mortality%3A%20a%20simulation%20of%20the%20results%20of%20the%20Anglo-Danish-Dutch%20Study%20of%20Intensive%20Treatment%20in%20People%20With%20Screen-Detected%20Diabetes%20in%20Primary%20Care%20%28ADDITION-Europe%29.&amp;author=WH%20Herman&amp;author=W%20Ye&amp;author=SJ%20Griffin&amp;publication_year=2015&amp;journal=Diabetes%20Care&amp;volume=38&amp;pages=1449-1455" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.2337/dc14-2459" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.2337/dc14-2459" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r18">18.</a><div class="reference-content">Knowler
         WC﻿, Barrett-Connor
         E﻿, Fowler
         SE﻿, 
     et al; Diabetes Prevention Program Research Group.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. ﻿ <i xmlns:helper="urn:XsltStringHelper"> N Engl J Med</i>. 2002;346(6):393-403. doi:<a href="http://dx.doi.org/10.1056/NEJMoa012512">10.1056/NEJMoa012512</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/11832527" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Reduction%20in%20the%20incidence%20of%20type%202%20diabetes%20with%20lifestyle%20intervention%20or%20metformin.&amp;author=WC%20Knowler&amp;author=E%20Barrett-Connor&amp;author=SE%20Fowler&amp;publication_year=2002&amp;journal=N%20Engl%20J%20Med&amp;volume=346&amp;pages=393-403" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jus210018r19">19.</a><div class="reference-content">Diabetes Prevention Program Research Group.  Long-term effects of metformin on diabetes prevention: identification of subgroups that benefited most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetes Care</i>. 2019;42(4):601-608. doi:<a href="http://dx.doi.org/10.2337/dc18-1970">10.2337/dc18-1970</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/30877090" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Long-term%20effects%20of%20metformin%20on%20diabetes%20prevention%3A%20identification%20of%20subgroups%20that%20benefited%20most%20in%20the%20Diabetes%20Prevention%20Program%20and%20Diabetes%20Prevention%20Program%20Outcomes%20Study.&amp;publication_year=2019&amp;journal=Diabetes%20Care&amp;volume=42&amp;pages=601-608" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.2337/dc18-1970" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.2337/dc18-1970" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r20">20.</a><div class="reference-content">Curry
         SJ﻿, Krist
         AH﻿, Owens
         DK﻿, 
     et al; US Preventive Services Task Force.  Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force recommendation statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. 2018;320(11):1163-1171. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2018.13022">10.1001/jama.2018.13022</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/30326502" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Behavioral%20weight%20loss%20interventions%20to%20prevent%20obesity-related%20morbidity%20and%20mortality%20in%20adults%3A%20US%20Preventive%20Services%20Task%20Force%20recommendation%20statement.&amp;author=SJ%20Curry&amp;author=AH%20Krist&amp;author=DK%20Owens&amp;publication_year=2018&amp;journal=JAMA&amp;volume=320&amp;pages=1163-1171" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jus210018r21">21.</a><div class="reference-content">Siu
         AL﻿; US Preventive Services Task Force.  Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Ann Intern Med</i>. 2015;163(11):861-868. doi:<a href="http://dx.doi.org/10.7326/M15-2345">10.7326/M15-2345</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/26501513" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Screening%20for%20abnormal%20blood%20glucose%20and%20type%202%20diabetes%20mellitus%3A%20U.S.%20Preventive%20Services%20Task%20Force%20recommendation%20statement.&amp;author=AL%20Siu&amp;publication_year=2015&amp;journal=Ann%20Intern%20Med&amp;volume=163&amp;pages=861-868" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.7326/M15-2345" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.7326/M15-2345" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r22">22.</a><div class="reference-content">Chung
         S﻿, Azar
         KM﻿, Baek
         M﻿, Lauderdale
         DS﻿, Palaniappan
         LP﻿.  Reconsidering the age thresholds for type II diabetes screening in the U.S. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Am J Prev Med</i>. 2014;47(4):375-381. doi:<a href="http://dx.doi.org/10.1016/j.amepre.2014.05.012">10.1016/j.amepre.2014.05.012</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/25131213" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Reconsidering%20the%20age%20thresholds%20for%20type%20II%20diabetes%20screening%20in%20the%20U.S.&amp;author=S%20Chung&amp;author=KM%20Azar&amp;author=M%20Baek&amp;author=DS%20Lauderdale&amp;author=LP%20Palaniappan&amp;publication_year=2014&amp;journal=Am%20J%20Prev%20Med&amp;volume=47&amp;pages=375-381" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/j.amepre.2014.05.012" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/j.amepre.2014.05.012" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r23">23.</a><div class="reference-content">Jonas
         DE﻿, Crotty
         K﻿, Yun
         JD﻿, 
     et al.  Screening for prediabetes and type 2 diabetes: updated evidence report and systematic review for the US Preventive Services Task Force. ﻿ <i xmlns:helper="urn:XsltStringHelper"> JAMA</i>. Published August 24, 2021. doi:<a href="http://jamanetwork.com/article.aspx?doi=10.1001/jama.2021.10403">10.1001/jama.2021.10403</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Screening%20for%20prediabetes%20and%20type%202%20diabetes%3A%20updated%20evidence%20report%20and%20systematic%20review%20for%20the%20US%20Preventive%20Services%20Task%20Force.&amp;author=DE%20Jonas&amp;author=K%20Crotty&amp;author=JD%20Yun&amp;publication_year=2021&amp;journal=JAMA&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jus210018r24">24.</a><div class="reference-content">Echouffo-Tcheugui
         JB﻿, Simmons
         RK﻿, Williams
         KM﻿, 
     et al.  The ADDITION-Cambridge trial protocol: a cluster-randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients. ﻿ <i xmlns:helper="urn:XsltStringHelper"> BMC Public Health</i>. 2009;9:136. doi:<a href="http://dx.doi.org/10.1186/1471-2458-9-136">10.1186/1471-2458-9-136</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/19435491" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=The%20ADDITION-Cambridge%20trial%20protocol%3A%20a%20cluster-randomised%20controlled%20trial%20of%20screening%20for%20type%202%20diabetes%20and%20intensive%20treatment%20for%20screen-detected%20patients.&amp;author=JB%20Echouffo-Tcheugui&amp;author=RK%20Simmons&amp;author=KM%20Williams&amp;publication_year=2009&amp;journal=BMC%20Public%20Health&amp;volume=9&amp;pages=136" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1186/1471-2458-9-136" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1186/1471-2458-9-136" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r25">25.</a><div class="reference-content">Simmons
         RK﻿, Echouffo-Tcheugui
         JB﻿, Sharp
         SJ﻿, 
     et al.  Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet</i>. 2012;380(9855):1741-1748. doi:<a href="http://dx.doi.org/10.1016/S0140-6736(12)61422-6">10.1016/S0140-6736(12)61422-6</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/23040422" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Screening%20for%20type%202%20diabetes%20and%20population%20mortality%20over%2010%20years%20%28ADDITION-Cambridge%29%3A%20a%20cluster-randomised%20controlled%20trial.&amp;author=RK%20Simmons&amp;author=JB%20Echouffo-Tcheugui&amp;author=SJ%20Sharp&amp;publication_year=2012&amp;journal=Lancet&amp;volume=380&amp;pages=1741-1748" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S0140-6736(12)61422-6" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S0140-6736(12)61422-6" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r26">26.</a><div class="reference-content">Echouffo-Tcheugui
         JB﻿, Simmons
         RK﻿, Prevost
         AT﻿, 
     et al.  Long-term effect of population screening for diabetes on cardiovascular morbidity, self-rated health, and health behavior. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Ann Fam Med</i>. 2015;13(2):149-157. doi:<a href="http://dx.doi.org/10.1370/afm.1737">10.1370/afm.1737</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/25755036" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Long-term%20effect%20of%20population%20screening%20for%20diabetes%20on%20cardiovascular%20morbidity%2C%20self-rated%20health%2C%20and%20health%20behavior.&amp;author=JB%20Echouffo-Tcheugui&amp;author=RK%20Simmons&amp;author=AT%20Prevost&amp;publication_year=2015&amp;journal=Ann%20Fam%20Med&amp;volume=13&amp;pages=149-157" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1370/afm.1737" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1370/afm.1737" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r27">27.</a><div class="reference-content">Simmons
         RK﻿, Rahman
         M﻿, Jakes
         RW﻿, 
     et al.  Effect of population screening for type 2 diabetes on mortality: long-term follow-up of the Ely cohort. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetologia</i>. 2011;54(2):312-319. doi:<a href="http://dx.doi.org/10.1007/s00125-010-1949-8">10.1007/s00125-010-1949-8</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/20978739" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Effect%20of%20population%20screening%20for%20type%202%20diabetes%20on%20mortality%3A%20long-term%20follow-up%20of%20the%20Ely%20cohort.&amp;author=RK%20Simmons&amp;author=M%20Rahman&amp;author=RW%20Jakes&amp;publication_year=2011&amp;journal=Diabetologia&amp;volume=54&amp;pages=312-319" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1007/s00125-010-1949-8" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1007/s00125-010-1949-8" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r28">28.</a><div class="reference-content">Rahman
         M﻿, Simmons
         RK﻿, Hennings
         SH﻿, Wareham
         NJ﻿, Griffin
         SJ﻿.  How much does screening bring forward the diagnosis of type 2 diabetes and reduce complications? twelve year follow-up of the Ely cohort. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetologia</i>. 2012;55(6):1651-1659. doi:<a href="http://dx.doi.org/10.1007/s00125-011-2441-9">10.1007/s00125-011-2441-9</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/22237689" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=How%20much%20does%20screening%20bring%20forward%20the%20diagnosis%20of%20type%202%20diabetes%20and%20reduce%20complications%3F%20twelve%20year%20follow-up%20of%20the%20Ely%20cohort.&amp;author=M%20Rahman&amp;author=RK%20Simmons&amp;author=SH%20Hennings&amp;author=NJ%20Wareham&amp;author=SJ%20Griffin&amp;publication_year=2012&amp;journal=Diabetologia&amp;volume=55&amp;pages=1651-1659" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1007/s00125-011-2441-9" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1007/s00125-011-2441-9" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r29">29.</a><div class="reference-content">Rahman
         M﻿, Simmons
         RK﻿, Hennings
         SH﻿, Wareham
         NJ﻿, Griffin
         SJ﻿.  Effect of screening for type 2 diabetes on population-level self-rated health outcomes and measures of cardiovascular risk: 13-year follow-up of the Ely cohort. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabet Med</i>. 2012;29(7):886-892. doi:<a href="http://dx.doi.org/10.1111/j.1464-5491.2012.03570.x">10.1111/j.1464-5491.2012.03570.x</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/22283392" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Effect%20of%20screening%20for%20type%202%20diabetes%20on%20population-level%20self-rated%20health%20outcomes%20and%20measures%20of%20cardiovascular%20risk%3A%2013-year%20follow-up%20of%20the%20Ely%20cohort.&amp;author=M%20Rahman&amp;author=RK%20Simmons&amp;author=SH%20Hennings&amp;author=NJ%20Wareham&amp;author=SJ%20Griffin&amp;publication_year=2012&amp;journal=Diabet%20Med&amp;volume=29&amp;pages=886-892" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1111/dme.2012.29.issue-7" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1111/dme.2012.29.issue-7" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r30">30.</a><div class="reference-content">Griffin
         SJ﻿, Borch-Johnsen
         K﻿, Davies
         MJ﻿, 
     et al.  Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet</i>. 2011;378(9786):156-167. doi:<a href="http://dx.doi.org/10.1016/S0140-6736(11)60698-3">10.1016/S0140-6736(11)60698-3</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/21705063" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Effect%20of%20early%20intensive%20multifactorial%20therapy%20on%205-year%20cardiovascular%20outcomes%20in%20individuals%20with%20type%202%20diabetes%20detected%20by%20screening%20%28ADDITION-Europe%29%3A%20a%20cluster-randomised%20trial.&amp;author=SJ%20Griffin&amp;author=K%20Borch-Johnsen&amp;author=MJ%20Davies&amp;publication_year=2011&amp;journal=Lancet&amp;volume=378&amp;pages=156-167" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S0140-6736(11)60698-3" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S0140-6736(11)60698-3" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r31">31.</a><div class="reference-content">Simmons
         RK﻿, Sharp
         SJ﻿, Sandbæk
         A﻿, 
     et al.  Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? findings from the ADDITION-Europe cluster-randomized trial. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabet Med</i>. 2012;29(11):e409-e416. doi:<a href="http://dx.doi.org/10.1111/j.1464-5491.2012.03759.x">10.1111/j.1464-5491.2012.03759.x</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/22823477" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Does%20early%20intensive%20multifactorial%20treatment%20reduce%20total%20cardiovascular%20burden%20in%20individuals%20with%20screen-detected%20diabetes%3F%20findings%20from%20the%20ADDITION-Europe%20cluster-randomized%20trial.&amp;author=RK%20Simmons&amp;author=SJ%20Sharp&amp;author=A%20Sandbæk&amp;publication_year=2012&amp;journal=Diabet%20Med&amp;volume=29&amp;pages=e409-e416" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1111/dme.2012.29.issue-11" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1111/dme.2012.29.issue-11" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r32">32.</a><div class="reference-content">Simmons
         RK﻿, Borch-Johnsen
         K﻿, Lauritzen
         T﻿, 
     et al.  A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Health Technol Assess</i>. 2016;20(64):1-86. doi:<a href="http://dx.doi.org/10.3310/hta20640">10.3310/hta20640</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/27583404" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=A%20randomised%20trial%20of%20the%20effect%20and%20cost-effectiveness%20of%20early%20intensive%20multifactorial%20therapy%20on%205-year%20cardiovascular%20outcomes%20in%20individuals%20with%20screen-detected%20type%202%20diabetes%3A%20the%20Anglo-Danish-Dutch%20Study%20of%20Intensive%20Treatment%20in%20People%20With%20Screen-Detected%20Diabetes%20in%20Primary%20Care%20%28ADDITION-Europe%29%20study.&amp;author=RK%20Simmons&amp;author=K%20Borch-Johnsen&amp;author=T%20Lauritzen&amp;publication_year=2016&amp;journal=Health%20Technol%20Assess&amp;volume=20&amp;pages=1-86" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.3310/hta20640" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.3310/hta20640" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r33">33.</a><div class="reference-content">Griffin
         SJ﻿, Rutten
         GEHM﻿, Khunti
         K﻿, 
     et al.  Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet Diabetes Endocrinol</i>. 2019;7(12):925-937. doi:<a href="http://dx.doi.org/10.1016/S2213-8587(19)30349-3">10.1016/S2213-8587(19)30349-3</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/31748169" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Long-term%20effects%20of%20intensive%20multifactorial%20therapy%20in%20individuals%20with%20screen-detected%20type%202%20diabetes%20in%20primary%20care%3A%2010-year%20follow-up%20of%20the%20ADDITION-Europe%20cluster-randomised%20trial.&amp;author=SJ%20Griffin&amp;author=GEHM%20Rutten&amp;author=K%20Khunti&amp;publication_year=2019&amp;journal=Lancet%20Diabetes%20Endocrinol&amp;volume=7&amp;pages=925-937" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S2213-8587(19)30349-3" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S2213-8587(19)30349-3" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r34">34.</a><div class="reference-content">Li
         G﻿, Zhang
         P﻿, Wang
         J﻿, 
     et al.  Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet Diabetes Endocrinol</i>. 2014;2(6):474-480. doi:<a href="http://dx.doi.org/10.1016/S2213-8587(14)70057-9">10.1016/S2213-8587(14)70057-9</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/24731674" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Cardiovascular%20mortality%2C%20all-cause%20mortality%2C%20and%20diabetes%20incidence%20after%20lifestyle%20intervention%20for%20people%20with%20impaired%20glucose%20tolerance%20in%20the%20Da%20Qing%20Diabetes%20Prevention%20Study%3A%20a%2023-year%20follow-up%20study.&amp;author=G%20Li&amp;author=P%20Zhang&amp;author=J%20Wang&amp;publication_year=2014&amp;journal=Lancet%20Diabetes%20Endocrinol&amp;volume=2&amp;pages=474-480" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S2213-8587(14)70057-9" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S2213-8587(14)70057-9" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r35">35.</a><div class="reference-content">Gong
         Q﻿, Zhang
         P﻿, Wang
         J﻿, 
     et al; Da Qing Diabetes Prevention Study Group.  Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet Diabetes Endocrinol</i>. 2019;7(6):452-461. doi:<a href="http://dx.doi.org/10.1016/S2213-8587(19)30093-2">10.1016/S2213-8587(19)30093-2</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/31036503" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Morbidity%20and%20mortality%20after%20lifestyle%20intervention%20for%20people%20with%20impaired%20glucose%20tolerance%3A%2030-year%20results%20of%20the%20Da%20Qing%20Diabetes%20Prevention%20Outcome%20Study.&amp;author=Q%20Gong&amp;author=P%20Zhang&amp;author=J%20Wang&amp;publication_year=2019&amp;journal=Lancet%20Diabetes%20Endocrinol&amp;volume=7&amp;pages=452-461" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S2213-8587(19)30093-2" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S2213-8587(19)30093-2" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r36">36.</a><div class="reference-content">UK Prospective Diabetes Study (UKPDS) Group.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet</i>. 1998;352(9131):837-853. doi:<a href="http://dx.doi.org/10.1016/S0140-6736(98)07019-6">10.1016/S0140-6736(98)07019-6</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/9742976" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Intensive%20blood-glucose%20control%20with%20sulphonylureas%20or%20insulin%20compared%20with%20conventional%20treatment%20and%20risk%20of%20complications%20in%20patients%20with%20type%202%20diabetes%20%28UKPDS%2033%29.&amp;publication_year=1998&amp;journal=Lancet&amp;volume=352&amp;pages=837-853" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S0140-6736(98)07019-6" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S0140-6736(98)07019-6" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r37">37.</a><div class="reference-content">Holman
         RR﻿, Paul
         SK﻿, Bethel
         MA﻿, Matthews
         DR﻿, Neil
         HA﻿.  10-Year follow-up of intensive glucose control in type 2 diabetes. ﻿ <i xmlns:helper="urn:XsltStringHelper"> N Engl J Med</i>. 2008;359(15):1577-1589. doi:<a href="http://dx.doi.org/10.1056/NEJMoa0806470">10.1056/NEJMoa0806470</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/18784090" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=10-Year%20follow-up%20of%20intensive%20glucose%20control%20in%20type%202%20diabetes.&amp;author=RR%20Holman&amp;author=SK%20Paul&amp;author=MA%20Bethel&amp;author=DR%20Matthews&amp;author=HA%20Neil&amp;publication_year=2008&amp;journal=N%20Engl%20J%20Med&amp;volume=359&amp;pages=1577-1589" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1056/NEJMoa0806470" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1056/NEJMoa0806470" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r38">38.</a><div class="reference-content">UK Prospective Diabetes Study (UKPDS) Group.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). ﻿ <i xmlns:helper="urn:XsltStringHelper"> Lancet</i>. 1998;352(9131):854-865. doi:<a href="http://dx.doi.org/10.1016/S0140-6736(98)07037-8">10.1016/S0140-6736(98)07037-8</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/9742977" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Effect%20of%20intensive%20blood-glucose%20control%20with%20metformin%20on%20complications%20in%20overweight%20patients%20with%20type%202%20diabetes%20%28UKPDS%2034%29.&amp;publication_year=1998&amp;journal=Lancet&amp;volume=352&amp;pages=854-865" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/S0140-6736(98)07037-8" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/S0140-6736(98)07037-8" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r39">39.</a><div class="reference-content">Davies
         MJ﻿, Heller
         S﻿, Skinner
         TC﻿, 
     et al; Diabetes Education and Self Management for Ongoing and Newly Diagnosed Collaborative.  Effectiveness of the Diabetes Education and Self Management for Ongoing and Newly Diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. ﻿ <i xmlns:helper="urn:XsltStringHelper"> BMJ</i>. 2008;336(7642):491-495. doi:<a href="http://dx.doi.org/10.1136/bmj.39474.922025.BE">10.1136/bmj.39474.922025.BE</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/18276664" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Effectiveness%20of%20the%20Diabetes%20Education%20and%20Self%20Management%20for%20Ongoing%20and%20Newly%20Diagnosed%20%28DESMOND%29%20programme%20for%20people%20with%20newly%20diagnosed%20type%202%20diabetes%3A%20cluster%20randomised%20controlled%20trial.&amp;author=MJ%20Davies&amp;author=S%20Heller&amp;author=TC%20Skinner&amp;publication_year=2008&amp;journal=BMJ&amp;volume=336&amp;pages=491-495" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1136/bmj.39474.922025.BE" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1136/bmj.39474.922025.BE" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r40">40.</a><div class="reference-content">Khunti
         K﻿, Gray
         LJ﻿, Skinner
         T﻿, 
     et al.  Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care. ﻿ <i xmlns:helper="urn:XsltStringHelper"> BMJ</i>. 2012;344:e2333. doi:<a href="http://dx.doi.org/10.1136/bmj.e2333">10.1136/bmj.e2333</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/22539172" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Effectiveness%20of%20a%20diabetes%20education%20and%20self%20management%20programme%20%28DESMOND%29%20for%20people%20with%20newly%20diagnosed%20type%202%20diabetes%20mellitus%3A%20three%20year%20follow-up%20of%20a%20cluster%20randomised%20controlled%20trial%20in%20primary%20care.&amp;author=K%20Khunti&amp;author=LJ%20Gray&amp;author=T%20Skinner&amp;publication_year=2012&amp;journal=BMJ&amp;volume=344&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jus210018r41">41.</a><div class="reference-content">Yang
         Y﻿, Yao
         JJ﻿, Du
         JL﻿, 
     et al.  Primary prevention of macroangiopathy in patients with short-duration type 2 diabetes by intensified multifactorial intervention: seven-year follow-up of diabetes complications in Chinese. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetes Care</i>. 2013;36(4):978-984. doi:<a href="http://dx.doi.org/10.2337/dc12-0227">10.2337/dc12-0227</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/23230099" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Primary%20prevention%20of%20macroangiopathy%20in%20patients%20with%20short-duration%20type%202%20diabetes%20by%20intensified%20multifactorial%20intervention%3A%20seven-year%20follow-up%20of%20diabetes%20complications%20in%20Chinese.&amp;author=Y%20Yang&amp;author=JJ%20Yao&amp;author=JL%20Du&amp;publication_year=2013&amp;journal=Diabetes%20Care&amp;volume=36&amp;pages=978-984" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.2337/dc12-0227" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.2337/dc12-0227" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r42">42.</a><div class="reference-content">O’Brien
         MJ﻿, Perez
         A﻿, Scanlan
         AB﻿, 
     et al.  PREVENT-DM comparative effectiveness trial of lifestyle intervention and metformin. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Am J Prev Med</i>. 2017;52(6):788-797. doi:<a href="http://dx.doi.org/10.1016/j.amepre.2017.01.008">10.1016/j.amepre.2017.01.008</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/28237635" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=PREVENT-DM%20comparative%20effectiveness%20trial%20of%20lifestyle%20intervention%20and%20metformin.&amp;author=MJ%20O’Brien&amp;author=A%20Perez&amp;author=AB%20Scanlan&amp;publication_year=2017&amp;journal=Am%20J%20Prev%20Med&amp;volume=52&amp;pages=788-797" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1016/j.amepre.2017.01.008" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1016/j.amepre.2017.01.008" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r43">43.</a><div class="reference-content">Ratner
         R﻿, Goldberg
         R﻿, Haffner
         S﻿, 
     et al; Diabetes Prevention Program Research Group.  Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention Program. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetes Care</i>. 2005;28(4):888-894. doi:<a href="http://dx.doi.org/10.2337/diacare.28.4.888">10.2337/diacare.28.4.888</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/15793191" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Impact%20of%20intensive%20lifestyle%20and%20metformin%20therapy%20on%20cardiovascular%20disease%20risk%20factors%20in%20the%20Diabetes%20Prevention%20Program.&amp;author=R%20Ratner&amp;author=R%20Goldberg&amp;author=S%20Haffner&amp;publication_year=2005&amp;journal=Diabetes%20Care&amp;volume=28&amp;pages=888-894" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jus210018r44">44.</a><div class="reference-content">Park
         P﻿, Simmons
         RK﻿, Prevost
         AT﻿, Griffin
         SJ﻿.  Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety: a randomised controlled trial in British general practice. ﻿ <i xmlns:helper="urn:XsltStringHelper"> BMC Public Health</i>. 2008;8:350. doi:<a href="http://dx.doi.org/10.1186/1471-2458-8-350">10.1186/1471-2458-8-350</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/18840266" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Screening%20for%20type%202%20diabetes%20is%20feasible%2C%20acceptable%2C%20but%20associated%20with%20increased%20short-term%20anxiety%3A%20a%20randomised%20controlled%20trial%20in%20British%20general%20practice.&amp;author=P%20Park&amp;author=RK%20Simmons&amp;author=AT%20Prevost&amp;author=SJ%20Griffin&amp;publication_year=2008&amp;journal=BMC%20Public%20Health&amp;volume=8&amp;pages=350" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1186/1471-2458-8-350" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1186/1471-2458-8-350" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r45">45.</a><div class="reference-content">Eborall
         HC﻿, Griffin
         SJ﻿, Prevost
         AT﻿, Kinmonth
         AL﻿, French
         DP﻿, Sutton
         S﻿.  Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial. ﻿ <i xmlns:helper="urn:XsltStringHelper"> BMJ</i>. 2007;335(7618):486. doi:<a href="http://dx.doi.org/10.1136/bmj.39303.723449.55">10.1136/bmj.39303.723449.55</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/17761995" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Psychological%20impact%20of%20screening%20for%20type%202%20diabetes%3A%20controlled%20trial%20and%20comparative%20study%20embedded%20in%20the%20ADDITION%20%28Cambridge%29%20randomised%20controlled%20trial.&amp;author=HC%20Eborall&amp;author=SJ%20Griffin&amp;author=AT%20Prevost&amp;author=AL%20Kinmonth&amp;author=DP%20French&amp;author=S%20Sutton&amp;publication_year=2007&amp;journal=BMJ&amp;volume=335&amp;pages=486" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.1136/bmj.39303.723449.55" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.1136/bmj.39303.723449.55" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r46">46.</a><div class="reference-content">Paddison
         CA﻿, Eborall
         HC﻿, French
         DP﻿, 
     et al.  Predictors of anxiety and depression among people attending diabetes screening: a prospective cohort study embedded in the ADDITION (Cambridge) randomized control trial. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Br J Health Psychol</i>. 2011;16(pt 1):213-226. doi:<a href="http://dx.doi.org/10.1348/135910710X495366">10.1348/135910710X495366</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/21226792" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Predictors%20of%20anxiety%20and%20depression%20among%20people%20attending%20diabetes%20screening%3A%20a%20prospective%20cohort%20study%20embedded%20in%20the%20ADDITION%20%28Cambridge%29%20randomized%20control%20trial.&amp;author=CA%20Paddison&amp;author=HC%20Eborall&amp;author=DP%20French&amp;publication_year=2011&amp;journal=Br%20J%20Health%20Psychol&amp;volume=16&amp;pages=213-226" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="jus210018r47">47.</a><div class="reference-content">Metformin [package insert]. Bristol Myers Squibb. Accessed June 29, 2021. <a href="https://packageinserts.bms.com/pi/pi_glucophage.pdf">https://packageinserts.bms.com/pi/pi_glucophage.pdf</a></div></div><div class="reference"><a class="reference-number" id="jus210018r48">48.</a><div class="reference-content">American Diabetes Association.  Classification and diagnosis of diabetes: standards of medical care in diabetes—2018. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Diabetes Care</i>. 2018;41(suppl 1):S13-S27. doi:<a href="http://dx.doi.org/10.2337/dc18-S002">10.2337/dc18-S002</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/29222373" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Classification%20and%20diagnosis%20of%20diabetes%3A%20standards%20of%20medical%20care%20in%20diabetes%E2%80%942018.&amp;publication_year=2018&amp;journal=Diabetes%20Care&amp;volume=41&amp;pages=S13-S27" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.2337/dc18-S002" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.2337/dc18-S002" xmlns:helper="urn:XsltStringHelper"> </span></div></div><div class="reference"><a class="reference-number" id="jus210018r49">49.</a><div class="reference-content">Handelsman
         Y﻿, Bloomgarden
         ZT﻿, Grunberger
         G﻿, 
     et al.  American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for developing a diabetes mellitus comprehensive care plan—2015. ﻿ <i xmlns:helper="urn:XsltStringHelper"> Endocr Pract</i>. 2015;21(suppl 1):1-87. doi:<a href="http://dx.doi.org/10.4158/EP15672.GLSUPPL">10.4158/EP15672.GLSUPPL</a><a class="pubmed-link" href="https://www.ncbi.nlm.nih.gov/pubmed/25869408" target="_blank" xmlns:helper="urn:XsltStringHelper">PubMed</a><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=American%20Association%20of%20Clinical%20Endocrinologists%20and%20American%20College%20of%20Endocrinology%20clinical%20practice%20guidelines%20for%20developing%20a%20diabetes%20mellitus%20comprehensive%20care%20plan%E2%80%942015.&amp;author=Y%20Handelsman&amp;author=ZT%20Bloomgarden&amp;author=G%20Grunberger&amp;publication_year=2015&amp;journal=Endocr%20Pract&amp;volume=21&amp;pages=1-87" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a><a href="https://doi.org/10.4158/EP15672.GLSUPPL" class="crossref-doi" target="_blank" xmlns:helper="urn:XsltStringHelper">Crossref</a><span class="inst-open-url-holders" data-targetId="10.4158/EP15672.GLSUPPL" xmlns:helper="urn:XsltStringHelper"> </span></div></div></div>

</div>
 
    </div>

        <div class="movable-ad bta">
    <div class="widget-WidgetLoader widget-instance-AMA_AdTag_textbreak_bta_dual">
        
    <div class="SCM-SharedWidgets-AsyncAdLoader" data-url="/AMA/AdTag/AMA_AdTag_textbreak_bta_dual" data-params="{&quot;parameters&quot;:{&quot;siteName&quot;:&quot;jama&quot;,&quot;siteId&quot;:3,&quot;journalId&quot;:67,&quot;adDisplay&quot;:8,&quot;adSection&quot;:&quot;textbreak&quot;,&quot;adPosition&quot;:&quot;bta&quot;,&quot;fromGoogle&quot;:false},&quot;dynamicParameters&quot;:{}}"></div>
 
    </div>

        </div>
    </div> 

</div> 

<div class="hidden-jobs-ad hide">
    <div class="widget-WidgetLoader widget-instance-AMA_JobsAd">
        
<div class="SCM-SharedWidgets-AsyncJobsAdLoader" data-url="/AMA/JobsAd/AMA_JobsAd" data-params="{&quot;parameters&quot;:{&quot;SiteId&quot;:3},&quot;dynamicParameters&quot;:{&quot;localParams&quot;:&quot;[REPLACE_WITH_LOCAL]&quot;}}"></div>
 
    </div>

</div>



<script>
                var App = App || {};
                App.ArticleSplitScreen = App.ArticleSplitScreen || {};
                App.ArticleSplitScreen.siteName = 'jama';
                App.ArticleSplitScreen.siteId = 3;
                App.ArticleSplitScreen.journalId = 67;
                App.ArticleSplitScreen.adDisplay = 'ArticleContentsSkyBox';
                App.ArticleSplitScreen.adSection = "scholarly";
                App.ArticleSplitScreen.adPosition = "contab";
                App.ArticleSplitScreen.controlId = "AMA_AdTag_Contents_Skybox";
                App.ArticleSplitScreen.fromGoogle = "False";
                App.ArticleSplitScreen.slotLocationOverride = "50";

</script> 
    </div>


 
    </div>

    </section>


    <section id="secFooterControl" class="master-footer">
        

        <script>
            var App = App || {};

            function scmByClass(className) {
                return document.getElementsByClassName(className);
            }

            function scmById(id) {
                return document.getElementById(id);
            }

            function scmquery(selector) {
                return document.querySelector(selector);
            }

            function queryAll(selector) {
                return document.querySelectorAll(selector);
            }

            function isTrueString(string) {
                if (typeof string === 'string') {
                    return string.toLowerCase() === 'true';
                }

                return undefined;
            }

            function updateViewportDimensions() {
                var w = window, d = document, e = d.documentElement, g = d.getElementsByTagName('body')[0], x = w.innerWidth || e.clientWidth || g.clientWidth, y = w.innerHeight || e.clientHeight || g.clientHeight;
                return { width: x, height: y };
            }

            var viewport = updateViewportDimensions();

            var debounce = function (func, wait, immediate) {
                var timeout;
                return function () {
                    var context = this, args = arguments;
                    var later = function () {
                        timeout = null;
                        if (!immediate) func.apply(context, args);
                    };
                    var callNow = immediate && !timeout;
                    clearTimeout(timeout);
                    timeout = setTimeout(later, wait);
                    if (callNow) func.apply(context, args);
                };
            };

            (function (App) {
                App.mobileUpperBreakpoint = 767;
                App.mobileAltBreakpoint = 640;
                App.mobileMinBreakpoint = 547;
                App.tabletUpperBreakpoint = 1023;

                function setVariables() {
                    viewport = updateViewportDimensions();
                    App.isMobile = (viewport.width <= App.mobileUpperBreakpoint);
                    App.isMobileAlt = (viewport.width <= App.mobileAltBreakpoint);
                    App.isTablet = (viewport.width > App.mobileUpperBreakpoint && viewport.width <= App.tabletUpperBreakpoint);
                    App.isTabletDown = (viewport.width <= App.tabletUpperBreakpoint);
                    App.isDesktop = (viewport.width > App.tabletUpperBreakpoint);
                    App.activeViewport = App.isMobile ? 'small' : App.isTablet ? 'med' : 'large';
                }

                setVariables();

                App.cachedViewport = App.isMobile ? 'small' : App.isTablet ? 'med' : 'large';
                App.isAnyArticle = !!(scmByClass('widget-ArticleFullView').length || scmByClass('pg_abstract').length
                    || scmByClass('widget-MagazineView').length || scmByClass('widget-ChannelsMagazineView').length);
                App.isSplitScreen = !!scmByClass('widget-ArticleFullView').length;
                App.isAbstract = !!scmByClass('pg_abstract').length;
                App.isMag = !!(scmByClass('widget-MagazineView').length);
                App.isChannel = !!(scmByClass('channel-site').length);
                App.isChannelMag = !!(scmByClass('widget-ChannelsMagazineView').length);
                App.isFreeArticle = !!(scmquery('.widget-ArticleTopInfo .free-access') ||
                                        scmquery('.widget-ArticleTopInfo .open-access') ||
                                        scmquery('.widget-ArticleTopInfo .icon-free') || 
                                        scmquery('.widget-ChannelsMagazineView .free-access'));
                App.isTollFreeAccess = false;
                App.isIssue = !!scmByClass('pg_issue').length || !!scmByClass('pg_newonline').length || !!scmByClass('pg_currentissue').length || !!scmByClass('pg_pastissues').length;
                App.isNewOnline = !!scmByClass('pg_newonline').length;
                App.isCurrentIssue = !!scmByClass('pg_currentissue').length;
                App.isPastIssues = !!scmByClass('pg_pastissues').length;
                App.isJournal = !!scmByClass('pg_journal').length;
                App.isNetworkHome = !!scmByClass('pg_index').length;
                App.isSearch = !!scmByClass('pg_searchresults').length;
                App.isAdvancedSearch = !!scmByClass('pg_advancedsearch').length;
                App.isPlayer= !!scmByClass('pg_multimediaplayer').length;
                App.isSelfServe = !!scmByClass('pg_sspage').length;
                App.isCmsPage = !!scmByClass('pg_cmspage').length; 
                App.isMyAccount = !!scmByClass('pg_myaccount').length;
                App.supportsFlexbox = !!scmByClass('flexbox').length;
                App.isCollection = !!scmByClass('pg_collection').length;
                App.isPaidUser = isTrueString(scmById('hfAppIsPaidUser').getAttribute('value'));
                App.isMember = isTrueString(scmById('hfAppIsMember').getAttribute('value'));
                App.isIndividual = isTrueString(scmById('hfAppIsIndividual').getAttribute('value'));
                App.hasAccess = isTrueString(scmById('hfAppHasAccess').getAttribute('value'));
                App.isReferredFromGoogle = isTrueString(scmById('hfAppIsReferredFromGoogle').getAttribute('value'));
                var subscribedTo = scmById('hfAppSubscribedTo').getAttribute('value');
                App.userSubscribedTo = subscribedTo ? subscribedTo.split(',') : undefined;
                App.isLucy = isTrueString(scmById('hfAppIsLucy').getAttribute('value'));
                App.currentJournalCount = 26;
                App.isChannelPage = !!(scmByClass('channels-page'));
                App.updateAppVariables = debounce(function () {
                    setVariables();
                }, 50, false);
            })(App);
        </script>
        

        
<div class="footer-ad-wrapper">
    <div id="BodyContent_Footer_divAds" class="footer-ad desktop-only">
        
            <div class="widget-WidgetLoader widget-instance-AMA_AdTag_AnchorboardAd_btf">
        
    <div class="SCM-SharedWidgets-AsyncAdLoader" data-url="/AMA/AdTag/AMA_AdTag_AnchorboardAd_btf" data-params="{&quot;parameters&quot;:{&quot;siteName&quot;:&quot;jama&quot;,&quot;siteId&quot;:3,&quot;journalId&quot;:67,&quot;adDisplay&quot;:11,&quot;adSection&quot;:&quot;scholarly&quot;,&quot;adPosition&quot;:&quot;btf&quot;,&quot;fromGoogle&quot;:false},&quot;dynamicParameters&quot;:{&quot;localParams&quot;:&quot;[REPLACE_WITH_LOCAL]&quot;}}"></div>
 
    </div>
</div>
</div>

 
 <div class="ad-riser-wrap desktop-only">
     <div class="ad-riser--dismiss t-c">X</div>
         <div class="widget-WidgetLoader widget-instance-AMA_AdTag_Riser">
        
    <div class="SCM-SharedWidgets-AsyncAdLoader" data-url="/AMA/AdTag/AMA_AdTag_Riser" data-params="{&quot;parameters&quot;:{&quot;siteName&quot;:&quot;jama&quot;,&quot;siteId&quot;:3,&quot;journalId&quot;:67,&quot;adDisplay&quot;:12,&quot;adSection&quot;:&quot;scholarly&quot;,&quot;adPosition&quot;:&quot;Riser&quot;,&quot;fromGoogle&quot;:false},&quot;dynamicParameters&quot;:{&quot;localParams&quot;:&quot;[REPLACE_WITH_LOCAL]&quot;}}"></div>
 
    </div>

 </div>


<div class="footer-wrap">
    
    <footer class="footer" id="footer">
        
        <div id="footer-microsite" class="footer-microsite">
            



    <input type="hidden" class="SelfServeContentId" value="v2_Footer_Left" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<style type="text/css">
    @media (min-width: 1024px) {.split-screen .footer-microsite-contents {border-bottom:0 !important;}}
    .footer-microsite-contents {margin-bottom:1em;width:100%;}
    .footer-network-other .link-apps:before {width: 23px;}
    .footer-network-other .link-institutions-librarians:before {width: 23px;}
    .jn-ss-footer-border-top {border-top:1px solid #555;padding-top:15px;}
    .jn-ss-footer-border-bottom {border-bottom:1px solid #555;padding-bottom:10px;padding-right:3px;}
</style>
<div class="footer-heading-wrap">
<h3 id="BodyContent_Footer_h3SiteName" class="footer-heading is-b footer-microsite-heading" data-mobile-tog-target=".footer-microsite-links-wrap">JAMA</h3>
</div>
<div class="footer-microsite-links-wrap">
<div class="footer-microsite-contents  jn-ss-footer-border-bottom">
<h4 id="BodyContent_Footer_ContentHeader" class="footer-subheading">Content</h4>
<a href="/journals/jama">Home</a>
<a href="/journals/jama/newonline">New Online</a>
<a href="/journals/jama/currentissue">Current Issue</a>
</div>
<div class="footer-microsite-contents  jn-ss-footer-border-bottom">
<h4 class="footer-subheading">Podcasts</h4>
<a href="/journals/jama/pages/covid-19-interviews#audio">Coronavirus (COVID-19)&nbsp;Q&amp;A</a>
<a href="/journals/jama/pages/jama-clinical-reviews">Clinical Reviews</a>
<a href="/journals/jama/pages/jama-editors-summary">Editors' Summary</a>
<a href="/journals/jama/pages/jama-medical-news">Medical News</a>
<a href="/journals/jama/pages/jama-author-interviews">Author Interviews</a>
<a href="/journals/jama/pages/jamaevidence-jama-guide-to-statistics-and-methods">JAMAevidence: <em>JAMA Guide to Statistics and Methods</em></a>
<a href="/journals/jama/pages/jamaevidence-the-rational-clinical-examination">JAMAevidence: The Rational Clinical Examination</a>
<a href="/journals/jama/pages/jamaevidence-users-guides-to-the-medical-literature">JAMAevidence: Users' Guides to the Medical Literature</a>
</div>
<div class="footer-microsite-services cf">
<h4 id="BodyContent_Footer_ServiceHeader" class="footer-subheading">Journal Information</h4>
<a href="/journals/jama/pages/for-authors">For Authors</a>
<a href="/journals/jama/pages/jama-editors">JAMA Editors</a>
<a href="/journals/jama/editors-and-publishers">Editors &amp; Publishers</a>
<a href="/pages/rss">RSS</a>
<a href="/journals/jama/pages/contact-us">Contact Us</a>
</div>
<div class="footer-network-other  jn-ss-footer-border-bottom">
<a href="https://edhub.ama-assn.org/jn-learning" class="link-network-other is-b link-learning">JN Learning / CME</a>
<a href="https://store.jamanetwork.com" class="link-network-other is-b link-store" target="_blank">Store</a>
<a href="/pages/apps" class="link-network-other is-b link-mobile" target="_blank">Apps</a>
<a href="https://careers.jamanetwork.com/" class="link-network-other is-b link-jobs" target="_blank">Jobs</a>
<a href="/pages/resources-for-librarians" class="link-network-other is-b link-institutions-librarians" target="_blank">Institutions</a>
<a href="/pages/reprints-and-permissions" class="link-network-other is-b link-reprints-permissions">Reprints &amp; Permissions</a>
</div>
<div id="BodyContent_Footer_divSubscribe" class="footer-microsite-subscribe">
<img src="//cdn.jamanetwork.com/UI/app/img/covers/jama.jpg" class="subscribe-image" alt="Journal Cover">
<div class="subscribe-meta">
<h4 class="subscribe-heading footer-subheading">Subscribe</h4>
<a href="https://store.jamanetwork.com/productDetails.aspx?productcodeID=64" class="subscribe-submit btn">Go</a>
</div>
</div>
</div>





        </div>

        
        <div id="footer-network" class="footer-network">
            



    <input type="hidden" class="SelfServeContentId" value="v2_Footer_Middle" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<style type="text/css">
    .footer-network-sites {width: 62.85542%;}
    .footer-network-info {width: 35.93976%}
    .jn-ss-subheading-mt {margin-top: 1.5em;}
    .jn-registered:after {content: "\00AE";font-size: 50%;vertical-align: top;}
    .jn-trademark:after {content: "\2122";font-size: 50%;vertical-align: top;}
</style>
<div class="footer-heading-wrap">
<h3 class="footer-heading is-b jn-registered" data-mobile-tog-target=".footer-network-links-wrap"><strong>JAMA</strong> Network</h3>
</div>
<div class="footer-network-links-wrap">
<div class="footer-network-sites">
<div class="internal">
<h4 id="BodyContent_Footer_JournalHeader" class="footer-subheading">Publications</h4>
<a href="/journals/jama">JAMA</a>
<a href="/journals/jamanetworkopen" target="_blank">JAMA Network Open</a>
<a href="/journals/jamacardiology">JAMA Cardiology</a>
<a href="/journals/jamadermatology">JAMA Dermatology</a>
<a href="/journals/jama-health-forum">JAMA Health Forum</a>
<a href="/journals/jamainternalmedicine">JAMA Internal Medicine</a>
<a href="/journals/jamaneurology">JAMA Neurology</a>
<a href="/journals/jamaoncology">JAMA Oncology</a>
<a href="/journals/jamaophthalmology">JAMA Ophthalmology</a>
<a href="/journals/jamaotolaryngology">JAMA Otolaryngology–Head &amp; Neck Surgery</a>
<a href="/journals/jamapediatrics">JAMA Pediatrics</a>
<a href="/journals/jamapsychiatry">JAMA Psychiatry</a>
<a href="/journals/jamasurgery">JAMA Surgery</a>
<a href="/journals/archneurpsyc">Archives of Neurology &amp; Psychiatry (1919-1959)</a>
</div>
<div class="external">
<h4 class="footer-subheading">Sites</h4>
<div id="BodyContent_Footer_ssFooterSiteMenu">
<div class="selfServe">
<a target="_blank" href="https://sites.jamanetwork.com/art-and-images-in-psychiatry/">Art and Images in Psychiatry</a>
<a target="_blank" href="/channels/ai">Artificial Intelligence (AI) Resource Center</a>
<a target="_blank" href="/journals/jama/pages/2023-most-viewed-jama">Best of the JAMA Network</a>
<a target="_blank" href="/channels/caring-for-the-critically-ill-patient">Caring for the Critically Ill Patient</a>
<a target="_blank" href="/journals/jama/pages/crosswords">Clinical Crosswords from JAMA</a>
<a target="_blank" href="/journals/jama/pages/coronavirus-alert">Coronavirus Resource Center</a>
<a target="_blank" href="https://ebm.jamanetwork.com/index.html">Evidence-Based Medicine: An Oral History</a>
<a target="_blank" href="/pages/fishbein-fellowship">Fishbein Fellowship</a>
<a target="_blank" href="/channels/genomics/">Genomics and Precision Health</a>
<a target="_blank" href="/channels/hypertension">Hypertension</a>
<a target="_blank" href="/channels/health-forum/archive">JAMA Forum Archive</a>
<a target="_blank" href="https://sites.jamanetwork.com/audio">JAMA Network Audio</a>
<a target="_blank" href="/pages/video">JAMA Network Video</a>
<a target="_blank" href="/pages/conferences">JAMA Network Conferences </a>
<a target="_blank" href="/pages/jama-summit">JAMA Summit </a>
<a target="_blank" href="/journals/jamasurgery/pages/statistics-and-methods">JAMA Surgery Guide to Statistics and Methods</a>
<a target="_blank" href="/channels/medical-news">Medical News</a>
<a target="_blank" href="/channels/monkeypox">Mpox (Monkeypox)</a>
<a target="_blank" href="https://sites.jamanetwork.com/research-ethics/">Research Ethics</a>
<a target="_blank" href="/pages/collections">Topics and Collections</a>
<a target="_blank" href="/pages/visual-abstracts">Visual Abstracts</a>
<a target="_blank" href="/channels/war">War and Health</a>
<a target="_blank" href="/channels/womens-health">Women's Health</a>
<h4 class="footer-subheading jn-ss-subheading-mt">Featured Articles</h4>
<a href="/journals/jama/fullarticle/2799240">Antiretroviral Drugs for HIV Treatment and Prevention in Adults - 2022 IAS-USA Recommendations</a>
<a href="/journals/jama/fullarticle/2781397">CONSERVE 2021 Guidelines for Reporting Trials Modified for the COVID-19 Pandemic</a>
<a href="/journals/jama/fullarticle/2808296">Creation and Adoption of Large Language Models in&nbsp;Medicine</a>
<a href="/journals/jamaoncology/fullarticle/2787350">Global Burden of Cancer, 2010-2019</a>
<a href="/journals/jama/fullarticle/2797443">Global Burden of Long COVID</a>
<a href="/journals/jamadermatology/fullarticle/2790344">Global Burden of Melanoma</a>
<a href="/journals/jamadermatology/fullarticle/2787350">Global Burden of Skin Diseases, 1990-2017</a>
<a href="/journals/jamaneurology/fullarticle/2793874">Global Disparities in Parkinson Disease</a>
<a href="/journals/jama/fullarticle/2799547">Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension</a>
<a href="/journals/jamapsychiatry/fullarticle/2799486">Mass Violence and the Complex Spectrum of Mental Illness and Mental Functioning</a>
<a href="/journals/jamapsychiatry/fullarticle/2793903">Neuropsychiatry Sequelae of COVID-19</a>
<a href="/journals/jamaneurology/fullarticle/2810313">A New Framework for Dementia Nomenclature</a>
<a href="/journals/jama/fullarticle/2800656">Organization and Performance of US Health Systems</a>
<a href="/journals/jama-health-forum/fullarticle/2791195">Pharmacy Benefit Managers: History, Business Practices, Economics, and Policy</a>
<a href="/journals/jama-health-forum/fullarticle/2791195">Promoting EDI in Genetics Research</a>
<a href="/journals/jamacardiology/fullarticle/2781972">PTSD and Cardiovascular Disease</a>
<a href="/journals/jama/fullarticle/2810754">Red Blood Cell Transfusion: 2023 AABB International Guidelines</a>
<a href="/journals/jamapediatrics/fullarticle/2797600">Reimagining Children’s Rights in the US</a>
<a href="/journals/jama/fullarticle/2794049">Spirituality in Serious Illness and Health</a>
<a href="/journals/jama/fullarticle/2796374">The US Medicaid Program: Coverage, Financing, Reforms, and Implications for Health Equity</a>
<h4 class="footer-subheading jn-ss-subheading-mt">USPSTF Recommendation Statements</h4>
<a href="/journals/jama/fullarticle/2779985">Screening for Colorectal Cancer</a>
<a href="/journals/jama/fullarticle/2779190">Screening for Hypertension</a>
<a href="/journals/jama/fullarticle/2777244">Screening for Lung Cancer</a>
<a href="/journals/jama/fullarticle/2796244">Screening for Prediabetes and Type 2 Diabetes In Children</a>
<a href="/journals/jama/fullarticle/2783414">Screening for Prediabetes and Type 2 Diabetes In Adults</a>
<a href="/journals/jama/fullarticle/2795521">Statins for Primary Prevention of Cardiovascular Disease</a>
<a href="/journals/jama/fullarticle/2793446">Vitamin and Mineral Supplements for Primary Prevention of of Cardiovascular Disease and Cancer</a>
<h4 class="footer-subheading jn-ss-subheading-mt">Blogs</h4>
<a target="_blank" href="https://amastyleinsider.com/">AMA Style Insider</a>
</div>
</div>
</div>
</div>
<div id="footer-network-info" class="footer-network-info">
<div class="information-for-links">
<h4 id="BodyContent_Footer_InfoHeader" class="footer-subheading">Information</h4>
<a href="/pages/for-authors">For Authors</a>
<a href="/pages/resources-for-librarians">For Institutions &amp; Librarians</a>
<a href="/pages/advertisers">For Advertisers</a>
<a href="/pages/subscription-agents">For Subscription Agents</a>
<a href="https://careers.jamanetwork.com/" target="_blank">For Employers &amp; Job Seekers</a>
<a href="https://media.jamanetwork.com" rel="nofollow" target="_blank">For the Media</a>
<a href="/pages/equity-diversity-inclusion">Equity, Diversity, Inclusion</a>
<a href="/pages/commenting-policy">Online Commenting Policy</a>
<a href="/pages/access-at-jama-network">Public Access and Open Access Policy</a>
<a href="/pages/offensive-content-statement">Statement on Potentially Offensive Content</a>
</div>
<div class="services-links">
<h4 id="BodyContent_Footer_JAMANetworkProductsHeader" class="footer-subheading">JAMA Network Products</h4>
<a href="http://www.amamanualofstyle.com/" class="footer-service-link" target="_blank">AMA Manual of Style</a>
<a href="https://jamaevidence.mhmedical.com/" class="footer-service-link" target="_blank"><span class="jn-registered">JAMAevidence</span></a>
<a href="http://www.peerreviewcongress.org/" class="footer-service-link" target="_blank">Peer Review Congress</a>
</div>
<div class="learning-links">
<h4 id="BodyContent_Footer_LearningHeader" class="footer-subheading">JN Learning</h4>
<a href="https://edhub.ama-assn.org/jn-learning">Home</a>
<a href="https://edhub.ama-assn.org/jn-learning/state-cme">State CME</a>
<a href="https://edhub.ama-assn.org/jn-learning/pages/clinical-challenge-courses">Clinical Challenge CME</a>
<a href="https://edhub.ama-assn.org/jn-learning/course/288 ">Atrial Fibrillation Course</a>
<a href="https://edhub.ama-assn.org/jn-learning/course/294 ">Women's Health Course</a>
<a target="_blank" href="https://edhub.ama-assn.org/pages/auto-credit-reporting">CME / MOC Reporting Preferences</a>
<a href="https://edhub.ama-assn.org/jn-learning/pages/about-cme">About CME &amp; MOC</a>
</div>
</div>
</div>





        </div>
        
        <div id="footer-resources-wrap" class="footer-resources-wrap">
            



    <input type="hidden" class="SelfServeContentId" value="v2_Footer_Right" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<style type="text/css">
    .footer-resources-wrap .footer-subheading {color: grey;display:block !important;font-size: 1.17647em;font-weight: 400;text-transform: uppercase;}
</style>
<div class="footer-heading-wrap">
<h3 class="footer-heading is-b footer-resources-heading" data-mobile-tog-target=".footer-resources">Help</h3>
</div>
<div class="footer-resources">
<a href="https://store.jamanetwork.com" class="footer-service-link" target="_blank">Subscriptions &amp; Renewals</a>
<a href="https://jamanetwork.com/oauthsignin?return_url=http%3A%2F%2Fjamanetwork.com%2Fmyaccount%23my-alerts" class="footer-service-link" rel="nofollow">Manage Emails</a>
<a href="https://jamanetwork.com/oauthsignin?return_url=http%3A%2F%2Fjamanetwork.com%2Fmyaccount%23my-profile" class="footer-service-link" rel="nofollow">Update My Address</a>
<a href="https://support.jamanetwork.com/hc/en-us" class="footer-service-link">Support Center</a>
<a href="/myaccount " class="footer-service-link">My Account</a>
<h4 class="footer-subheading jn-ss-subheading-mt">JAMA Career Center</h4>
<a href="https://careers.jamanetwork.com/" class="footer-service-link" target="_blank">Physician Job Listings</a>
</div>








    <input type="hidden" class="SelfServeContentId" value="v2_Footer_Socials" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<style type="text/css">
    .widget-instance-AMA_Journal_Home_Socials .iconsocial {display: inline-block !important;width: 34px;height: 34px;min-width: unset !important;margin: 0 2px !important;background-color: #fff;border-radius: 20px;border: 1px solid #191919;vertical-align: middle;}
    .widget-instance-AMA_Journal_Home_Socials .iconsocial.instagram {background-image: url(https://cdn.jamanetwork.com/ImageLibrary/JamaNetwork/social/instagram-icon-black.svg);background-position: 7px 7px;background-repeat: no-repeat;background-size: 18px;}
    .widget-instance-AMA_Journal_Home_Socials .iconsocial.instagram:hover, .widget-instance-AMA_Journal_Home_Socials .iconsocial.instagram:focus {background-image: url(https://cdn.jamanetwork.com/ImageLibrary/JamaNetwork/social/instagram-icon-fill.png);border-color: #C13584;}
    .footer-resources-wrap .iconsocial {display: inline-block !important;width: 32px;height: 32px;min-width: unset !important;margin: 0 2px 0 3px !important;background-color: #fff;border-radius: 20px;border: 1px solid #191919;vertical-align: middle;}
    .footer-resources-wrap .iconsocial.instagram {background-image: url(https://cdn.jamanetwork.com/ImageLibrary/JamaNetwork/social/instagram-icon-black.svg);background-position: 6px 6px;background-repeat: no-repeat;background-size: 18px;}
    .footer-resources-wrap .iconsocial.instagram:hover, .footer-resources-wrap .iconsocial.instagram:focus {background-color: #C13584;border-color: #191919;}
    #load-instagram-image { background: url(https://cdn.jamanetwork.com/ImageLibrary/JamaNetwork/social/instagram-icon-fill.png) no-repeat -9999px -9999px; }
</style>
<div id="BodyContent_Footer_divSocial" class="social-links footer-social-links">
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://www.facebook.com/JAMAJournal/" class="social-link is-b facebook"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://twitter.com/JAMA_current" class="social-link is-b twitter"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://www.instagram.com/jamanetwork/?hl=en" class="iconsocial instagram"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://www.linkedin.com/company/jamanetwork/" class="social-link is-b linked-in"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://www.youtube.com/jamanetwork" class="social-link is-b you-tube"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://www.pinterest.com/jamanetwork/" class="social-link is-b pinterest"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="/rss/site_3/67.xml" class="social-link is-b rss"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://jamanetwork.com/journals/jama/pages/jama-editors-summary" class="social-link is-b podcast"></a>
<div id="load-instagram-image">&nbsp;</div>
</div>




<div id="BodyContent_Footer_divEmailUpdate" class="footer-email-updates">
                
                    <div class="widget-EmailListSignUp widget-instance-AMAv2_EmailListSignUp_Footer">
        <div class="email-signup">
    
    <div class="email-signup--text sb-pc">Get the latest from JAMA</div>
    <div class="email-signup--input-wrap is-b">
        <input type="text" name="email" class="email-signup--input" placeholder="Email address" title="Email address" />
        <a rel="nofollow" href="javascript:;" class="email-signup--submit sb-sc btn">Sign Up</a>
    </div>
    <div class="email-signup--link"> <a class="email-signup--privacy" href="/pages/privacy-policy">Privacy Policy</a> | <a class="email-signup--terms" href="/pages/terms-of-use">Terms of Use</a></div>
    <div class="email-signup--user-message"></div>
</div> 
    </div>
</div>
        </div>

        
        <div class="footer-bar" itemscope itemtype="https://schema.org/Organization">
            



    <input type="hidden" class="SelfServeContentId" value="v2_Footer_Bottom_Bar" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<style type="text/css">
    .nav-journals a.theme-jama-health-forum:before {background: #133763;}
    .jn-bottom-bar {color: #fff; float: left;font-size: 10px;padding: 13px 20px;width: 33.33%;}
    .jn-bottom-bar p {line-height: 2;}
    @media (max-width: 900px) {.jn-bottom-bar {float: none;width: 100%;}}
    .jn-footer-copyright {font-size:12px;line-height:1.5;margin-bottom:10px;}
    .jn-footer-pipe {margin:0 10px;}
    .footer-bar-jn-logo img {width: 230px;}
    @media (max-width: 900px) {.footer-bar-jn-logo img {width: 200px;}}
    [data-thm=umb] .jobs-ad--text h6 {color: #d71635 !important;}
    [data-thm=jama] .jobs-ad--text h6 {color: #d71635 !important;}
    [data-thm=jaman] .jobs-ad--text h6 {color: #ed0973 !important;}
    [data-thm=cardi] .jobs-ad--text h6 {color: #be1e32 !important;}
    [data-thm=derm] .jobs-ad--text h6 {color: #006f3b !important;}
    [data-thm=faci] .jobs-ad--text h6 {color: #ed1c24 !important;}
    [data-thm=jama-] .jobs-ad--text h6 {color: #fb5252 !important;}
    [data-thm=intem] .jobs-ad--text h6 {color: #006e96 !important;}
    [data-thm=neur] .jobs-ad--text h6 {color: #981b1e !important;}
    [data-thm=oncol] .jobs-ad--text h6 {color: #3b923f !important;}
    [data-thm=ophth] .jobs-ad--text h6 {color: #66bc29 !important;}
    [data-thm=otol] .jobs-ad--text h6 {color: #34b6e4 !important;}
    [data-thm=peds] .jobs-ad--text h6 {color: #0084c0 !important;}
    [data-thm=psych] .jobs-ad--text h6 {color: #005276 !important;}
    [data-thm=surg] .jobs-ad--text h6 {color: #f47920 !important;}
    .blockquote .para {margin: 0 0 1em 1em;}
    .jn-footer-copyright {display: block;}
    .inline-block {display: inline-block;}
    #selfserve-maintenance {display:block;margin:20px 0;max-height:none !important;min-height:200px;visibility:visible;}
</style>
<a class="footer-bar-jn-logo d-b no-mw mb1" href="/" title="JAMA Network Home"><img class="mw-100" src="https://cdn.jamanetwork.com/ImageLibrary/global/jn-signature-reversed-r.svg?versionId=81373" alt="Jama Network Logo"></a>
<div class="jn-bottom-bar">
<p>
<span class="jn-footer-copyright">© 2024 American Medical Association. <span class="inline-block">All rights reserved,</span> including those for text and data mining, AI training, <span class="inline-block">and similar technologies.</span></span>
<span class="inline-block"><a href="https://www.ama-assn.org/about/terms-use" rel="nofollow" class="p0">Terms of Use</a><span class="jn-footer-pipe">|</span></span>
<span class="inline-block"><a href="https://www.ama-assn.org/about/privacy-policy" rel="nofollow" class="p0">Privacy Policy</a><span class="jn-footer-pipe">|</span></span>
<span class="inline-block"><a href="https://www.ama-assn.org/about/accessibility-statement" rel="nofollow" class="p0">Accessibility Statement</a><span class="jn-footer-pipe">|</span></span>
<span class="inline-block"><a onclick="OneTrust.ToggleInfoDisplay()" rel="nofollow" class="p0" id="CookieFooter">Cookie Settings</a></span>
</p>
</div>
<!-- 
	#selfserve-maintenance {display:block;margin:20px 0;max-height:none !important;min-height:200px;visibility:visible;}
	-->





            <a class="footer-bar-sis no-mw relative nudge-down" href="https://www.silverchair.com" target="_blank"><img class="footer-bar-sis-img mt05 mw-100" width="600" height="70" src="//cdn.jamanetwork.com/UI/app/img/powered.png" alt="Silverchair Logo" /></a>
        </div>
    </footer>

</div>
<div class="ss-ui-only">
        <div class="widget-SelfServeContent widget-instance-AMA_SS_UI_Only">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SsUiOnly" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

.


</div>

 
    </div>

</div>

    </section>


        

        
        
        <div id="revealModal" class="reveal-modal" data-reveal>
            <div id="revealContent"></div>
            <a class="close-reveal-modal icon-close"></a>
        </div>

        
        <div class="artmet-modal" id="MetricsModal">
            <div class="artmet-modal-contents">
                <a class="artmet-close-modal">&#215;</a>
            </div>
        </div>

        
        
    


            <div class="widget-SigninModals widget-instance-AMA_SigninModals">
        <div class="js-modal-no-access-reveal no-access reveal-modal modal tiny" data-reveal>
    <div class="modal--box">
        <div class="modal--title">Access your subscriptions</div>
        <hr />
                <button type="button" role="button" class="modal--btn js-btn-signin-personal" data-oauth-signin-url="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2783414">
            Sign in<span class="fw-normal"> | personal account</span>
        </button>

            <div class="widget-AmaAdvancedSeamlessAccess widget-instance-AMA_NoAccess_AdvancedSeamlessAccessButton">
        <div class="seamless-access-button--wrap">
    <button class="d-flex sa-button align-items-center" role="button" type="button">
        <div class="sa-button-logo-wrap">
            <img src="//cdn.jamanetwork.com/UI/app/svg/seamless-access.svg" class="sa-button-logo" alt="Seamless Access Logo" />
        </div>
        <div class="d-flex justify-content-center align-items-center sa-button-text text-truncate">
            <div class="sa-button-text-primary text-truncate">Access through your institution</div>
        </div>
    </button>
    <div class="sa-access-text text-truncate hide">
        <div class="sa-cta-access"><span>Add or change institution</span></div>
    </div>
</div>
 
    </div>

    <div class="widget-SelfServeContent widget-instance-AMA_NoAccess_SigninModal_CreateAccount">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_CreateAccount" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Free access to newly published articles</div>
<hr>
<button class="modal--btn js-btn-create-personal-account" type="button" role="button">
<div class="text-truncate">Create a free personal account</div>
</button>
<div class="modal--btn-desc">To register for email alerts, access free PDF, and more</div>
<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_CreateAccount</div>-->


</div>

 
    </div>
            <div class="widget-SelfServeContent widget-instance-AMA_NoAccess_SigninModal_PurchaseOptions_NoAccessAndPaidPDF">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_PurchaseOptions_NoAccessAndPaidPDF" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Purchase access</div>
<hr>
<button class="modal--btn js-btn-subscribe-journal" type="button" role="button">
<div class="text-truncate">Subscribe to journal</div>
</button>
<div class="modal--btn-desc">Get full journal access for 1 year</div>
<button class="modal--btn js-btn-purchase-article" type="button" role="button">
<div class="text-truncate">Buy article</div>
</button>
<div class="modal--btn-desc">Get unlimited access and a printable PDF ($40.00)—<br>
<em>Sign in or create a free account</em></div>
<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_PurchaseOptions_NoAccessAndPaidPDF</div>-->


</div>

 
    </div>

            <div class="widget-DeepDyve widget-instance-AMA_NoAccess_DeepDyve">
                <button type="button" role="button" class="modal--btn js-deepdyve-link hiddenRentalLink" data-deepdyveurl="https://www.deepdyve.com/doc-view?docId=10.1001/jama.2021.12531&amp;fieldName=journal_doi&amp;affiliateId=JAMA" data-doi="10.1001/jama.2021.12531" data-fieldname="journal_doi" 
                data-issneissn="0098-7484" data-affiliate="JAMA">Rent article</button>
        <div class="modal--btn-desc js-deepdyve-desc hiddenRentalLink">Rent this article from DeepDyve</div>
 
    </div>

    </div>
        <a class="close-reveal-modal icon-close"></a>

</div>

<div class="js-modal-paid-pdf-reveal no-access reveal-modal modal tiny" data-reveal>
    <div class="modal--box">
        <div class="modal--title">Access your subscriptions</div>
        <hr />
                <button type="button" role="button" class="modal--btn js-btn-signin-personal" data-oauth-signin-url="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2783414">
            Sign in<span class="fw-normal"> | personal account</span>
        </button>

            <div class="widget-AmaAdvancedSeamlessAccess widget-instance-AMA_PaidPdf_AdvancedSeamlessAccessButton">
        <div class="seamless-access-button--wrap">
    <button class="d-flex sa-button align-items-center" role="button" type="button">
        <div class="sa-button-logo-wrap">
            <img src="//cdn.jamanetwork.com/UI/app/svg/seamless-access.svg" class="sa-button-logo" alt="Seamless Access Logo" />
        </div>
        <div class="d-flex justify-content-center align-items-center sa-button-text text-truncate">
            <div class="sa-button-text-primary text-truncate">Access through your institution</div>
        </div>
    </button>
    <div class="sa-access-text text-truncate hide">
        <div class="sa-cta-access"><span>Add or change institution</span></div>
    </div>
</div>
 
    </div>

    <div class="widget-SelfServeContent widget-instance-AMA_PaidPdf_SigninModal_CreateAccount">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_CreateAccount" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Free access to newly published articles</div>
<hr>
<button class="modal--btn js-btn-create-personal-account" type="button" role="button">
<div class="text-truncate">Create a free personal account</div>
</button>
<div class="modal--btn-desc">To register for email alerts, access free PDF, and more</div>
<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_CreateAccount</div>-->


</div>

 
    </div>
            <div class="widget-SelfServeContent widget-instance-AMA_PaidPdf_SigninModal_PurchaseOptions_NoAccessAndPaidPDF">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_PurchaseOptions_NoAccessAndPaidPDF" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Purchase access</div>
<hr>
<button class="modal--btn js-btn-subscribe-journal" type="button" role="button">
<div class="text-truncate">Subscribe to journal</div>
</button>
<div class="modal--btn-desc">Get full journal access for 1 year</div>
<button class="modal--btn js-btn-purchase-article" type="button" role="button">
<div class="text-truncate">Buy article</div>
</button>
<div class="modal--btn-desc">Get unlimited access and a printable PDF ($40.00)—<br>
<em>Sign in or create a free account</em></div>
<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_PurchaseOptions_NoAccessAndPaidPDF</div>-->


</div>

 
    </div>

            <div class="widget-DeepDyve widget-instance-AMA_PaidPDF_DeepDyve">
                <button type="button" role="button" class="modal--btn js-deepdyve-link hiddenRentalLink" data-deepdyveurl="https://www.deepdyve.com/doc-view?docId=10.1001/jama.2021.12531&amp;fieldName=journal_doi&amp;affiliateId=JAMA" data-doi="10.1001/jama.2021.12531" data-fieldname="journal_doi" 
                data-issneissn="0098-7484" data-affiliate="JAMA">Rent article</button>
        <div class="modal--btn-desc js-deepdyve-desc hiddenRentalLink">Rent this article from DeepDyve</div>
 
    </div>

    </div>
        <a class="close-reveal-modal icon-close"></a>

</div>

<div class="js-modal-free-pdf-reveal no-access reveal-modal modal tiny" data-reveal>
    <div class="modal--box">
        <div class="modal--title">Sign in to access free PDF</div>
        <hr />
                <button type="button" role="button" class="modal--btn js-btn-signin-personal" data-oauth-signin-url="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2783414">
            Sign in<span class="fw-normal"> | personal account</span>
        </button>

            <div class="widget-AmaAdvancedSeamlessAccess widget-instance-AMA_FreePdf_AdvancedSeamlessAccessButton">
        <div class="seamless-access-button--wrap">
    <button class="d-flex sa-button align-items-center" role="button" type="button">
        <div class="sa-button-logo-wrap">
            <img src="//cdn.jamanetwork.com/UI/app/svg/seamless-access.svg" class="sa-button-logo" alt="Seamless Access Logo" />
        </div>
        <div class="d-flex justify-content-center align-items-center sa-button-text text-truncate">
            <div class="sa-button-text-primary text-truncate">Access through your institution</div>
        </div>
    </button>
    <div class="sa-access-text text-truncate hide">
        <div class="sa-cta-access"><span>Add or change institution</span></div>
    </div>
</div>
 
    </div>

    <div class="widget-SelfServeContent widget-instance-AMA_FreePdf_SigninModal_CreateAccount">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_CreateAccount" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Free access to newly published articles</div>
<hr>
<button class="modal--btn js-btn-create-personal-account" type="button" role="button">
<div class="text-truncate">Create a free personal account</div>
</button>
<div class="modal--btn-desc">To register for email alerts, access free PDF, and more</div>
<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_CreateAccount</div>-->


</div>

 
    </div>
    </div>
        <a class="close-reveal-modal icon-close"></a>

</div>

<div class="js-modal-save-search-reveal no-access reveal-modal modal tiny" data-reveal>
    <div class="modal--box">
        <div class="modal--title">Save your search</div>
        <hr />
                <button type="button" role="button" class="modal--btn js-btn-signin-personal" data-oauth-signin-url="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2783414">
            Sign in<span class="fw-normal"> | personal account</span>
        </button>

    <div class="widget-SelfServeContent widget-instance-AMA_SaveSearch_SigninModal_CreateAccount">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_CreateAccount" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Free access to newly published articles</div>
<hr>
<button class="modal--btn js-btn-create-personal-account" type="button" role="button">
<div class="text-truncate">Create a free personal account</div>
</button>
<div class="modal--btn-desc">To register for email alerts, access free PDF, and more</div>
<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_CreateAccount</div>-->


</div>

 
    </div>
            <div class="widget-SelfServeContent widget-instance-AMA_SigninModal_PurchaseOptions_SaveSearch">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_PurchaseOptions_SaveSearch" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Purchase access</div>
		<hr />
		<button class="modal--btn js-btn-subscribe-now">Subscribe now</button>
		<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_PurchaseOptions_SaveSearch</div>-->


</div>

 
    </div>

    </div>
        <a class="close-reveal-modal icon-close"></a>

</div>

<div class="js-modal-follow-collection-reveal no-access reveal-modal modal tiny" data-reveal>
    <div class="modal--box">
        <div class="modal--title">Customize your interests</div>
        <hr />
                <button type="button" role="button" class="modal--btn js-btn-signin-personal" data-oauth-signin-url="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2783414">
            Sign in<span class="fw-normal"> | personal account</span>
        </button>

    <div class="widget-SelfServeContent widget-instance-AMA_FollowCollection_SigninModal_CreateAccount">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_CreateAccount" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Free access to newly published articles</div>
<hr>
<button class="modal--btn js-btn-create-personal-account" type="button" role="button">
<div class="text-truncate">Create a free personal account</div>
</button>
<div class="modal--btn-desc">To register for email alerts, access free PDF, and more</div>
<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_CreateAccount</div>-->


</div>

 
    </div>
            <div class="widget-SelfServeContent widget-instance-AMA_SigninModal_PurchaseOptions_FollowCollection">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_PurchaseOptions_FollowCollection" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--sub-title">Create a personal account or sign in to:</div>
		<ul>
			<li>Register for email alerts with links to free full-text articles</li>
			<li>Access PDFs of free articles</li>
			<li>Manage your interests</li>
			<li>Save searches and receive search alerts</li>
		<ul>
		<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_PurchaseOptions_FollowCollection</div>-->


</div>

 
    </div>

            <div class="modal--link-wrap">
        <a class="modal--link" href="/pages/privacy-policy" rel="nofollow">Privacy Policy</a>
    </div>

    </div>
        <a class="close-reveal-modal icon-close"></a>

</div>

<div class="js-modal-user-comment-reveal no-access reveal-modal modal tiny" data-reveal>
    <div class="modal--box">
        <div class="modal--title">Make a comment</div>
        <hr />
                <button type="button" role="button" class="modal--btn js-btn-signin-personal" data-oauth-signin-url="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f2783414">
            Sign in<span class="fw-normal"> | personal account</span>
        </button>

    <div class="widget-SelfServeContent widget-instance-AMA_UserComment_SigninModal_CreateAccount">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_CreateAccount" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--title">Free access to newly published articles</div>
<hr>
<button class="modal--btn js-btn-create-personal-account" type="button" role="button">
<div class="text-truncate">Create a free personal account</div>
</button>
<div class="modal--btn-desc">To register for email alerts, access free PDF, and more</div>
<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_CreateAccount</div>-->


</div>

 
    </div>
            <div class="widget-SelfServeContent widget-instance-AMA_SigninModal_PurchaseOptions_UserComment">
        


<div class="self-serve">
    <input type="hidden" class="SelfServeContentId" value="SigninModal_PurchaseOptions_UserComment" />
    <input type="hidden" class="SelfServeVersionId" value="0" />

<div class="modal--sub-title">Create a personal account or sign in to:</div>
		<ul>
			<li>Register for email alerts with links to free full-text articles</li>
			<li>Access PDFs of free articles</li>
			<li>Manage your interests</li>
			<li>Save searches and receive search alerts</li>
		<ul>
		<!--<div class="jn-selfServe-modal-label">JAMA|SigninModal_PurchaseOptions_UserComment</div>-->


</div>

 
    </div>

            <div class="modal--link-wrap">
        <a class="modal--link" href="/pages/privacy-policy" rel="nofollow">Privacy Policy</a>
    </div>

    </div>
        <a class="close-reveal-modal icon-close"></a>

</div>

<div class="hidden-true js-modal-page-data"
     data-store-url="https://store.jamanetwork.com"
     data-store-purchase-url="https://jamanetwork.com/oauthsignin?return_url=https://store.jamanetwork.com"
     data-store-subscribe-url="https://store.jamanetwork.com/index.aspx?productcode=64">
</div>






 
    </div>

        

        
        <script src="//cdn.jamanetwork.com/UI/app/vendor/jquery-2.2.4.min.js?v=638473295270790799"></script>
        <script>window.jQuery || document.write('<script src="/UI/app/vendor/jquery-2.2.4.min.js">\x3C/script>')</script>

        <script src="//cdn.jamanetwork.com/UI/app/dist/app.min.js?v=638488852374030681"></script>
        
    
    
    <script src="//cdn.jsdelivr.net/chartist.js/latest/chartist.min.js" type="text/javascript"></script>

    
    
        <script src="//d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script>
    
    <script defer src='//js.trendmd.com/trendmd.min.js' data-trendmdconfig='{"element":"#trendmd-suggestions"}'></script>
        <script type='text/javascript' src='https://platform-api.sharethis.com/js/sharethis.js#property=643701de45aa460012e1032e&amp;product=sop' async='async'></script>


    <script>
        var App = App || {};
        App.showCmePromo = false;
    </script>


    </form>
    

    
    
    <link rel="stylesheet" href="//cdn.jamanetwork.com/UI/app/scss/modules/_trendMD.css">
</body>
</html>

 contentType 9 text/html url 61 https://jamanetwork.com:443/journals/jama/fullarticle/2783414 responseCode 3 200 